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 In mammalian cells, DNA polymerase θ (POLQ) is an unusual specialized DNA 
polymerase whose in vivo function is under active investigation. The protein is comprised of 
an N-terminal helicase-like domain, a C-terminal DNA polymerase domain, and a large 
central domain that spans between the two. This arrangement is also found in the 
Drosophila Mus308 protein, which helps confer resistance to DNA interstrand crosslinking 
agents. Homologs of POLQ and Mus308 are found in eukaryotes, including plants, but a 
comparison of phenotypes suggests that not all of these genes are functional orthologs. 
Flies with defective Mus308 are sensitive to DNA interstrand crosslinking agents, while 
mammalian cells with defective POLQ are primarily sensitive to DNA double-strand breaking 
agents. Cells from Polq-null mice are hypersensitive to radiation and the peripheral blood 
cells of these mice display increased spontaneous and ionizing radiation-induced levels of 
micronuclei (a hallmark of gross chromosomal aberrations), though the mice apparently 
develop normally. 
 Although a defect in the DNA polymerase POLQ leads to ionizing radiation sensitivity 
in mammalian cells, the relevant enzymatic pathway has not been identified. Here we define 
the specific mechanism by which POLQ restricts harmful DNA instability. Our experiments 
show that Polq-null murine cells are selectively hypersensitive to DNA strand-breaking 
agents, and that damage resistance requires the DNA polymerase activity of POLQ. Using a 
DNA break end joining assay in cells, the repair of DNA ends with long 3′ single-stranded 
overhangs was monitored. End joining events that retained much of the overhang were 
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dependent on POLQ, and independent of Ku70. To analyze this repair function in more 
detail, immunoglobulin class switch joining between DNA segments in antibody genes was 
examined. POLQ participates in the end joining of a DNA break during immunoglobulin 
class-switching, producing insertions of base pairs at the joins with homology to IgH switch-
region sequences. Biochemical experiments with purified human POLQ protein revealed the 
mechanism generating the insertions during DNA end joining, relying on the unique ability of 
POLQ to extend DNA from minimally paired primers.  
 DNA breaks at the IgH locus can sometimes join with breaks in Myc, creating a 
chromosome translocation. A marked increase in Myc/IgH translocations was observed in 
Polq-defective mice, showing that POLQ suppresses genomic instability and genome 
rearrangements originating at DNA double-strand breaks. This work clearly defines a role 
and mechanism for mammalian POLQ in an alternative end joining pathway (termed 
synthesis-dependent end joining) that suppresses the formation of chromosomal 
translocations. Our findings depart from the prevailing view that alternative end joining 
processes are generically translocation-prone.  
 Class switch and junction analysis was also performed in mice lacking POLN, 
another DNA polymerase related to POLQ. I observed that POLN does not operate in the 
same alternative end joining pathway as does POLQ. Loss of Poln does not enhance the 
DNA damage hypersensitivity seen in cells lacking Polq.  These findings suggest that while 
these two polymerases are structurally related they appear to have distinct functions in the 
cell. Analysis of the Poln phenotype is still ongoing. Further analysis of POLN and POLQ is 
required to clarify the mechanism by which they function in the cell.   
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Chapter 1:  DNA polymerase POLQ and cellular defense against DNA damage 
Note this chapter is based on: Yousefzadeh, M.J., and Wood, R.D. (2013). DNA polymerase 
POLQ and cellular defense against DNA damage. DNA Repair 12, 1-9. With permission 
from the copyright holder. 
1.1 Introduction 
The functions of the 16 known mammalian DNA polymerases are currently being 
explored (Garcia-Gomez et al., 2013; Hubscher et al., 2002; Lange et al., 2011). DNA 
polymerases (pols) play pivotal roles not only in DNA replication (pols α, δ, ε), but also in 
base excision repair (pol β), mitochondrial replication and repair (pol γ), non-homologous 
end-joining and immunological diversity (pols λ, µ, and terminal-deoxynucleotidyl 
transferase), and DNA damage tolerance including translesion synthesis (η, κ, ζ, Rev1). 
Some DNA polymerases have roles in more than one pathway of DNA processing. 
Identification of mammalian POLQ initially arose from interest in the Mus308 gene 
product of the fruit fly Drosophila melanogaster. Mus308 mutants are hypersensitive to 
agents that cause DNA interstrand cross-links (ICL), with only modest sensitivity to 
monofunctional alkylating agents (Aguirrezabalaga et al., 1995; Harris et al., 1996). This 
suggested that Mus308 might play a specific role in repair of ICLs in DNA. Characterization 
of the Mus308 gene showed that it encodes an unusual domain configuration, with the C-
terminal part of the protein encoding a DNA polymerase, and the N-terminal part of the 
protein encoding a DNA helicase (Harris et al., 1996) (Figure 1). 
A cDNA encoding the DNA polymerase domain of a homologous enzyme, 
designated DNA polymerase θ (POLQ), was identified by Sharief et al. (Sharief et al., 1999). 
The predicted protein of 1762 amino acids did not include a helicase-like domain, and is 
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now recognized to correspond to the C-terminal portion of full-length POLQ. Independently, 
Abbas and Linn assembled a larger 9.1 kb cDNA encoding both polymerase and helicase 
domains and predicted it to encode a protein of 2724 amino acids (Abbas, 2000). Seki et al. 
independently isolated the first complete and functional POLQ cDNA, showing that it 
encodes a 2590 amino acid protein with both a DNA polymerase and helicase-like domain 
(Seki et al., 2003). An orthologous mouse POLQ of 2544 amino acids was predicted from 
the genomic sequence by Shima et al. (Shima et al., 2003). 
 
 
Figure 1. Structural comparison and related grouping of POLQ gene family members. 
The boundaries of the conserved domains and core catalytic domains of the helicase-like 
(yellow/orange) and polymerase (purple/blue) domains are noted in color and determined 
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through the Conserved Domain Database (Marchler-Bauer et al., 2011). Numbers above the 
proteins indicate amino acid positions. Percentages indicating the individual % similarity 
between the helicase-like and polymerase domains of POLQ were generated in MacVector. 
 
The polymerase domains of POLQ and Mus308 belong to the “A” family of DNA 
polymerases, showing sequence similarity to E. coli DNA polymerase I (Harris et al., 1996; 
Marini et al., 2003). As described in more detail below, however, the polymerase domain of 
POLQ contains three unique “insert” regions within the DNA polymerase sequence (Figure 
2A and B), which determine some of its biochemical properties (Seki et al., 2004). While 
much is known about the enzymatic properties of POLQ in vitro, further study is needed to 
better determine its functions in cells. Below I review data on the published literature 
regarding the function of POLQ and role in DNA repair.  
 
POLQ gene family distribution in nature 
Genes with similarity to POLQ and Mus308 are present in protists, plants, as well as 
eukaryotes (Figure 1), but not in yeast or other fungi. It remains to be determined whether 
all POLQ-like genes are true orthologs, as it appears that there are functional differences 
between species. Mutations in the polq-1 gene of C. elegans confer sensitivity to ICL-
inducing agents (Muzzini et al., 2008). TEBICHI, a POLQ-like protein found in Arabidopsis, 
is important for normal plant development and contributes to alleviating DNA replication 
stress and perhaps recombination. Tebichi mutant plants are sensitive to both the ICL-
inducing agent mitomycin C (MMC) and to the monofunctional alkylating agent methyl 
methane sulfonate (MMS) (Inagaki et al., 2009; Inagaki et al., 2006). 
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The availability of numerous high quality protein sequences allows direct comparison 
by primary alignment, revealing several evolutionary patterns in the POLQ family. The length 
between the core polymerase and helicase-like domains of POLQ is about 1500–1600 
amino acids in vertebrates, but only about 800 residues in plant homologs and 800–1000 
amino acids in invertebrate animals (Table 1A). Further, the positions of the polymerase 
domain “inserts” are conserved within the entire POLQ family, but the inserts are much 
shorter in the non-vertebrate family members (Table 1B). Expansion of the size of the 
central domain and the inserts apparently arose contemporaneously in a common 
vertebrate ancestor. The variations in the central domain and polymerase domain insert 
lengths may account for some of the differences in damage sensitivities associated with 
defects in POLQ family genes in different organisms (Table 1A and B, Figure 2C). 
Recently, a report found three RAD51 interaction sites within the central domain of POLQ 
and the authors suggest that POLQ interacts with RAD51 to suppress homologous 
recombination (Ceccaldi et al., 2015). This serves as the first suggestion that the central 
domain may have an important role in the function of POLQ. 
Two other genes in multicellular eukaryotes show significant and intriguing 
relationships with POLQ. HELQ (formerly HEL308) is a DNA repair helicase with amino acid 
sequence similarity to the helicase-like domain of POLQ. HELQ homologs are found in both 
animals (Marini and Wood, 2002) and archaea (Woodman and Bolt, 2009), but not in fungi 
or bacteria. POLN is a 900 amino acid protein in human cells, harboring an A-family DNA 
polymerase domain related to that of Mus308 and POLQ (Marini et al., 2003; Takata et al., 
2010; Takata et al., 2006). In contrast with POLQ, the phylogenetic distribution of POLN 
appears to be limited to the deuterostome lineage of eukaryotes, including vertebrates. 
Phylogenetic analysis suggests that POLN is no more related to POLQ than it is to the 
bacterial pol I polymerases (Figure 2C). 
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Figure 2. Map and alignment of POLQ polymerase domain. (A) The C-terminal portion of 
POLQ (amino acids 1792-2590) necessary for polymerase activity is displayed. The core 
polymerase domain of POLQ is displayed in blue. Conserved A-family DNA polymerase 
motifs are noted in black. The unique sequence inserts found in POLQ are shown in yellow. 
An inactive DnaQ-like 3'→5' exonuclease domain (including insertion loops shaded in 
orange), Chaos1 mutation (Ser1932 in mouse/Ser1977 in human), and the 5'-dRP lyase 
activity of POLQ mapped to the polymerase domain are noted. An asterisk notes the 
tyrosine residue 2337 in motif 4 of the polymerase domain that facilitates ddNTP 
incorporation. The location of the serine to proline mutation found in the Chaos1 mutant 
mouse is noted in the central domain. (B) Sequence alignment of POLQ family members 
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constructed in MacVector. Amino acid numbers for each species in the alignment are 
notated in brackets. (C). The dendogram illustrating evolutionary relatedness of POLQ gene 
family members was created using SeaView. POLQ, POLN, and bacterial pol I homologs 
are shown in orange, cyan, and magenta outlined groups, respectively.  
MycoPolI: Mycobacterium tuberculosis pol I; EcPolI: Escherichia coli pol I; TaqPolI: Thermus 
aquaticus pol I; TEBICHI: Arabidopsis thaliana TEBICHI; Rice: Oryza sativa pol I; 
Soybean: Glycine max POLQ-like; CePolq-1: Caenorhabditis elegans Polq-1; 
Mosquito: Aedes aegypti POLQ; Mus308: Drosophlia melanogaster Mus308; Anole: Anolis 
carolinensis POLQ-like; Tilapia: Oreochromis niloticus POLQ; Zebrafish: Danio rerio POLQ; 
Xenopus: Xenopus tropicalis POLQ; Chicken: Gallus gallus POLQ; Finch: Taeniopygia 
guttata POLQ; Dog: Canis lupus POLQ; Rabbit: Oryctolagus cuniculus; Horse: Equus 
caballus POLQ; Cow: Bos taurus POLQ; Rat: Rattus norvegicus POLQ; Mouse: Mus 
musculus POLQ; Rhesus: Macaca mulatta POLQ; Chimp: Pan troglodytes POLQ; 
Human: Homo sapiens POLQ; HsPOLN: Homo sapiens POLN; PtPOLN: Pan 
troglodytes POLN; MmPOLN: Mus musculus POLN; DrPOLN: Danio rerio POLN. 
The scale bar indicates a distance of 0.1 amino acid substitution per site. 
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Table 1. Conservation of POLQ functional interdomain distance and polymerase 
domain inserts in evolution. Length of (A) the amino acid separation between the core 
catalytic domains of the helicase-like and polymerase domains and (B) polymerase domain 
inserts in POLQ gene family members. All lengths are in amino acids. 
 
Low fidelity and translesion synthesis activities of POLQ 
Human POLQ has been purified as a recombinant protein from a baculovirus-
infected insect cell expression system (Seki et al., 2003; Seki et al., 2004). The protein is 
active on substrates including oligonucleotide primer-templates, hairpin primer-templates, 
activated calf thymus DNA and poly (dA)-oligo (dT) (Seki et al., 2003; Seki et al., 2004). The 
activity of recombinant POLQ is relatively resistant to aphidicolin, a potent inhibitor of 
eukaryotic replicative DNA polymerases (pols α,δ,ε) (Cheng and Kuchta, 1993; Dresler et 
al., 1988; Seki et al., 2003; Sheaff et al., 1991). POLQ is sensitive to dideoxynucleoside 
A B
       Distance 
    core catalyt
Species
Human
Chimp
Mouse
Cow
Horse
Chicken
Finch
Xenopus
Zebrafish
Tilapia
Anole
Pea Aphid
Western Mite
Fruit Fly
Mosquito
C. elegans
Arabidopsis
Soybean
between
ic domains
Length (aa)
1565
1596
1552
1593
1599
1610
1581
1557
1457
1271
1364
905
1018
1042
801
888
806
817
    Length of POLQ polymerase domain inserts (aa)
Species Insert 1 Insert 2 Insert 3
Human 22 52 33
Chimp 22 52 33
Mouse 22 52 33
Chicken 22 52 33 Vertebrates
Vertebrates Dog 22 52 33
Xenopus 22 48 28
Zebrafish 19 51 24
Tilapia 19 42 25
Fruit Fly 4 9 9
Mosquito 0 10 7 Invertebrates
C. elegans 3 9 0
Soybean 5 18 13
Rice 5 0 16 Plants
Invertebrates Arabidopsis 5 17 13
Plants
  11
triphosphate (ddNTP), consistent with the presence of a tyrosine residue in motif 4 of family-
A DNA polymerases that facilitates ddNTP incorporation (Figure 2B) (Doublié et al., 1998; 
Seki et al., 2003). Sequence alignment shows that POLQ contains an inactive DnaQ-like 
3'→5' exonuclease that lacks conservation in the key HxAxxD ExoIIIε metal binding motif. 
Purified POLQ lacks a 3'→5' exonuclease activity, which is a common feature of low fidelity 
DNA polymerases (Figure 2A). Primer extension assays to measure DNA polymerase 
fidelity, found that purified POLQ frequently misincorporated a G or T across from a T in the 
template (Seki et al., 2003; Seki et al., 2004). In a gap-filling assay to measure mutation 
frequency, human POLQ generated single base errors at a 10 to 100-fold higher rate than 
the other A family DNA polymerase members (γ, ν) (Arana et al., 2008). POLQ adds single 
nucleotides to homopolymeric runs at particularly high rates during gap filling, exceeding 1% 
in certain sequence contexts. The enzyme generates single base substitutions at an 
average rate of 2.4 × 10−3, comparable in rate to the inaccurate family Y human pol κ (5.8 × 
10−3). This is unusual, as the most studied low fidelity polymerases belong to the Y family (η, 
ι, κ, Rev1) rather than the A family of polymerases (Goodman, 2002). 
Maga et al. purified an activity, thought to be from POLQ, from HeLa cell nuclear 
extracts that could efficiently utilize abasic site-containing DNA as a template. The purified 
preparation contained several polypeptides of about 100 kDa, one of which was recognized 
by an antibody raised against a fragment of recombinant POLQ (Maga et al., 2002). The 
active fraction exhibited relatively high fidelity of DNA polymerization, and a 3' → 5' 
exonuclease activity, but no ATPase or helicase activities (Maga et al., 2002). It seems likely 
that this preparation may have contained an active fragment of POLQ, co-purifying with a 3' 
→ 5' nuclease activity. The identity of this exonuclease is unknown but it may be 
physiologically relevant to POLQ activity. 
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POLQ has the ability to catalyze DNA synthesis across specific forms of endogenous 
and exogenous DNA damage in a process called translesion DNA synthesis (TLS). A 
notable POLQ enzymatic trait is its ability to incorporate an A residue opposite abasic (AP) 
sites and extend from the incorporated nucleotide. Although many DNA polymerases tend to 
insert an A opposite an AP site (known as the “A” rule (Avkin et al., 2002; Strauss et al., 
1982; Strauss, 2002), the highly efficient extension from the A opposite an AP site is unique 
to POLQ (Seki et al., 2004). For example, POLH (η) can insert a base opposite an AP site 
but cannot efficiently extend from the lesion, a property common to human Y family 
polymerases (Johnson et al., 2000; Lawrence, 2002; Masutani et al., 2000; Seki et al., 2004; 
Vaisman et al., 2002; Zhang et al., 2001). About 18,000 AP sites arise in each diploid 
mammalian cell per day by hydrolytic depurination, but insertion of an A opposite such a site 
would be mutagenic (Friedberg et al., 2006). Abasic sites are also generated frequently as 
intermediates in the base excision repair of uracil following the accidental incorporation of 
dUTP during genomic DNA replication (Guillet and Boiteux, 2003; Lindahl, 1993; Nakamura 
et al., 1998). If a DNA replication fork encounters such an AP site before it is repaired, 
introduction of an A would reconstitute the original undamaged template and be 
physiologically useful. It remains to be determined whether this AP site bypass activity is a 
function of POLQ in vivo.  
POLQ cannot insert a base opposite the common UV-radiation induced cyclobutane 
pyrimidine dimers or 6-4 photoproducts (6-4PP). However, if pol ι (Vaisman et al., 2004) is 
used to incorporate bases opposite a 6-4PP, POLQ can extend the poorly matched primer-
terminus (Seki et al., 2004; Seki and Wood, 2008). POLQ was also able to efficiently extend 
mismatched A:G, A:T, and A:C termini (Seki and Wood, 2008). The ability of POLQ to 
catalyze extension from minimally primed or mispaired DNA ends is quite important for its 
function in cells and is discussed in Chapter 2 of this thesis (Yousefzadeh et al., 2014). 
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Thymine glycol (Tg) is a common product of reactive oxygen species-mediated 
damage to DNA. POLQ and POLN can efficiently bypass both enantiomers (5R,5S) of a Tg 
adduct, whereas pol η extends efficiently only from the 5R-Tg (Kusumoto et al., 2002; Seki 
et al., 2004; Takata et al., 2006). Translesion synthesis bypass of a Tg residing on a shuttle 
vector was reduced in human MRC5 cell lines with diminished levels of POLQ (Yoon et al., 
2014). This finding was clouded, in my opinion, by knowledge that siRNA suppression of 
POLQ can be variable and knockdown was measured by semiquantitative RT-PCR, rather 
than other detection methods that are more sensitive and quantitative. Furthermore, 
immunoblotting for POLQ was carried out using an unvalidated rabbit polyclonal antibody. 
The Abcam ab80906 rabbit polyclonal antibody against POLQ used by the authors is 
reported by the manufacturer to recognize a band between 144 and 168 kDa when blotted 
against placenta lysate. Notably, POLQ has a predicted molecular weight of 290 kDa. 
Further, the authors did not show full immunoblots thus leaving open the question of 
whether they actually detected the proper band for POLQ or whether it was some other non-
specific band. The authors presented similar controversial immunoblotting results with a 
rabbit polyclonal antibody against POLN (Abnova POLN A01 H000353497-A01), thus calling 
additional experimental conclusions into doubt regarding the knockdown efficiency of either 
POLN or POLQ by siRNA. If the findings do hold true, it suggests that POLQ bypasses Tg 
adducts in vivo, through an error prone TLS process. However if POLQ cannot bypass Tg in 
vivo then in vitro evidence of POLQ’s ability to bypass Tg could be explained by the 
enzyme’s unique ability to utilize minimally or misprimed ends to catalyze extension (Seki 
and Wood, 2008; Yousefzadeh et al., 2014). Lesion bypass by POLQ could be useful in 
catalyzing the extension of 3’ single-stranded DNA ends (See Chapter 2 of this thesis), 
which can be easily damaged through for example methylation, deamination, and 
oxidization. 
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The ability of POLQ to extend from mismatched, poorly matched or unmatched 
termini is unusual and will be understood better after high-resolution structural features of 
the active site are determined. The three “inserts” in the catalytic domain are unique to 
POLQ (Figure 2A and B), and some specific deletions of these inserts have been analyzed 
with respect to activity. Insert 1 comprises 22 amino acids between the first and second 
conserved motifs in the “thumb” subdomain, and its sequence is highly conserved 
throughout vertebrates (Seki et al., 2004). In other A-family DNA polymerases, the thumb 
region influences DNA binding and frameshift fidelity. Deletions in the thumb region of E. 
coli Pol I can cause errors in processivity and an increased use of misaligned 
primer/template complexes (Cannistraro and Taylor, 2004; Doublié et al., 1998; Minnick et 
al., 1996). Insert 2 is 52 amino acids long and falls between the second and third motif and 
has the least sequence conservation among the inserts while insert 3 is 33 amino acids that 
lies between the fifth and sixth motif (Figure 2A and B). A fragment of POLQ (residues 
1792–2590) containing the pol domain and a portion of the central domain (Figure 2A), is 
active as a DNA polymerase when produced as a recombinant protein in E. coli. Shorter 
fragments are much less active, or inactive (Hogg et al., 2011; Prasad et al., 2009) 
indicating that this region of the central domain is required for efficient polymerase activity. 
The active fragment is able to bypass AP sites and Tg adducts, showing that these bypass 
activities are independent of the N-terminal helicase-like domain. Elimination of Insert 1 of 
this POLQ fragment reduced processivity of the enzyme but had little, if any, bearing on the 
translesion synthesis properties of the enzyme. However, removal of either inserts 2 or 3 
reduced activity on undamaged DNA and eliminated the ability of POLQ to bypass AP sites 
or Tg adducts (Hogg et al., 2011). 
The helicase-like domain of POLQ has 7 conserved motifs of the superfamily II DNA 
and RNA helicase family (Seki et al., 2003). The POLQ helicase-like domain exhibits some 
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single-stranded DNA-dependent ATPase activity, though lower in comparison to that of 
HELQ. No overt helicase activity of POLQ has been reported (Seki et al., 2003). It is 
possible that POLQ will only display helicase activity with an as yet untested substrate or 
alternatively, requires additional accessory factors. Another possibility is that the helicase-
like domain of POLQ could function as a protein-displacement motor, in lieu of unwinding 
DNA. Several cellular functions have been suggested for POLQ. These are summarized in 
the next sections. 
 
Hematopoiesis and immunological diversity 
Some investigations have explored the possibility of a specialized immunological 
function for POLQ, either in somatic hypermutation (SHM) or in class switch recombination 
(CSR) of immunoglobulin genes. POLQ is expressed in hematopoietic cells, including 
germinal center B cells (Kawamura et al., 2004). SHM acts to introduce point mutations in 
the variable (V) region of antibodies to alter their affinities while CSR changes the 
immunoglobulin constant region. Both processes are set in motion by the AID enzyme which 
can deaminate cytosine to uracil in DNA (Honjo et al., 2004). Mutations may then arise from 
low-fidelity repair synthesis or nucleotide misincorporation opposite an AP site (Neuberger 
et al., 2005; Seki et al., 2005). 
With respect to SHM, Polq−/− mice were previously reported to have decreased 
mutations of C:G sequences at SHM hotspots, whereas mutations at A:T sequences were 
unaffected (Masuda et al., 2005). POLH is important for A:T mutagenesis in SHM 
and Polh−/− Polq−/− mice do not exhibit a decrease in A:T mutations when compared 
to Polh−/− mice (Masuda et al., 2007; Ukai et al., 2006). POLQ extends beyond mispairs with 
A or T and can extend weakly from mispaired termini generated by POLH, suggesting that 
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POLQ and POLH might cooperate during A:T mutagenesis (Masuda et al., 2007). In an 
independent set of experiments, mice carrying a gene disruption that completely eliminates 
the POLQ enzyme had a frequency of SHM that was reduced by 60–80% (Zan et al., 2005). 
There was no overall change in the proportion of events at A:T and C:G positions. Finally, 
Martomo et al. found similar mutation frequencies of V genes in Peyer's patches 
of Polh−/− Polq+/+ and Polh−/− Polq−/− mutant mice, suggesting that POLQ has only a minor 
role, if any, in SHM point mutagenesis (Martomo et al., 2008). 
The role of POLQ in immunoglobulin (Ig) gene conversion, a functionally analogous 
process to SHM in avian species, but biochemically quite distinct, as it relies on homologous 
recombination rather than point mutagenesis, was investigated. The Polq gene was 
disrupted in the DT40 chicken B cell line by Yoshimura et al. using gene targeting (Kohzaki 
et al., 2010; Yoshimura et al., 2006). Strikingly, a Poln Polq double mutant showed a five-
fold decrease in Ig gene conversion, the primary method of V region diversity in avian 
species. Further, a triple Polh Poln Polq mutant failed to exhibit any Ig gene conversion 
(Kohzaki et al., 2010).  
The absence of POLQ does not seem to impair CSR in mammals as the mouse 
CH12F3 B-cell line (defective for Polq) can efficiently switch from IgM to IgA after 
appropriate stimulation (Li et al., 2011). In vivo CSR frequency was not impaired in mice 
lacking Polq, Polh, or both (Martomo et al., 2008). Nevertheless, my research uncovered a 
role for POLQ in a subset of CSR events as described in Chapter 2 of this thesis 
(Yousefzadeh et al., 2014). 
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1.2 POLQ and DNA Repair 
Base excision repair 
POLQ might serve as a backup DNA polymerase for base excision repair (BER). In 
mammalian cells, single-nucleotide BER is performed by POLB (pol β) (Prasad et al., 2009; 
Yoshimura et al., 2006). A fragment of human POLQ was shown to display 5'-deoxyribose-
phosphate lyase (dRp-lyase) activity, an activity necessary for single-nucleotide BER 
(Prasad et al., 2009). This dRp-lyase activity is present within a 24 kDa region of the POLQ 
polymerase domain (Figure 2). This is in contrast to the much stronger dRp-lyase activity of 
pol β, which is present in a distinct domain separate from the polymerase domain. 5'-dRp 
lyase activity was still present in a catalytically inactive 98 kDa polymerase fragment of 
POLQ (Prasad et al., 2009). 
In chicken DT40 cells, Polq and Polq Polb double mutants were examined in regard 
to BER (Yoshimura et al., 2006). The Polq single mutant is sensitive to hydrogen peroxide 
(which can cause oxidative damage to bases) but not to MMS, although both agents cause 
damage that is repaired by BER (Table 2A). The Polq Polb double mutant was more 
sensitive to MMS than either of the Polq or Polb single mutants. Extracts from 
the Polq mutant DT40 cell line appear to have a reduced capacity for both single-nucleotide 
and long patch BER (Yoshimura et al., 2006). 
Mouse bone marrow stromal cells lacking Polq do not show increased sensitivity to 
either hydrogen peroxide or paraquat in comparison to controls (Goff et al., 2009). Human 
SQ20B head and neck cancer cells depleted for POLQ with siRNA are not sensitive to 
treatment with temozolomide, an alkylating agent that is related to MMS (Table 2B) (Higgins 
et al., 2010b). CH12 mouse B lymphoma cells containing a deletion in an exon required for 
POLQ catalytic activity are somewhat more sensitive to MMS in the presence or absence of 
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methoxyamine, which reacts with AP sites and prevents single-nucleotide BER by pol β 
(Ukai et al., 2006). Taken together, it appears that POLQ is not a major contributor to BER. 
POLQ may be a backup enzyme for BER in the nematode C. elegans, which lacks pol β, 
although at least one additional DNA polymerase also appears to function in BER in this 
organism (Asagoshi et al., 2012). 
 
Interstrand crosslink repair 
Mus308, the Drosophila ortholog of POLQ, is implicated in an alternative form of end 
joining that may contribute to ICL repair (Chan et al., 2010). Drosophila mus308, C. elegans 
polq-1, and Arabidopsis TEBICHI are all sensitive to the ICL-inducing agent MMC (Table 
2C) (Aguirrezabalaga et al., 1995; Inagaki et al., 2006; Muzzini et al., 2008). In vertebrate 
cells, there are conflicting reports concerning the sensitivity of POLQ to ICL-inducing agents. 
DT40 cells lacking POLQ are not hypersensitive to cisplatin, a clinically used ICL agent 
(Kohzaki et al., 2010; Yoshimura et al., 2006). However, deletion of Polq slightly sensitized 
murine CH12B-lymphoma cells to cisplatin and MMC (Li et al., 2011). The chaos1 mutant 
mice and cells derived from them exhibited no hypersensitivity to MMC, suggesting that 
POLQ does not play a major role in the repair of ICLs in mammalian cells (Shima et al., 
2004). The investigation of a role for POLQ in the repair of ICL-induced DNA damage is 
further explored in Chapter 2 (Yousefzadeh et al., 2014). 
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Table 2. Sensitivity of POLQ-deficient cells to DNA damaging agents. This table 
summarizes the sensitivity of POLQ (A) vertebrate knockouts and mutants, (B) siRNA-
depleted cell lines, and (C) non-vertebrate animal and plants knockouts to various DNA 
damaging agents when I initiated my project. Sensitivity of cells to damaging agents were 
described as (+) hypersensitive, (−) no sensitivity, or (ND) not described. 
 
 
 
A
Vertebrate POLQ knockouts and mutants
Agent Chaos1 BMSC CH12 Pol CH12 TKO DT40
IR + ++ + + -
Bleomycin ND ++ ND ND ND
Etoposide ND ND + + ND
Peroxide ND - ND ND +
Paraquat ND - ND ND ND
MMS ND ND - - -
MMC - ND ND ND -
Cisplatin ND ND +/- +/- -
UVC ND + + ND -
B
POLQ-depleted human cells
Agent siPOC siMRC5 SiQ20B siHeLa
IR - - + ++
Temozolomide ND ND - ND
C
POLQ knockouts in Drosophila, C. elegans, and Arabidopsis
Agent Mus308 polq-1 TEBICHI
IR - +/- ND
MMS - + +
MMC + ND +
Cisplatin + + ND
HN2 + + ND
UVC ND - ND
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Tolerance of DNA double strand breaks and alternative end joining (altEJ) of breaks 
While evidence for multiple POLQ functions has been discovered, the strongest 
evidence to date, supports a role for POLQ in the defense against radiation-mediated 
genomic instability. The chaos1 (chromosome aberration occurring spontaneously 1) mouse 
was produced in a phenotype-driven screen (Shima et al., 2003). Male mice were 
periodically dosed with N-ethyl-N-nitrosourea (ENU) to induce germline mutations before 
mating. Generation 1 male offspring were backcrossed with generation 2 females to create 
generation 3 offspring that were potentially homozygous. The frequency of micronuclei (MN) 
was measured in male generation 3 mice. MN arise from acentric chromosome fragments 
arising from chromosome breakage or from whole chromosomes that was not properly 
segregated or packaged into the nucleus at the time of cell division (Nusse et al., 1996). 
DNA damaging agents induce MN, and those that form shortly before the nucleus is ejected 
can be assayed in peripheral blood reticulocytes by flow cytometry (Dertinger et al., 1996). 
The chaos1 mice show increased spontaneous MN in blood samples, and the level is further 
elevated by ionizing radiation (IR) and MMC (Shima et al., 2003). The chaos1 recessive 
mutation was mapped to a region of chromosome 16 that included the Polq gene, and was 
determined to be a T to C point mutation in exon 19 of mouse Polq. This missense mutation 
converts Ser to Pro at amino acid 1932, located near the C-terminal end of the central 
domain, adjacent to the polymerase domain of POLQ (Figure 2A). Expression of wild-
type Polq from a bacterial artificial chromosome was able to suppress 
the chaos1 phenotype, suggesting that chaos1 mice possess a mutant allele of Polq (Shima 
et al., 2003). 
A Polq−/− knockout mouse was then generated by Naoko Shima in John Schimenti’s 
laboratory, introducing a point mutation in exon 1 to create a premature stop codon and 
replacing exons 2–5 with a neomycin resistance cassette (Shima et al., 2004). A lack of 
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complementation was observed between the chaos1 and Polq-null alleles demonstrating 
that chaos1 is a mutant allele of Polq. The authors also noted a marked developmental 
disadvantage for Atm−/− Polq−/−double mutant mice. The few mice that did survive displayed 
signs of severe DNA damage stress, including increased chromosomal instability, 
decreased body weight and a delayed onset of thymic lymphomas in comparison 
to Atm−/− mice (Shima et al., 2004). Goff et al. found that Polq−/− mice have increased levels 
of IR-induced MN and confirmed that the levels of spontaneous MN formation were nearly 
identical to those reported for chaos1 mice (Goff et al., 2009; Shima et al., 2004). Further 
Goff et al. found that bone marrow stromal cells from the Polq−/− mice were hypersensitive to 
gamma irradiation and to bleomycin, a drug that causes DNA double-strand breaks (Table 
2A) (Goff et al., 2009). Inhibition of ATM activation with the drug KU55933 increased 
radiosensitivity in wild-type but not in Polq−/− cells. Li et al. constructed a Polq-null mutant in 
mouse CH12F3 B cells. These cells are more sensitive than normal cells to gamma-
irradiation and etoposide (Li et al., 2011). POLQ was also uncovered in a siRNA screen of 
genes that affect the IR sensitivity of human cells. Depletion of POLQ in SQ20B and HeLa 
cancer cell lines caused an increase in IR-induced γH2AX foci and sensitized the cells to 
gamma-irradiation (Table 2B) (Higgins et al., 2010b). These observations indicate that 
POLQ has a role in either the tolerance or repair of DNA double-strand breaks. 
The mechanism by which POLQ aids in the defense against IR-mediated genomic 
instability is under investigation. Studies of Drosophila Mus308 function point towards a role 
of this gene in an alternative form of end joining which relies upon annealing of 
microhomologies in order for DNA end joining to occur. Yu et al. investigated the inaccurate 
repair of DSBs mediated by the I-SceI nuclease in Mus308 mutants and found a decrease in 
a process termed synthesis-dependent microhomology-mediated end joining (SD-MMEJ) 
(Yu and McVey, 2010). This repair pathway is independent of Ku70, Lig4, and Rad51 and 
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distinct from “canonical” non-homologous end-joining (cNHEJ) of DNA breaks. SD-MMEJ is 
related to, or identical to, pathways defined in other biological systems as alternative end 
joining (altEJ), or micro-homology-mediated end-joining (MMEJ). Analysis 
of mus308 mutants showed a decrease in the use of long microhomologies at the junction 
site and abrogation of complex T-nucleotide insertion events. Further analysis suggested 
that this altEJ pathway is occurring in parallel to LIG4-mediated canonical end-joining (Chan 
et al., 2010). Mus308 is also necessary for the incorporation of additional nucleotides (via an 
altEJ pathway) that allows for retrohoming of group II introns in flies (White and Lambowitz, 
2012). Worms lacking the functional POLQ homolog also show a defect in this altEJ repair 
pathway and exhibit enhanced genomic instability (Koole et al., 2014; Roerink et al., 2014). 
One would hypothesize that if cells lacking or with reduced POLQ levels were 
hypersensitive to a particular DNA damaging agent, then POLQ may play a role in the repair 
of that specific type of DNA damage. However, although such sensitivity assays have been 
performed in a number of species (Table 2) there is no unified evolutionarily consensus of 
what genotoxic agents that POLQ mutants are hypersensitive to and what DNA repair 
pathways it may participate in. In Drosophila, Mus308 does not appear to participate in 
homology-directed repair. Mus308 mutant larvae are not more sensitive to IR than wild-type, 
but they are synergistically sensitized to radiation by addition of spn-A (Rad51) mutation, 
indicating that Mus308-dependent repair is independent of homologous recombination in 
Drosophila (Chan et al., 2010). This is in contrast to the Polq mutant in chicken DT40 cells, 
which are only hypersensitive to peroxide and showed decreased levels of HR repair of I-
SceI-mediated DNA DSBs (Kohzaki et al., 2010; Yoshimura et al., 2006). Recently, a mutant 
of POLQ (Z16) in the green algae C. reinhardtii was shown to be hypersensitive to the DSB-
inducing agent zeocin (Plecenikova et al., 2014). Human and mouse POLQ mutants are 
radiosensitive, suggesting some divergence of POLQ and Mus308 functions. To understand 
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a role for POLQ in mammalian cells, hypersensitivity to a broad spectrum of DNA damaging 
agents needs to be tested in a better controlled manner (See Chapter 2) (Yousefzadeh et 
al., 2014). 
Functions in replication and at the replication fork 
There are some suggestions that POLQ might work at the DNA replication fork or in 
close connection with DNA replication proteins. As described below, POLQ gene expression 
correlates with expression of genes involved in cell cycle control and DNA replication 
(Pillaire et al., 2009). MRC5VA human lung fibroblast cells were engineered to stably 
express recombinant POLQ, and this resulted in an increase in γH2AX foci, an increase in 
chromosomal abnormalities and defective DNA replication fork progression (Lemée et al., 
2010). These data show that it is imperative for cells to keep levels of POLQ tightly 
controlled to avoid detrimental effects on the cell. A recent report provided evidence that 
POLQ interacts with replication origin factors ORC2 and ORC4 and reduced POLQ levels 
alter replication timing (Fernandez-Vidal et al., 2014). In the same screen that identified 
the chaos1 allele of POLQ, a second mutant termed chaos3 showed a similar phenotype of 
increased micronuclei. Chaos3 has been identified as a hypomorphic allele of Mcm4, a 
component of the helicase operating during semiconservative replication (Shima et al., 
2007). In Arabidopsis, TEBICHI gene mutants show striking defects in G2/M checkpoints 
that could be due to abnormal DNA replication (Inagaki et al., 2006). 
 
POLQ expression in normal and cancerous tissue 
The POLQ gene is ubiquitously expressed in human and mouse tissues and cell 
lines, as measured by northern blot analysis, reverse transcriptase polymerase chain 
reaction (RT-PCR), and microarrays. Levels of expression appear to be highest in the testis, 
human placental tissue and hematopoietic cells (Kawamura et al., 2004; Seki et al., 2003; 
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Shima et al., 2003), but POLQ transcripts can be found throughout the body (Table 3). 
POLQ is a member of a cluster of genes in which higher levels of expression correlate with 
lower patient survival for several cancers. This cluster includes genes involved in DNA 
replication, repair, recombination and cell cycle control. Higher expression of POLQ mRNA 
was observed in some tumor samples from stomach, lung, and particularly colon cancers 
compared to matched control non-tumor tissue (Kawamura et al., 2004). Stratification of 
colon cancers based on POLQ expression alone indicated that the “POLQ high” group had 
poorer survival than the “POLQ low” group by an average of ~24 months. Another study of 
colorectal cancer patients indicated that tumors with higher expression of a group of 47 DNA 
replication-related genes (including POLQ) were significantly correlated with poorer patient 
survival (Pillaire et al., 2009). POLQ expression levels alone were correlated with poor 
patient survival (Pillaire et al., 2009). In an analysis focusing on the expression of DNA 
polymerases in human breast cancers, Lemée et al. found that of all 14 nuclear DNA 
polymerases, only POLQ expression was significantly higher in cancer samples than in 
normal tissue samples. Stratification, according to expression, showed that higher levels 
of POLQ expression were correlated with poorer survival outcomes (Lemée et al., 2010). 
Another study of POLQ expression in early breast cancer indicated that samples with the 
highest POLQ expression level were in ER negative and high-grade tumors. Further, higher 
POLQ expression was correlated with poor relapse-free survival (Higgins et al., 2010a). 
Considering that radiation therapy is a frontline treatment for breast cancer and that human 
cancer cells depleted for POLQ are sensitive to ionizing radiation, POLQ is a molecule of 
interest in the study of breast cancers and is a potentially druggable target. 
In some non-tumor cells, reduced POLQ levels resulting from siRNA treatment had 
little effect on radiation sensitivity (Higgins et al., 2010b). It would be clinically beneficial if 
tumor cells but not normal cells could be sensitized by POLQ suppression or inhibition, but it 
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remains to be seen whether this is generally the case. As described above, genetic ablation 
of POLQ from normal mouse cell lines leads to radiation hypersensitivity. Despite this 
radiation sensitivity, the hematopoietic system of Polq−/− mice seems resilient. Mice 
irradiated with a sub-lethal dose of 7 Gy of γ-irradiation showed a subsequent depression of 
counts for white blood cells, red blood cells, lymphocytes and platelets, as expected after 
immunoablation. Recovery to normal levels took place in Polq−/− mice as well as wild-type 
mice (Goff et al., 2009). Due to its unique properties and clinical interest, further work to 
understand POLQ and its role in the cell is pivotal. 
 
 
Table 3. POLQ transcripts are found throughout the body. Expressed Sequence Tag 
(EST) data collected from Unigene for POLQ. For each body site, transcript per million 
(TPM), gene-specific (Gene) EST and total EST’s for each body site (EST Pool). 
Body Site TPM Gene EST EST Pool Body Site TPM Gene EST EST Pool
adipose tissue 0 0 / 12866 nerve 0 0 / 15535
adrenal gland 30 1 / 32940 ovary 19 2 / 101488
ascites 0 0 / 39834 pancreas 0 0 / 213440
bladder 0 0 / 29860 parathyroid 0 0 / 20594
blood 32 4 / 122252 pharynx 24 1 / 40725
bone 13 1 / 71618 pituitary gland 0 0 / 16526
bone marrow 0 0 / 48737 placenta 0 0 / 283019
brain 1 2 / 1092688 prostate 0 0 / 189536
cervix 0 0 / 48486 salivary gland 0 0 / 20265
connective tissue 6 1 / 149072 skin 4 1 / 210759
ear 124 2 / 16100 spleen 0 0 / 53397
embryonic tissue 14 3 / 212896 stomach 10 1 / 95679
esophagus 0 0 / 20154 testis 9 4 / 435204
eye 14 3 / 208840 thymus 25 2 / 79697
heart 0 0 / 89524 thyroid 0 0 / 46583
intestine 21 5 / 231981 tonsil 0 0 / 17021
kidney 14 3 / 210778 trachea 38 2 / 51780
larynx 1022 24 / 23466 umbilical cord 0 0 / 13764
liver 9 2 / 205291 uterus 30 7 / 232093
lung 5 2 / 334815 vascular 19 1 / 51649
lymph 22 1 / 44302
lymph node 66 6 / 89748
mammary gland 26 4 / 151230
mouth 15 1 / 66150
muscle 9 1 / 106371
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1.3 Aims of this thesis 
 The full-length POLQ cDNA was cloned in the Wood Laboratory in 2003, sparking 
research into this specialized DNA polymerase (Seki et al., 2003). From the initial discovery 
POLQ was unique, it was a fairly large enzyme (predicted molecular weight of 290 kDa) and 
stood out from the other mammalian DNA polymerases because POLQ also contained a 
helicase (-like) domain. When I started in the Wood Laboratory, a fair amount of information 
regarding the in vitro biochemical properties of recombinant human POLQ was known; 
however, a cellular function for POLQ was still unclear. From the outset of the project, Dr. 
Wood and I felt a profound sense of excitement to determine what mammalian POLQ was 
doing in the cell. With a minimal amount of knowledge of the DNA repair field, a lot of 
curiosity, and the steady guidance of a mentor, I embarked on a roughly six year intellectual 
journey to determine the function of mammalian POLQ.  
 An early hypothesis that I had in the infancy of my dissertation project was that 
POLQ played a role in at least one or more DNA repair pathways. 
 
Specific Aim 1 – To determine what DNA repair pathway(s) POLQ participates in. 
Investigation of this aim was accomplished by analyzing isogenic sets of long-term bone 
marrow stromal cells derived from Polq-null mice and their wild-type littermate controls for 
hypersensitivity to different DNA damaging agents by clonogenic survival assays. Further 
mechanistic investigation into the repair of DNA damage utilized in vivo analysis of wild-type 
and Polq-null mice, in vitro and biochemical assays. 
 
Specific Aim 2 – To determine the biological consequences of the loss of POLQ.  
Polq-deficient mice and cells derived from them were analyzed for hypersensitivity to DNA 
damage, markers of DNA damage signaling, cytologic markers of chromosomal instability, 
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and in vivo chromosomal translocation. The working hypothesis is that loss of POLQ 
contributes to impaired DNA repair and enhanced genomic instability. 
 
Specific Aim 3 – To determine the role of POLQ in immunological diversity 
mechanisms through high-resolution analysis. 
In order to investigate the role of POLQ in immunological diversification mechanisms, 
Peyer’s patches and stimulated naïve B cells from wild-type and Polq-null mice were 
analyzed for V region mutagenesis, and class switch recombinant junction composition, 
respectively, through a mix of standard and next-generation DNA sequencing. 
 
Specific Aim 4 – To determine the interplay between POLN and POLQ. 
A colony of Polq-null mice were established at Science Park and then crossed to Poln 
knockout mice developed by Dr. Kei-ichi Takata to generate Poln−/− Polq−/− mice. Functional 
analysis of single mutant mouse controls as well as Poln−/− Polq−/− mice, and cells derived 
from them, were performed to determine whether POLN and POLQ operate within the DNA 
repair pathway. 
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Chapter 2. Mechanism of suppression of chromosomal instability by DNA polymerase 
POLQ 
Note this chapter is based on: Yousefzadeh, M.J., Wyatt, D.W., Takata, K., Mu, Y., Hensley, 
S.C., Tomida, J., Bylund, G.O., Doublie, S., Johansson, E., Ramsden, D.A., et al. (2014). 
Mechanism of suppression of chromosomal instability by DNA polymerase POLQ. PLoS 
Genet 10, e1004654. With permission from the copyright holder. 
2.1 Introduction 
DNA double-strand breaks (DSBs) can be formed in cellular genomes by 
environmental agents such as ionizing radiation. DSBs also arise during normal cellular 
duplication cycles, when DNA replication stalls at naturally occurring structures or at sites of 
internally-generated DNA damage. In diversification steps of the mammalian immune 
system, DSBs are deliberately formed by regulated enzymatic action, to initiate 
rearrangement of antibody and receptor segments, and as a means to introduce local 
variation. Because DSBs are toxic and/or mutagenic if not repaired, organisms have multiple 
mechanisms for DSB repair (Kass and Jasin, 2010; Rassool and Tomkinson, 2010). The 
primary repair strategies are end-joining mechanisms, which process and rejoin the ends of 
a DSB, and homologous recombination (HR) pathways which employ an undamaged copy 
of the DNA as a repair template (Figure 3) (Thompson, 2012). End-joining pathways appear 
to be the first line of defense against DSBs. The most studied pathway is “classical” non-
homologous end-joining (cNHEJ), which relies on the DNA-binding Ku70 (XRCC6) and 
Ku80 (XRCC5) gene products, and the DNA protein kinase (DNA-PK, PRKDC). One or 
more “alternative” end-joining pathways (altEJ) also exist, which are independent of these 
factors (Figure 3) (Decottignies, 2013; Ramsden and Asagoshi, 2012).  
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Figure 3. DNA double-strand break repair pathways. Upon recognition of a DNA double-
strand break (DSB), DNA damage signaling is activated. Dependent upon cell cycle and 
sister chromatid availability, the homologous recombination (HR) pathway may be available. 
Classical non-homologous end joining (cNHEJ), a repair process that is reliant upon the Ku 
heterodimer and DNA Ligase IV (LIG4), is the predominant repair pathway in mammals and 
does not rely upon DNA nucleolytic processing to create resected 3’ DNA ends. In the 
absence of, or when either Ku or LIG4 are impaired, alternative end joining (altEJ) anneals 
minimally resected DNA ends to anneal at existing or newly created microhomologies (5 or 
nucleotides) as noted in orange. Longer resection is required in order to facilitate HR. 
 
 
During immunoglobulin diversification, the regional end-joining process of class 
switch recombination (CSR) replaces one constant region coding exon for another (Figure 
4). This CSR process is known to occur through both cNHEJ and alternative end joining 
pathways (Boboila et al., 2012a). In mammalian cells, an alternative end-joining repair 
pathway repair of DSBs is thought to play a role in driving the formation of chromosomal 
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translocations, although the specific enzymology is unclear (Simsek and Jasin, 2010; Zhang 
and Jasin, 2011). 
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Figure 4. Immunoglobulin class switch recombination. The mammalian immunoglobulin 
heavy-chain locus of an IgM-expressing B cell is displayed. The heavy-chain variable (VH), 
diversity region (D), and joining region (JH) gene segments are shown in orange, grey, and 
teal, respectively. The other shaded rectangles represent different constant region exons, 
and the black dots denote switch regions. After V(D)J recombination, which occurs in the 
bone marrow, class switch recombination (CSR) takes place in the peripheral lymphoid 
tissues. Upon AID-induced DNA double-strand breaks at different switch regions, CSR 
facilitates the joining of a proximal variable region exon to a downstream constant region 
exon. The diagram denotes the joining of a break between the Sµ and Sγ1 switch region to 
yield a gene product that would produce functional IgG1. The deleted gene segment is 
released as a circularized DNA product. 
 
 
In this chapter, I report experiments that define a specific function and mechanism of 
action for POLQ in a pathway for alternative end-joining of DNA double-strand breaks in 
mammalian cells. 
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2.2 Material and Methods 
Cellular proliferation assay 
Polq+/+ and Polq−/− bone marrow stromal cells and mouse embryonic fibroblasts were plated 
in triplicate (2 ×105 cells per 10 cm dish) with 15 mL of complete media (Dulbecco's Modified 
Eagle Medium+Glutamax, 10% FBS, 1% PenStrep). On the indicated days, cells were 
trypsinized and live cells were counted using trypan blue exclusion (Countess automated 
cell counter, Life Technologies). Experiments were repeated three times in order to generate 
standard deviations. Viability was consistently high for all cell lines examined (>95% trypan 
blue-excluding cells). 
 
Clonogenic assays with bone marrow stromal cells 
For X-irradiation 5 ×105 cells were plated on a 10 cm plastic culture dish, and exposed the 
following day at 2 Gy/min, 160 kV peak energy (Rad Source 2000 irradiator, Suwanee, GA). 
Cells were then trypsinized for replating. For UVC-irradiation (254 nm peak germicidal lamp) 
cells were irradiated in 500 µl PBSA (105 cells/ml) at 5 J m−2 min−1 and then plated. For 
psoralen-UVA treatment, 5 ×105 cells were plated on a 10 cm dish and incubated in medium 
with the indicated concentration of HMT-psoralen for 1 h, the dish was irradiated with 0.9 kJ 
m−2 UVA (365 nm peak, 30 min, 0.5 J m−2 sec−1), the psoralen-containing medium was 
removed, and fresh medium was added before UVA-irradiating for an additional 30 min 
before replating. Chemicals were added at the indicated concentrations to dishes at the 
beginning of the experiment. Drugs were solubilized in ethanol (mitomycin c), DMSO (ICRF-
193, etoposide, camptothecin, HMT-psoralen, temozolomide, olaparib), or 150 mM NaCl 
(cisplatin). All chemicals were from Sigma (St. Louis, MO) except ICRF-193 (Enzo 
LifeScience, Farmingdale, NY), olaparib (AZD2281, Selleck Chemicals, Houston, TX), and 
mitomycin c (Calbiochem, Darmstadt, Germany). Cells were plated in triplicate in 10 cm 
dishes and grown for 7–10 days before being fixed and stained with crystal violet. Colonies 
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of 50 or more cells were quantified and experiments were repeated three times to generate 
standard deviations. A clonogenic assay was performed 
with Rad51D+/+ and Rad51D−/− Chinese hamster ovary (CHO) cell lines (generously 
provided by Dr. Rodney Nairn) exposed to varying concentrations of olaparib. 
 
Micronucleus assay 
BMSCs were plated at 1.5 ×104 cells per well in chambered slides and treated with the 
indicated amount of x-rays or etoposide the following day. 48 h later, cells were fixed with 
2% para-formaldehyde, stained with DAPI and coverslips were added. Micronuclei were 
scored by DAPI immunofluorescence. 300 cells were counted per group. Experiments were 
repeated three times to generate standard deviations. 
 
Human cell transfections 
293T cells (kindly provided by Dr. Christopher Bakkenist, University of Pittsburgh Medical 
School) were plated at 1.5 ×105 cells per well in six-well plates and transfected the following 
day with 2.5 µg of either pCDH (System Biosciences, Mountain View, CA) containing empty 
vector control, POLQ, POLQ-K121M, POLQ-D2330A,Y2331A, POLQ-S1977P, or POLQ-DM 
cDNA using Lipofectamine 2000 (Life Technologies) according to manufacturer's 
specifications. 48 hr after transfection, cells were harvested for RNA isolation (RNeasy, 
Valencia, CA) or for immunoblotting. 
 
Immunoblotting 
For immunoblots, cells transfected in six-well dishes were resuspended in 200 µL of 2× SDS 
loading buffer (4% SDS, 0.2% bromophenol blue, 20% glycerol, 100 mM Tris HCl pH 6.8, 
12% 2-mercaptoethanol) and heated at 95°C for 5 min. 20 µL of extract was separated on a 
4–20% polyacrylamide gel, transferred to PVDF membrane, blocked, and blotted with anti-
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alpha-Tubulin (Abcam, Cambridge, UK ab4074, 1:10,000), anti-FLAG (Sigma F7425, 
1:5,000), anti-PCNA (Santa Cruz, Santa Cruz, CA, sc-56, 1:1,000), anti-HA (RW, 1:10,000), 
or anti-POLQ (MDACC POLQ20, 1:250) antibodies and corresponding secondary antibodies 
(Sigma A0168, A0545; 1:10,000) and visualized with ECL reagent (Pierce, Rockford, IL). 
 
Generation and complementation of Polq MEFs 
Polq-heterozygous (Polq+/−) mice (Shima et al., 2004) were obtained from Jackson 
Laboratories and maintained in a C57BL/6J background. Polq-heterozygous mice were 
crossed to generate Polq-null mice and maintained in a holding room that was positive for 
mouse parvovirus, minute virus of the mouse, and H. pylori. Isogenic primary MEFs were 
generated from 13.5 day pregnant females and cultured in a 2% O2 atmosphere. MEFs were 
then transfected with 1 µg of pSV-Tag (Lange et al., 2012; Sobol et al., 1996) and grown in 
atmospheric oxygen for six population doublings to allow for immortalization. To generate 
lentivirus used for transduction, 293T cells were cotransfected with psPAX2 (6 µg), pMD2G 
(6 µg), and pCDH (12 µg) expression vector (See below for construction of expression 
vectors) using Lipofectamine 2000. One day prior to transduction Polq−/− MEFs were seeded 
into a 10 cm dish at 1.5 ×105 cells with 12 mL complete media. 48 h post-transfection virus-
containing media was harvested, filtered through a 0.45 µm syringe filter and used to 
replace the media on the plated MEFs. MEFs were incubated in the virus-containing media 
for 24 h before being split into T-75 flasks and allowed to grow to 80% confluence before 
undergoing three weeks of puromycin selection (2.5 µg/mL). Following selection, pure 
clones were isolated and cultured with complete media containing puromycin (1 µg/mL). 
 
Quantitative real-time PCR analysis of complemented MEFs 
RNA isolated from the complemented MEF lines were analyzed for quality and purity using 
an RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of total RNA was used 
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to generate cDNA using the High Capacity cDNA RT kit (Life Technologies). qPCR analysis 
was performed in triplicate using the ABI Prism 7900 HT thermocycler and the following 
Taqman Probe set or primer set with iTAQ SYBR Green Supermix with ROX (Bio-Rad, 
Hercules, CA): MmPolQ_FWD 5′-GGCTCTGAAGAACTCTTTGCCTTT-3′, MmPolQ_REV 5′-
GCTGCTTCCTCTTCTTCATCCA-3′, probe 5′-TCCGGGCACTTTTG-3′; HsPOLD1_FWD 5′-
CGACCTTCCGTACCTCATCTCT-3′ HsPOLD1_R 5′-ACACGGCCCAGGAAAGG-3′, 
probe 5′-CCCTCAAGGTACAAACAT-3′; Qexon FWD 5′-
TGCCTTTCAAAAGTGCCCGGAAGGC3′, Qexon REV 5′-
TGCCAGTCACCCANATAGTTCNCAT-3′ (where dSpacer is represented as N to 
compensate for mismatches between the mouse and human sequences). Data were 
analyzed using the ∆∆Ct method. For absolute quantification, titration of pCR-XL-
TOPO/MmPolQ and pET/MmPold1 plasmids were used to generate standard curves for 
expression. Transcript abundance was determined by extrapolation from linear regression 
analysis of best-fit lines from titration experiments. GAPDH was used as an internal control 
in all experiments. 
 
Bleomycin sensitivity 
Complemented MEF lines were plated in triplicate into white 96 well plates at 1250 cells per 
well and grown overnight using complete media containing puromycin (1 µg/mL). The 
following day, cells were cultured with complete media containing the indicated amounts of 
bleomycin (dissolved in 150 mM NaCl) for 24 hr before the media was replaced. Cells were 
allowed to recover for 72 hr before cellular viability was measured using the ATPlite 1Step 
kit (Perkin Elmer, Waltham, MA) using a Biotek plate reader. Experiments were repeated 
three times. 
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Immunofluorescence 
Complemented MEF lines were plated at a density of 1.5 ×104 cells per well in 4-well 
chamber slides and the following day were irradiated with either 0 or 6 Gy of x-rays. Media 
was changed and cells were allowed to recover for 48 h after damage before fixation with 
2% para-formaldehyde and permeabilization with Triton X-100. Samples were blocked with 
donkey serum for 30 minutes before being incubated overnight with primary antibodies 
against 53BP1 (Bethyl, Montgomery, TX, A300-272A, 1:500) and γH2AX (EMD Millipore 05-
636, 1:400). Cells were later incubated with AlexaFluor-488 goat-anti-mouse or AlexaFluor-
594 goat-anti-rabbit secondary (Life Technologies, 1:1000) and then stained with DAPI 
before coverslips were placed. Cells were scored for DSBs by enumerating the percentage 
of cells with >2 53BP1 foci and >2 γH2AX foci (Lange et al., 2012; Ward et al., 2003). The 
majority of cells that contained >2 foci for each of the DSB markers, exhibited colocalization 
of the foci. Cells with pan-staining of γH2AX were not included in the analysis as they are 
proposed to represent pre-apoptotic cells (Marti et al., 2006). Many of the cells with 53BP1 
foci, exhibited enlarged foci that are associated with nuclear OPT (Oct-1, PTF, transcription) 
domains that sequester damaged DNA in G1 (Harrigan et al., 2011; Lukas et al., 2011). 
Thus, most of the MEFs that were foci positive contained DSBs (Harrigan et al., 2011). 
DAPI-stained micronuclei were also scored. For each experiment 250 cells were scored for 
three independent experiments for a total of 750 cells. 
 
DNA polymerase assays 
Purified POLQ was as described (Hogg et al., 2011).  Klenow Fragment (3′→5′ exo-) was 
purchased from NEB. POLQ was diluted in buffer containing 30 mM Tris-HCl pH 8.0, 50 mM 
NaCl, 2 mM DTT, 10% glycerol, 0.01% Triton X-100, and 0.1% BSA. Klenow Fragment 
(3′→5′ exo-) was diluted in buffer containing 25 mM Tris-HCl pH 7.4, 1 mM DTT, and 0.1 
mM EDTA. POLQ reaction mixtures (10 µl) contained 20 mM Tris-HCl pH 8.8, 4% glycerol, 
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2 mM dithiothreitol (DTT), 80 µg/ml bovine serum albumin (BSA), 8 mM MgCl2, 0.1 mM 
EDTA, 100 µM of each dNTP, 30 nM of the primer-template or primer (see below). Klenow 
Fragment (3′→5′ exo-) reaction mixtures (10 µl) contained 10 mM Tris-HCl pH 7.9, 50 mM 
NaCl, 1 mM DTT, 10 mM MgCl2, 100 µM of each dNTP, and 30 nM of the primer-template or 
primer. After incubation at 37°C for 10 min for a 16-1+PA42 substrate or 20 min for 16-1, 
C20, and C19THF substrates, reactions were terminated by adding 10 µl of formamide stop 
buffer (98% formamide, 10 mM EDTA pH 8.0, 0.025% xylene cyanol FF, 0.025% 
bromophenol blue) and boiling at 95°C for 3 min. Products were electrophoresed on a 
denaturing 20% polyacrylamide-7 M urea gel, exposed to BioMax MS film, and analyzed 
with a STORM 860 Phosphor Imager (Molecular Dynamics). 
 
Oligonucleotide Substrates 
Note: Substrates designed by Dr. Kei-ichi Takata and MJY. Assays performed by Dr. Kei-
ichi Takata and analyzed by Dr. Kei-ichi Takata and MJY. Gel purified primer 
oligonucleotides 16-1 and PA42 were purchased from Bio-Synthesis, C20 was purchased 
from Midland, C19+THF was from IDT. 16-1, C20, C19+THF were 5'-labeled using 
polynucleotide kinase (Promega) and [γ-32P] dATP (PerkinElmer). 5'-[32P]-labeled 16-1 
primer was annealed to PA42 to generate a double stranded DNA substrate as described 
(Takata et al., 2006) 
 16-1 (primer)+PA42 (template) substrate: 
5'-32P-CACTGACTGTATGATG-3' 
      3'-GTGACTGACATACTACTTCTACGACTGCTC-5' 
 16-1 substrate (primer only): 
5'-32P-CACTGACTGTATGATG-3' 
 C20 substrate (primer only): 
5'-32P-CCCCCCCCCCCCCCCCCCCC-3' 
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C19+THF (tetrahydrofuran, an AP site analog) substrate (primer only): 
5'-32P-CCCCCCCCCCCCCCCCCCC[THF]-3' 
 
Sequencing of DNA extended by POLQ 
Note:  Substrate and experimental procedures were designed by Dr. Göran Bylund and Dr. 
Erik Johansson. Polymerase assay and sequencing of extension products were performed 
by Dr. Göran Bylund and Sara Lundsten. Data was analyzed by Dr. Göran Bylund and Dr. 
Erik Johansson. A truncated version of human POLQ (residues 1792-2590) was expressed 
in E. coli and purified as described (Hogg et al., 2011). Oligonucleotides were purchased 
from Eurofins MWG operon (Germany). The 200 µl primer extension reaction contained: 
[20mM Tris-HCl (pH 8.8), 4% glycerol, 10 mM MgCl2, 0.1 mM EDTA, 80 g/ml bovine serum 
albumin (BSA), 10 pmol of the tetrachlorofluorescein (TET) labelled oligonucleotide “no-
hairpin” (5’-(TET)-GTTTGTGAGTTTCC-3’) and 1.25 g POLQ(1792-2590)]. The primer 
extension reaction was incubated at 22 oC for 2 h and terminated by the addition of 10 µl 0.5 
M EDTA and POLQ was heat inactivated for one min at 100 oC. As a control, 10 µl of the 
reaction mixture was separated on a polyacrylamide sequencing gel and the amount of 
POLQ extended products was evaluated with a Typhoon 9400 Variable Mode Imager (GE 
Healthcare). The remaining DNA was precipitated overnight at -20 oC with 4 µg carrier 
tRNA, 4 µg glycogen, 0.25 volumes of 5 M ammonium acetate and 2.5 volumes of ethanol. 
Precipitated DNA was dissolved in 100 µl 10mM Tris-HCl (pH 8.0) and used as template for 
terminal nucleotidyl transferase (TdT) (Thermo Scientific). 40 µl TdT reactions contained 20 
µl POLQ extended oligonucleotide, 1X TdT buffer, 3.2 M either of dATP/dTTP or 1.5M 
either of dCTP/dGTP and 30 U TdT. The reactions were incubated at 37 oC for 15 min 
followed by heat inactivation of TdT at 70 oC for 10 min. In control experiments TdT 
reactions were performed with a no-hairpin oligonucleotide, which had not been extended by 
POLQ, as template. 10 µl from each reaction was separated on a polyacrylamide 
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sequencing gel and the amount of TdT extended products was visualized and evaluated 
with a Typhoon 9400 Variable Mode Imager. POLQ + TdT extended no-hairpin DNA and 
only-TdT extended no-hairpin DNA were amplified by polymerase chain reaction (PCR). 25 
µl PCR reactions contained:  0.2 l from each respective TdT reaction, 5 pmol of the 
oligonucleotide EcoRI-nohairpin (5’- TTTTGAATTCGTTTGTGAGTTTCC-3’), 5 pmol of 
either HindIII-25A (5’-TTTTAAGCTTAAAAAAAAAAAAAAAAAAAAAAAAA-3’), HindIII-25T-R 
(5’-TTTTAAGCTTTTTTTTTTTTTTTTTTTTTTTTTTT-3’), HindIII-15C-R (5’-
TTTTAAGCTTCCCCCCCCCCCCCCC-3’) or HindIII-15G-R (5’-TTTTAAGCTTGG-
GGGGGGGGGGGGG-3’), 1X GoTaq buffer, 200 µM of each dNTP and 1 U GoTaq DNA 
polymerase (Promega). PCR cycling conditions were: five cycles (94 oC 30 s, 50 oC 30 s 
and 72 oC 10 s) followed by 30 cycles (94 oC 30 s, 55 oC 30 s and 72 oC 10 s). PCR 
reactions were purified with QIAquick Nucleotide Removal Kit (Qiagen, Germany) and 
digested with EcoRI and HindIII. Digested PCR products were then separated on a 2% 
agarose gel containing Gel Green Nucleic Acid Stain. DNA was excised, purified with 
QIAquick Gel Extraction Kit (Qiagen, Germany), ligated into an EcoRI-HindIII digested 
pUC18 vector and transformed into competent XL1-Blue bacterial cells. Plasmid containing 
bacterial clones were selected on LB plates containing 100µg/ml carbenicillin and plasmids 
were isolated with the E-Z 96 fastfilter plasmid kit (Omega bio-tek) and sent for sequencing 
(Eurofins MWG Operon, Germany). 
 
Extrachromosomal substrate assays 
Note:  Substrates were designed by David Wyatt and Dr. Dale Ramsden, assays were 
performed by David Wyatt, and data was analyzed by David Wyatt and Dr. Dale Ramsden. 
Polq-null and complemented cell lines were generated and provided by MJY. A dermal 
fibroblast line from Ku70 and p53 deficient mice (the gift of Dr. P. Hasty, University of Texas 
Health Sciences Center) was transduced with empty vector (pBABE-puro) retrovirus or a 
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retrovirus expressing mouse Ku70. Substrates were generated by ligating short linkers to 
the head and tail of a 556 bp linear double-stranded DNA fragment. Linkers possessed 16–
17 bp of double-stranded DNA and either 6 or 45 nt 3′ single-stranded overhangs. The 
linkers with 6 nt overhangs were made by annealing 5′- 
AGTCTGAGATGGGTGTGAGATCTGC-3′ to 5′-CACTCTCTCACACCCATCTTA-3′ (“head” 
linker), and 5′-TGACTATACAGCTAAGCGATGATGCAG-3′ to 5′-CATCGCTTAGCTGTATA-
3′ (“tail” linker). The linkers with 45 nucleotide 3′ overhangs were generated by annealing 5′-
AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTT
CGGAGTACTCCTTCTTTTGAGATCTGC-3′ to 5-CTCACACCCATCTCA-3′ (“head” linker) 
and5′-TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTAT
CTGCTGTGTTGTGGATGAATTAGATGCAG-3′ to 5′-CATCGCTTAGCTGTATA-3′ (“tail” 
linker). Excess linker was removed by QiaQuick purification and substrate purity validated by 
polyacrylamide gel electrophoresis. 75 ng of substrate was mixed with 1.1 µg of supercoiled 
pMAX-GFP (Lonza) plasmid carrier and introduced into 2 ×105 cells in a 10 µl volume by 
electroporation with one 30 ms 1350 V pulse (Neon, Invitrogen). Cells were harvested after 
incubation for 1 h at 37 °C, washed, resuspended in Hank's buffered saline solution 
supplemented with 5 mM MgCl2, and extracellular DNA digested by incubation with 6.25 U 
Benzonase (Novagen) for 15 min at 37 °C. Cells were pelleted and DNA purified with the 
Qiamp kit (Qiagen). Joining efficiency was determined by quantification of head-to-tail 
junctions by qPCR using primers that either anneal within double-stranded flanks (5′- 
CTTACGTTTGATTTCCCTGACTATACAG-3′ and 5′- GCAGGGTAGCCAGTCTGAGATG-3′; 
6 nt overhang, Figure 5B) or, for the 45 nt overhang substrate only, which anneal to 
overhang sequence (5′- TAAGCGATGCTCTCACCGAG and 5′- 
GATGGGTGTGAGAGTGAAGATC; 45 nt overhang, Figure 5C). Results from electroporated 
samples were further corrected for differences in transfection and sample processing 
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efficiency qPCR specific for substrate (5′- GGCACTCTCCAAGGCAAAGA and 5′- 
ACATGTCTAGCCTATTCCCGGCTT). 
 
B cell culture and CSR analysis 
Note: B cell isolation and culture was done with the assistance of Dr. Kevin McBride and 
Sean Hensley. FACS analysis was performed by Dr. Kevin McBride and DNA isolation, 
sequencing, and sequence analysis was performed by MJY. B cells were isolated from 
mouse spleens (n = 6 per genotype) by surgical dissection of mice to isolate spleens. 
Spleens were then ground up on a 70 µM filter using a syringe plunger to release B cells. 
Naïve B cells were isolated by anti-CD43 (Ly-48) bead negative selection using a MACS 
column (Miltenyi Biotec, Dallas, TX) and stimulated for class-switching in culture for 72 h. 
Where indicated, cultures were incubated with DNA-PKcs inhibitor 20 µM NU7026 (Tocris, 
Bristol, UK) dissolved in DMSO, or mock-treated. The stimulation procedure and flow-sorting 
for CSR analysis was as described (Callen et al., 2009; Reina-San-Martin et al., 2003). Prior 
to this analysis, cells were counted; numbers and viability were similar for all groups. Sµ-Sγ1 
CSR junctions were amplified by PCR using the following conditions for 25 cycles at 95 °C 
(30 s), 55 °C (30 s), 68 °C (180 s) using the primers (FWD 5′-
AATGGATACCTCAGTGGTTTTTAATGGTGGGTTTA-3′; REV 5′ 
CAATTAGCTCCTGCTCTTCTGTGG-3′) and Pfu Turbo (Stratagene, La Jolla, CA). To the 
PCR reaction, 5 U of Taq polymerase (Promega, Madison, WI) was added and incubated at 
72 °C for 10 min. The resulting product was TOPO TA cloned and transformed into 
Top10 E. coli cells (Life Technologies, Carlsbad, CA) and plasmids were purified and sent 
for sequencing using M13 FWD and REV primers in addition to the amplification primers for 
sequencing. 100 clones for each group were analyzed for mutations, deletions, insertions, 
and sequence overlaps at the junction and both 30 nt upstream and downstream of the 
junction. p-values were determined by using the two-tailed Fisher's exact test. 
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Translocation assay 
Note:  B cell isolation and culture and DNA isolation was performed by MJY. Sean Hensley 
performed PCR amplification of translocation derivative and Dr. Yunxiang Mu performed 
Southern Blotting. MJY and Dr. Kevin McBride analyzed the data. Naïve B cells from three 
pairs of Polq+/+ and Polq−/− mice were harvested as above, cultured for 72 h, and DNA was 
isolated. 32 separate PCR reactions, each containing the genome from 1 ×105 cells, was 
performed with primers to amplify Myc/IgH translocations and amplified translocations were 
verified by Southern blotting using internal probes to the Myc and IgH loci as described 
(Kovalchuk et al., 1997; Loveday et al., 2011). Three independent experiments were 
performed and the p-value was determined using the two-tailed Fisher's exact test. %IgG1 
was also measured as an internal control to ensure the B cells from each genotype were 
switching at a comparable level. 
 
Generation of POLQ monoclonal antibody 
The QL fragment of POLQ (Hogg et al, 2011) was used to immunize a mouse, and a 
monoclonal antibody that recognizes POLQ was generated. The epitope recognized by this 
antibody (MDACC POLQ20) was mapped using peptide arrays to amino acid residues 
2147-2151.  For more details see Chapter 6. 
 
Generation of POLQ expression constructs 
Note: All cloning and sequencing was performed by MJY. Dr. Junya Tomida generously 
provided the pCDH vector backbone with the C-terminal FLAG-HA epitope tags.  The POLQ 
cDNA was cloned from pFastbacHTc/POLQ (Seki et al., 2003) using KOD Xtreme (EMD 
Millipore, Billerica, MA) polymerase using the following primers and conditions (FWD 
5’ CGGGATCCTAGCACCATGAATCTTCTGCGTCGGAGTG 3’, REV 5’-
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CACATCAAAGTCCTTTAGCTCTCCCGCCGGCGTTTTCCTTTT-3’); 20 cycles at 95 °C (30 
s), 60 °C (30 s), 68 °C (10 min).  PCR products were subsequently digested with BamHI and 
NotI and ligated into a similarly digested pBluescript SKII+ vector. pBluescript/POLQ was 
propagated and sequenced to ensure no mutations, before the POLQ cDNA was digested 
with the aforementioned restriction enzymes and ligated into pCDH-FHC vector.  The final 
vector pCDH-FHC/POLQ was propagated and sequenced for insert verification and 
mutation analysis.  Engineering of the mutant pCDH/POLQ vectors is detailed below. The 
individual domains of POLQ (Helicase-like, Central, and Pol domain) were amplified from 
pBluescript/POLQ using KOD Xtreme and the following primers before being digested with 
BamHI and NotI, then ligated into pBluescript: 
 
Helicase-like (HLD) domain 
CDH HLD5’ CGGGATCCTAGCACCATGAATCTTCTGCGTCGGAGTG; 
CDH HLD3’ TGCCCATGCGGCCGCGATTATAAAACTCTCGAGCAATGATATCTGC 
Central (CEN) domain 
CDH CEN5’ AGGAAAGGATCCATTGCTCGAGAGTTTTATAATCTACATCATCAAGC; CDH 
CEN3’ TCGTTGCGGCCGCTTCCTTTCGCAAGCAAGATTGAAGGTACCACATC 
Polymerase (POL) domain 
CDH POL5’ AGGAAAGGATCCGATGTGGTACCTTCAATCTTGCTTGCGAAAGGAA; 
CDH POL3’ AAAAGGAAAagcggccgcCACATCAAAGTCCTTTAGCTCTCC 
 
Vectors were sequenced to verify no mutations before site-directed mutagenesis was 
performed with the following plasmid-primer combinations using KOD Xtreme: 
POLQ-K121M 
pBluescript/HLD 
Forward: 5' CTACAAGTGCTGGGATGACTCTTGTGGCAG 3';  
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Reverse: 5' CTGCCACAAGAGTCATCCCAGCACTTGTAG 3' 
POLQ-D2330A/Y2331A 
pBluescript/Pol 
Forward: 5' GTTCAATACTGGCTGCTGCCGCCTCTCAGCTTGAACTGAG 3'; 
Reverse: 5' CTCAGTTCAAGCTGAGAGGCGGCAGCAGCCAGTATTGAAC 3' 
 
POLQ-S1977P 
PBluescript/Pol 
Forward: 5' CTATAAAATTCTTCTTCTTCCTTGTGGCATCTCCTTGGAG 3'; 
Reverse: 5' CTCCAAGGAGATGCCACAAGGAAGAAGAAGAATTTTATAG 3' 
 
Following mutational verification, the individual domains were digested with the 
corresponding restriction enzymes before being ligated into pCDH-FHC that was previously 
digested with BamHI and NotI: 
pBluescript/HLD (BamHI, XhoI), pBluescript/CEN (XhoI, KpnI), 
pBluescript/POL (KpnI, NotI) 
 
Following ligation, plasmids were sequenced to ensure proper ligation and maintenance of 
engineered mutations. 
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2.3 Results 
Hypersensitivity to DNA strand-breaking agents in the absence of Polq 
As discussed in Chapter 1, mutants of POLQ in different species exhibit a broad 
range of hypersensitivity to various DNA damaging agents (Table 2) (Yousefzadeh and 
Wood, 2013). To clarify the cellular role of POLQ in response to DNA damage, we 
measured the sensitivities of Polq-null and Polq-proficient bone marrow stromal cell (BMSC) 
lines to various DNA damaging agents. BMSC lines lacking POLQ were previously shown to 
exhibit hypersensitivity to ionizing radiation (Goff et al., 2009; Higgins et al., 2010b), 
Interestingly, one of the reports found that only cancer cells with reduced POLQ levels were 
hypersensitive to IR. “Normal” cell lines suppressed for POLQ by siRNA did not show 
hypersensitivity to IR under the same conditions (Higgins et al., 2010b). These contrasting 
results warrant further investigation. 
We found that Polq−/− cells were also hypersensitive to agents that directly cause 
DNA breaks (Figure 5). These included topoisomerase II inhibitors etoposide and ICRF-193 
(Huang et al., 2001), and camptothecin, a topoisomerase I inhibitor. The observation of 
hypersensitivity of cells to camptothecin in the absence of Polq was intriguing. Camptothecin 
generates single-strand breaks and is only thought to induce DSBs indirectly when the 
replication or transcription machinery collides with the trapped cleavage complex (Strumberg 
et al., 2000). DSBs could also form if two trapped Topoisomerase I complexes on different 
strands are near each other, or if the single-stranded DNA near the trapped cleavage 
complex falls prey to nucleases. Loss of Polq did not cause hypersensitivity to agents that 
primarily form DNA replication-blocking adducts on one DNA strand including, for example 
ultraviolet radiation and the methylating agent temozolomide. The Polq−/− cells were also not 
more sensitive than control cells to mitomycin C, cisplatin, and UVA-photoactivated psoralen 
plus UVA, all of which induce some interstrand DNA crosslinks (ICLs) (Figure 5). In contrast 
to a prior report (Higgins et al., 2010b), our findings show that at least some Polq−/− non-
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cancer cell lines do, in fact, exhibit hypersensitivity to IR (Figure 5) (Yousefzadeh et al., 
2014). 
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Figure 5. Hypersensitivity of Polq−/− bone marrow stromal cells to DNA strand-
breaking agents. BMSCs were exposed to x-rays or UVC at the indicated doses, and to 
etoposide, ICRF-193, camptothecin, olaparib, temozolomide, mitomycin c, cisplatin, and 
HMT psoralen+UVA at the indicated concentrations and plated in triplicate. Two isogenic 
bone marrow stromal cell lines were used for each genotype: Polq+/+ or Polq−/−. Colonies 
were stained with crystal violet and counted seven to ten days later. Experiments were 
repeated three times. Circles, Polq+/+ clone 1; Squares, Polq+/+ clone 1; 
Triangles, Polq−/− clone 1; inverted triangles, Polq−/− clone 3. Clonogenic assay of Rad51D+/+ 
and Rad51D-/- CHO cells treated with the indicated doses of olaparib, as a positive control 
(Loveday et al., 2011). All clonogenic survival assays performed by MJY except those with 
the Rad51D CHO cells, which were performed by Megan Lowery. 
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These data indicate that POLQ is most important for a process conferring resistance 
to DNA strand-breaks, particularly double-strand breaks. Sensitivity to olaparib, a PARP 
inhibitor, was measured because homologous recombination mutants exhibit 
hypersensitivity to this agent. A current theory is that cells are ill-equipped to deal with the 
increase conversion of single-strand breaks that are converted to DSBs when PARP is 
impaired (Bryant et al., 2005; Farmer et al., 2005; Loveday et al., 2011). Cells 
lacking Polq were not hypersensitive to the PARP inhibitor olaparib (Figure 5) while control 
Rad51D-defective cells were hypersensitive (Figure 5). This suggests that POLQ does not 
function in the BRCA/homologous recombination pathway (Farmer et al., 2005). POLQ-
proficient cells treated with both olaparib and camptothecin were significantly sensitized 
compared to camptothecin alone. However, addition of olaparib to Polq-null cells only 
modestly increased the sensitivity to camptothecin (Figure 5). Besides being involved in 
single-strand break repair, PARP is also thought to operate within altEJ, that functions 
independently of cNHEJ factors Ku and DNA Ligase 4. Consequently, PARP and POLQ 
may operate within the same subpathway of DNA repair.   
 
Loss of Polq enhances chromosomal instability in somatic cells 
Previous work revealed an increase in micronuclei in Polq-defective cells in 
peripheral erythrocytes. To determine whether this phenomenon is also true in other cell 
types, matched wild-type and Polq−/− BMSC lines were exposed to etoposide or x-rays, and 
the number of cells with micronuclei after 48 h were enumerated (Figure 6A and B). Polq-
null cells exhibited a ~3 fold increase in the frequency of spontaneous micronuclei formation 
(Figure 6C). Upon exposure to DNA damaging agents, the percentage of cells with 
micronuclei increased about 1.5-fold more per unit of damage for Polq−/− cells in comparison 
to Polq+/+ cells (Figure 6A and B). This shows that the susceptibility to micronucleus 
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formation in Polq−/− cells is not confined to cells of the hematopoietic lineage, but occurs also 
in cultured cells, including fibroblast-like BMSCs. 
Cells lacking Polq were analyzed for their ability to proliferate in culture. Two 
independent BMSC lines devoid of Polq expression proliferated at a rate comparable to a 
pair of wild-type control cells. The Polq−/− BMSCs showed only a 5% lengthening of 
population doubling times (Figure 6D and E). I extended this analysis to isogenic 
immortalized mouse embryonic fibroblast (MEF) cell lines (Figure 6F and G). 
Again, Polq−/− cells divided at a rate comparable to Polq+/+ cells. These findings fit with 
previous observations from the Wood laboratory that hematopoietic cell counts in 
irradiated Polq-null mice recovered at rates comparable to wild-type mice (Goff et al., 2009). 
I observed no major alterations in growth or development in unchallenged Polq null or 
mutant mice, consistent with previous reports (Shima et al., 2003; Shima et al., 2004; Zan et 
al., 2005). These observations indicate that despite some increased chromosomal 
instability, POLQ-defective cells originating from a variety of tissues can proliferate at near-
normal rates. 
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Figure 6. Loss of Polq contributes to chromosomal instability both spontaneously 
and in the presence of DNA damage. Polq+/+ or Polq−/− bone marrow stromal cells 
(BMSCs)plated in chamber slides were exposed to (A) X-rays or (B) etoposide. 48 h after 
damage cells were fixed and stained with DAPI to enumerate cells with micronuclei. Counts 
represent the average percentage of cells with micronuclei scored in three independent 
experiments. [Slopes for X-ray and etoposide-induced MN: Polq+/+ clone 1 (2.8, 
0.73); Polq+/+ clone 2 (3.1, 0.85); Polq−/− clone 1 (4.8, 1.2); Polq−/− clone 3 (6.2, 1.3)] The 
frequency of spontaneous micronuclei for each of the clones in Figure 6A and B were 
combined to generate (C) total spontaneous micronuclei observed for all genotypes. The p-
value was determined by the Wilcoxon Mann Whitney rank sum test. Polq+/+ or Polq−/− (D) 
BMSCs and (F) mouse embryonic fibroblasts were plated in growth medium in triplicate. 
Cells were counted at the indicated days and cumulative population doublings were 
recorded. The experiment was repeated three times. (E and G) Absolute quantification 
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of Polq transcript numbers in three independent experiments. Enumeration of micronuclei, 
cell culture, RNA isolation, cumulative population doubling analysis, and data analysis was 
performed by MJY. qRT-PCR was performed by the Science Park Molecular Biology Core.  
 
 
The DNA polymerase activity of POLQ is required to confer resistance to DNA damaging 
agents 
Next I sought to investigate which catalytic activities of POLQ are necessary to 
confer resistance to DNA damaging agents. Lentiviral-delivered expression vectors were 
constructed with the assistance of Dr. Junya Tomida to express wild-type or mutant versions 
of POLQ in immortalized Polq−/− MEFs, in order to test for functional complementation 
(Figure 7A). A tandem (D2330A, Y2331A) mutation was introduced into the DNA 
polymerase domain (POL) mutation of the corresponding residues in other DNA 
polymerases completely inactivates polymerase activity (Patel and Loeb, 2000). In a 
separate construct, a mutation was introduced into the conserved ATP-binding site of the 
Walker A motif (K121M) in the helicase-like domain (HLD). An equivalent mutation 
eliminates DNA helicase activity in related enzymes, including HELQ (Marini and Wood, 
2002). A third construct (DM) was made harboring mutations in both domains. These 
vectors expressed full-length recombinant POLQ as tested in transfected 293T cells (Figure 
7B and C). 
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Figure 7. Complementation of the polymerase activity of POLQ rescues DNA damage 
hypersensitivity of cells lacking Polq. (A) POLQ cDNA was cloned into the pCDH-FH 
vector containing a FLAG-HA epitope tag on the C-terminus. (B) 293T cells were transiently 
transfected with pCDH containing either empty-vector control or POLQ cDNA. Crude 
extracts were immunoblotted with the indicated antibodies to confirm expression of full-
length recombinant POLQ and (C) mutant constructs that were transiently transfected in 
293T cells. (D) Stable Polq−/− MEF lines complemented with POLQ expression vectors (or 
empty vector control) were assayed for Polq expression by qPCR. WT4 and WT6 are 
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independent clones complemented by wild-type POLQ; POL, mutation in the DNA 
polymerase domain; HLD, mutation in the DNA helicase domain, DM, mutation in both 
domains. (E) The complemented MEF lines were treated with bleomycin for 24 hr and 
cellular ATP levels were measured 72 h later. (F) Spontaneous micronuclei and (G) DNA 
double-strand breaks (>2 colocalized γH2AX and 53BP1 foci per cell) were quantified for 
three independent experiments. The brightness of the entire microscope field was increased 
to better display the fluorescence for print, using Adobe Photoshop CS6. Dr. Junya Tomida 
generously provided the pCDH vector backbone containing the C-terminal FLAG-HA epitope 
tags and technical advice. All cloning of POLQ cDNA, transfections, lentiviral transductions, 
immunoblotting, cell sensitivity and DNA damage marker assays, and data analysis was 
performed by MJY.  qRT-PCR was performed by the Science Park Molecular Biology Core. 
 
 
The mutant cDNAs were tested for their ability to genetically complement the 
bleomycin sensitivity of Polq-null MEFs. Stable clones with each of the constructs were 
generated and analyzed for expression of POLQ (Figure 7D). Two independent clones of 
knockout MEFs expressing wild-type recombinant POLQ (WT4 and WT6) were able to 
rescue bleomycin hypersensitivity (Figure 7E). Neither the polymerase domain mutant 
(POL) nor the polymerase-helicase double mutant (DM) restored bleomycin sensitivity 
(Figure 7E, Figure 8). Expression of a construct with a mutation in only the helicase-like 
domain (HLD) was, however, still able to restore resistance to bleomycin. These data 
indicate that POLQ polymerase activity is essential for conferring resistance to DNA 
damage, whereas the ATPase activity of the helicase-like domain is not necessary. 
Similarly, reintroduction of POLQ polymerase activity into Polq-deficient MEFs was able to 
rescue chromosomal instability based on the analysis of micronuclei and DNA DSBs, as 
measured by 53BP1 and γH2AX colocalization (Figure 7F and G, Figure 9). 
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Figure 8. Complementation of polymerase-dead POLQ does not rescue DNA damage 
sensitivity. Polq+/+, Polq-/-, Polq-/-Empty, and multiple clones of Polq-/-POL and Polq-/-DM 
MEF lines were treated with 1 µM bleomycin for 24 h and cellular ATP levels were 
measured 72 h later. All sensitivity assays were performed by MJY. 
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Figure 9. Analysis of DNA double-strand breaks and micronuclei in complemented 
Polq MEFs. Representative immunofluorescence images of Polq-/-Empty and Polq-/-WT4 
MEF lines stained with DAPI and antibodies against 53BP1 and γH2AX.  Scale bar 
represents 25 µm.  Arrows note micronuclei.  Pan staining of γH2AX (P), OPT domain 
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staining by 53BP1 (OPT), and examples of colocalization (Co) are noted. All cell culture and 
staining, imaging, and analysis performed by MJY. 
 
 
Mice with an S1932P mutation in Polq (the “chaos1” allele) have an increased 
spontaneous frequency of micronuclei (Shima et al., 2003). We generated a 
human POLQ cDNA mimicking the chaos1 mutation (S1977P), but attempted expression of 
POLQ with this mutation in 293T cells did not yield detectable protein despite ample 
transcript levels (Figure 10). This suggests that the chaos1-encoded mutant protein is 
unstable, consistent with the finding that chaos1 mice have a phenotype essentially 
indistinguishable from Polq knockout mice (Shima et al., 2003). 
 
 
 
Figure 10. Full-length chaosI mutant protein is poorly expressed.  293T cells were 
transfected with pCDH constructs that contained either the human POLQ cDNA, ChaosI 
mutant (S1977P, corresponding to the S1932P mutated residue in mice), or empty control.  
(A) 48 h post transfection lysates were made and immunoblotted with antibodies against 
FLAG and alpha-Tubulin. (B) Total RNA was isolated from cells and qPCR analysis of 
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POLQ transcript levels were performed using the ∆∆Ct method. An asterisk (*) denotes a 
non-specific band. All cell culture, transfections, immunoblotting, RNA isolation, and data 
analysis were performed by MJY. qRT-PCR was performed by the Science Park Molecular 
Biology Core. 
 
 
POLQ operates in a pathway of altEJ during mouse Ig class-switching 
Immunoglobulin class-switch recombination (CSR) uses DNA end joining to 
exchange one constant region of an antibody gene for another constant region (Figure 4). 
CSR can occur by both Ku-dependent classical non-homologous end joining and Ku-
independent altEJ (Boboila et al., 2012a). The overall frequencies of CSR are similar 
in Polq-defective mice (Martomo et al., 2008) and cultured B cells (Li et al., 2011). To 
determine whether POLQ is involved in a mechanistically distinct subset of CSR joins, In 
2012 our lab began a collaboration with Dr. Kevin McBride, a molecular immunologist on the 
department faculty, who had expertise in CSR. I, with help from Dr. Kevin McBride and his 
laboratory, isolated and analyzed DNA sequences at such joins. Naïve B cells were isolated 
from the spleens of wild-type and Polq-null mice and stimulated for IgM to IgG class 
switching, and then the fraction of IgG1-positive B cells was measured by flow cytometry. 
Parallel B-cell cultures were incubated with NU7026, a DNA-PKcs inhibitor that suppresses 
cNHEJ (Callen et al., 2009). It has been shown that B cells incubated with NU7026 have an 
increased proportion of CSR junctions with >1 bp insertion at the junction (Callen et al., 
2009). This suggests that when altEJ is used during CSR, it more frequently results in the 
insertion of nucleotides. 
I found that B cells from Polq-proficient and deficient mice had similar overall 
frequencies of CSR (Figure 11A), and that inhibition of DNA-PKcs increased the frequency 
of CSR in both genotypes by 1.5 to 2-fold (Figure 11B). The Sµ-Sγ1 junction was then 
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sequenced from 100 clones of each group of IgG1-positive B cells. In wild-type B cells, 
insertions of >1 bp at Sµ-Sγ1 junctions, that are thought to be altEJ-dependent, comprised 
about 9% of total events, and was increased to ~21% in cells incubated with NU7026 
(Figure 11C, Table 4). 
Strikingly, in cells lacking Polq, this class of longer insertions at CSR junctions was 
absent, even in the presence of NU7026 (Figure 11D), only one insertion of 2 bp was 
observed, therefore insertions of >1 bp require POLQ. Polq-dependent joining events 
included insertions of between 2 and 35 bp. For longer insertions (greater than ~10 bp) 
homologous sequences were unambiguously detected up to 2–5 kbp away from the junction 
site (Table 4), as has been reported for long insertions at Sµ-Sγ1 junctions in ATM-defective 
B cells (Callen et al., 2009). This suggests that most, if not all, such insertions are formed in 
a templated manner during altEJ by POLQ. 
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Figure 11. Insertions >1 nt at CSR junctions are Polq-dependent. Isolated wild-type 
(WT) and Polq−/− (KO) naïve splenic B cells were stimulated for CSR and either mock-
treated or treated with NU7026. (A) Cells were assayed for IgG1 levels (y-axis) by flow 
cytometry. The x-axis displays forward scatter (FSC) for cell viability. Aicda−/− splenic B cells 
were used as a negative control since they do not undergo CSR. Numbers in boxes show 
the percentage of the population that is IgG1 positive; in (B) these data are plotted relative 
to wild-type. Genomic DNA isolated from B cells of wild-type (C) and Polq KO (D) mice was 
amplified by PCR and 100 Sµ-Sγ1 junctions from each group were sequenced and analyzed 
for overlaps and insertions at breakpoints. (E) Insertions >1 nt are plotted; p-values were 
determined by the two-tailed Fisher's exact test. Cell viabilities were comparable between 
genotypes. B cell isolation and culture was performed by MJY with assistance from Dr. 
Kevin McBride and Sean Hensley. FACS analysis was performed by Dr. Kevin McBride, and 
DNA isolation, PCR amplification, and sequencing analysis of switch junctions was 
performed by MJY. DNA sequencing was performed by the Science Park Molecular Biology 
Core. 
 
 
  62
 
 
 
 
Table 4. Sequence composition of >1 nucleotide CSR insertions in Polq mice. New 
mutations (different from the reference sequence) are shown in red. For some longer 
insertions (blue), homologies were identified in the switch region, at the positions indicated 
in the right column. Microhomologies at the junction site are underlined. Sequences 
(graphed in Figure 11) are from wild-type (Polq+/+) and Polq-null (Polq-/-) splenic B cells that 
were treated with NU7026 or mock-treated. Schematic below table shows CSR mu (Sµ) and 
gamma 1 (Sγ1) switch regions with areas of DNA breakage noted by red boxes. Numbers 
correlate to switch region length. Sequence analysis performed by MJY. 
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Loss of Polq impairs an altEJ pathway but not cNHEJ in cultured cells 
The most important factor in determining which double-strand break repair pathway 
is used is whether or not the 5′ termini of broken ends are resected (Symington and Gautier, 
2011). Ends with little or no single stranded overhang are typically rejoined by Ku-dependent 
cNHEJ. In contrast, CtIP and MRN-dependent resection of 5′ termini generates ends with 
extended single stranded 3′ overhangs; resection is thought to block cNHEJ (Frank-Vaillant 
and Marcand, 2002) and enable repair by altEJ (Bennardo et al., 2008; Lee and Lee, 2007). 
In 2013, Dr. Dale Ramsden (UNC Chapel Hill) contacted Dr. Wood to enquire about 
POLQ and DNA end joining. We initiated collaboration where I sent my complemented Polq 
MEF lines to be used to determine the impact of POLQ status on cNHEJ and altEJ. To 
analyze differing requirements for end joining, with or without end resection. David Wyatt, a 
graduate student in the Ramsden laboratory, prepared two linear DNA substrates with 3′ 
single stranded overhangs; one with a short overhang (6 nt), and one a long overhang (45 
nt, a “pre-resected end”) (Figure 12A). Both can be aligned with the same 4 nt of terminal 
complementary sequence. These substrates were then introduced into wild-type mouse 
fibroblasts or fibroblasts harboring deficiencies in Ku70 or Polq. Repaired products were 
recovered from cells and quantified. Repair of the short overhang substrate was, as 
anticipated, over 10-fold less efficient in cells without Ku70 (Figure 12B) when compared to 
Ku70-complemented controls. The absence of Polq had no consequence for the repair of 
this substrate. 
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Figure 12. End joining with extrachromosomal substrates. (A) Substrates were 
designed to resemble DNA double-strand breaks that are repaired through Ku-dependent 
NHEJ (6 nt tail with 4 nt of terminal complementary sequence) or alternate end joining of 
resected DNA substrates (45 nt tail with 4 nt terminal complementary sequence), introduced 
into cells, and joining of head-to-tail products assessed by qPCR. (B) qPCR for the classical 
NHEJ assay uses primers to detect all events having sequences in the duplex immediately 
flanking the break. Joining efficiencies are expressed as fractions of the mean joining 
determined for matched wild-type controls (Polq+/+ or Ku70 complemented lines, as 
appropriate). Three independent triplicate measurements were made for the Polq cell lines 
and two independent triplicates for the Ku cell lines. Error bars represent the standard error 
of the mean. Joining efficiency was not significantly different, whether cells were deficient 
in Polq(Polq−/−Empty) or not (Polq+/+, Polq−/−WT4, Polq−/−WT6), but was different when cells 
expressed Ku (Ku70−/−Ku70) when compared to Ku70−/−Empty cells (t-test, p<0.05) (C) 
qPCR for the altEJ assay used primers to detect that subset of products including at least 10 
nt of each 3′ overhang. Mean relative joining efficiencies, standard error of the mean, and 
statistical analysis performed as for panel B. Joining efficiency was significantly different in 
cells expressing Polq (Polq+/+, Polq−/−WT4, or Polq−/−WT6) when compared to Polq−/−Empty 
cells (p<0.05), and in cells expressing Ku (Ku70−/−Ku70) when compared to Ku70−/−Empty 
cells (t-test, p<0.05). The background observed in a mock transfected sample was 
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determined to be 0.038, +/− 0.02 of wild-type controls. p values are represented as: * p<.05, 
** p<.01, *** p<.001, ****p<.0001, and not significant (ns). Substrates were designed by 
David Wyatt and Dr. Dale Ramsden, assay performed by David Wyatt, and data analyzed by 
David Wyatt and Dr. Dale Ramsden. Polq-null and complemented cell lines were generated 
and provided by MJY 
 
 
End joining with the 45 nt overhang substrate was assessed using qPCR primers 
located to ensure that at least 10 nt of overhang was included in joined products (Figure 
12A). Recovery of these products was no longer dependent on Ku; instead, it was increased 
2.8-fold in Ku70-deficient cells (Figure 12C). This is consistent with previous studies 
demonstrating that Ku suppresses repair by altEJ. Strikingly, joining of the long overhang 
substrate in Polq−/− cells was reduced 10-fold, approaching background levels of signal 
observed using this assay. Complementation of the knockout cells with POLQ returned altEJ 
joining to wild-type levels (Figure 12C). These data demonstrate that POLQ participates in 
some form of altEJ, but that cells lacking POLQ maintain proficiency for cNHEJ. 
 
POLQ extends 3′ DNA ends in a template-dependent manner 
Our results demonstrate that POLQ is necessary to form the insertions found in CSR 
junctions in a process of altEJ. We next sought to determine the mechanism. Dr. Kei-ichi 
Takata, an expert in DNA polymerase assays in the Wood laboratory, generously provided 
technical advice and performed primer extension analysis to further analyze the polymerase 
properties of POLQ in vitro. Like other DNA polymerases, an active polymerase fragment of 
POLQ (Hogg et al., 2011) can catalyze template-dependent DNA synthesis from an 
annealed primer (Figure 13A). As is common for family-A DNA polymerases, only a single 
nucleotide is added to the end of duplex DNA (Seki et al., 2004). Unusually, however, POLQ 
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can catalyze extension of single-stranded oligonucleotides (Hogg et al., 2012). It was 
unclear whether this reflects a robust terminal deoxynucleotide transferase activity of POLQ 
on single-stranded DNA, or some form of template-dependent synthesis. For example, 
POLQ can extend a single-stranded 16-mer oligonucleotide provided without a 
complementary template (products up to 35 nt long), while E. coli pol I Klenow fragment has 
no activity on this substrate (Figure 13B). The major 22 nt extension product produced by 
POLQ on the 16-mer used in Figure 13B may be accounted for by inter- or intra-
oligonucleotide pairing (Figure 13C). Neither POLQ nor Klenow fragment could extend an 
oligonucleotide that was incapable of annealing to itself (Figure 13D and E) (Hogg et al., 
2012). 
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Figure 13. Unique template dependent DNA polymerase activity of POLQ. 
Exonuclease-defective E. coli pol I Klenow fragment (Kf exo-) or POLQ was incubated at the 
indicated protein concentrations with (A) a 5′-32P-labeled 16-mer primer and 30-mer 
complementary template, or a (B) 5′-32P-labeled 16-mer primer and no template. All reaction 
mixtures included all four deoxynucleotide triphosphates and were incubated at 37°C for 10 
min (A) or 20 min (B). The first lane contained no enzyme. The percentage (%) of the primer 
extended is shown below each lane. (C) Model of major 22 nt product formation produced 
by extension from the primer in Figure 13B, which has a limited ability to self-anneal.  
Similar reactions were performed with (D) 5′-32P-labeled 20-mer dC oligonucleotide or (E) a 
20-mer dC oligonucleotide with a synthetic abasic site on the 3’ end. Primer extension 
assays were performed by Dr. Kei-ichi Takata and MJY. 
 
 
In the summer of 2013 at a meeting in St. Petersburg, Russia, Dr. Erik Johansson 
(Umeå University, Umeå, Sweden) approached Dr. Wood with some very interesting 
biochemical data about POLQ. To identify the mechanism of 3′ single-stranded DNA 
extension by POLQ, Dr. Göran Bylund and Sara Lundsten of the Johansson laboratory.  
They used a single-stranded oligonucleotide designed to be unable to form self-
complementary base pairs longer than a single nucleotide (Hogg et al., 2012), and 
sequenced the products of POLQ-mediated extension. Individual extension products of 1 to 
30 nt were found (Table 5). Most of the sequenced extension products feature AAC or 
AAAC sequences that could arise from copying GTTT sequences in the template via inter- 
or intra-molecular priming and re-priming (Figure 14) following minimal base pairing at the 
3′-primer end. My analysis of these data reveal that POLQ uniquely extends 3′ DNA tails 
through template-dependent DNA synthesis from a primer with minimal base pairing rather 
than through a true TdT-like activity. POLQ indeed has unique biochemical properties 
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compatible with these observations. Unlike other DNA polymerases, POLQ can efficiently 
extend a DNA chain with a nucleotide incorporated opposite an abasic site (Seki et al., 
2004), or from a mismatched primer-terminus (Seki and Wood, 2008). Further, there is 
evidence that primers slip on DNA templates with an increased frequency during POLQ-
mediated synthesis, as shown by the high frequency of single base pair frameshift mutations 
generated by purified POLQ (Arana et al., 2008). 
 
 
 
 
Table 5. POLQ-dependent extension of 3’ DNA ends relies upon homology.  Primer 
extension assays were carried out with a defined substrate (top) incubated in the presence 
of an active polymerase fragment of POLQ.  Products were then incubated with terminal 
deoxynucleotidyl transferase (TdT) in the presence of only dA, dC, dG, or dTTP to create 
extension products that terminate with homopolymeric runs.  The reaction products were 
then cloned and sequenced for analysis of extension products. Extension products are listed 
Substrate GTTTGTGAGTTTCC
Seq Length Extension Product Homopolymer
29 11 AAACAACCAAC A
30 11 ACAACCCCAAC A
31 9 AAACAAACG A
32 8 GGGCGAGT G
33 8 AAACAAAC A
34 8 AACAAGAC A
35 6 GCGCCG C
36 5 AAAAC A
37 5 AAGAC A
38 5 CACCC A
39 5 CACAC A
40 5 AAGAC A
41 4 TCGT G
42 4 GAGG A
43 4 AAGC A
44 3 AAA G
45 3 CAC A
46 2 AA G
47 2 CC A
48 1 A G
49 1 T G
50 1 T G
51 1 T G
52 1 C G
53 1 T A
54 1 C A
Substrate GTTTGTGAGTTTCC
Seq Length Extension Product Homopolymer
1 30 AAACAAACAAACAAACAAACAAACAAACAA T
2 26 AAAACAAGCAAACAACCAAACTTTTG T
3 25 AAAAAAAAAAACAAACTCACGCGAT G
4 24 AACACAAACAAAACAACCCGCAAT C
5 23 ACAAACAAACAAACAAACACACG C
6 21 AAAACAACAAACAAAACTCCG C
7 21 AAACAAAACAAACAAACAAAG A
8 20 AAACAAACAAACAAGCCGGG C
9 20 AACAAACCTGTACCGGCCCG C
10 20 TCAAAAAACTCAAAACAAAC A
11 19 AAAACAAAACAAAACAAAC G
12 19 CAAACTCATCTCACGCGAA C
13 18 AAACAAACAAAACAAACC A
14 18 ACAAACAAACAAACACAC A
15 17 AACAAACAAAACAAACA C
16 17 ACAAACAAACAAACCGG C
17 17 AAAAACAAAAAAAACTC A
18 16 AAGCAAACAACAAAAA G
19 16 AAAAACAAAAAAAAAA G
20 14 AAAACAAAACAAAA G
21 14 AAACAAACAAACAC G
22 14 ACAAACAAACAAAC A
23 13 AAACAAACAAACG A
24 13 AAACAAACAAGAG A
25 13 AAACAAACAAACG A
26 12 ACAAAACAAACG C
27 12 AAACAAACAAAC A
28 12 AAACAAACAAAC A
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above for each homopolymeric run. Polymerase assay and sequencing of extension 
products were performed by Dr. Göran Bylund and Sara Lundsten. Data analysis was 
performed by MJY to make the model in Figure 14. 
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Figure 14. POLQ promiscuously extends single-stranded DNA ends through 
intermolecular templating. Model of intermolecular templating performed by POLQ in the 
process of extending a single-stranded oligonucleotide, used to produce the data in Table 5. 
This model depicts a 12 nt extension product in Table 5. The product can be produced by a 
series of annealing, extension, slippage and repriming events. DNA ends could also be 
elongated, in some cases, through intramolecular templating, extension, followed by 
slippage. 
 
 
POLQ suppresses Myc/IgH translocations in B cells 
Double-strand breaks initiated by AID activity in the immunoglobulin heavy chain 
(IgH) locus of B cells are necessary to generate immunological diversity, but breaks are 
sometimes generated at other chromosomal sites, providing an opportunity for dangerous 
chromosome translocations (Chiarle et al., 2011; Klein et al., 2011; Simsek and Jasin, 2010; 
Zhang and Jasin, 2011). For instance the oncogenic Myc/IgH translocation that causes 
Burkitt lymphoma is AID-dependent and requires breaks at both Myc and IgH, with breaks in 
the Myc gene being rate-limiting (Robbiani et al., 2008). An altEJ process is implicated in the 
formation of oncogenic translocations in lymphoid tissues, including 
the Myc/IgH translocation in murine B cells (Boboila et al., 2012b; Simsek et al., 2011a; 
Simsek and Jasin, 2010). cNHEJ suppresses the formation of such chromosomal 
translocations (Ferguson et al., 2000). To determine the role of POLQ in chromosomal 
translocations, Polq+/+ and Polq−/− naïve splenic B cells were stimulated in culture and 
assayed for the frequency of Myc/IgH translocations (Figure 15A). Notably, in the absence 
of Polq there was a 4-fold increase in translocation frequency (Figure 15B and C). This 
indicates that mammalian POLQ acts in a subset of altEJ events to suppress chromosomal 
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translocations. Additionally, an increase in intramolecular IgH rearrangements was found in 
B cells lacking Polq (Figure 15B). Therefore, although POLQ is involved in an altEJ 
pathway, it prevents rather than promotes chromosomal instability, rearrangements and the 
formation of Myc/IgH translocations. 
 
 
 
Figure 15. POLQ suppresses chromosomal translocation in vivo. (A) Representative 
schematic for the Myc/IgH translocation assay. PCR amplification primers are represented 
by black arrows. Closed circles denote centromeric locations on the chromosomes. Naïve B 
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cells from wild-type (WT) or Polq−/− mice were assayed for translocations after 72 h in 
culture. (B) Representative agarose gels stained with ethidium bromide and Southern blots 
probed with IgH and Myc probes as indicated. Each lane contains the DNA content of 1 
×105 genomes. Three independent experiments were performed. (C) Frequency of 
translocations was plotted and p-values determined using the two-tailed Fisher's exact test. 
Frequencies were calculated from the total number of translocations (Polq+/+: 5; Polq−/−: 17) 
divided by the total number of genomes surveyed (9.6 ×106). (D) Model of end joining-
mediated repair of DNA double-strand breaks (DSBs). (i) Schematic representing a DSB 
with existing microhomologies shown in orange. (ii) DSBs are preferentially processed by 
classical non-homologous end joining (cNHEJ), dependent upon Ku70–80 and Ligase4-
XRCC4. This pathway is not thought to promote DNA translocations. In the absence or 
impairment of critical cNHEJ factors (iii) alternative end joining (altEJ) pathways are utilized. 
These pathways appear to be suppressed by Ku70–80 and Ligase4-XRCC4. The MMEJ 
pathway (iv) can orchestrate annealing of ends at pre-existing microhomologies (2–5 bp) 
resulting in a net deletion of genomic information. Utilization of this pathway can enhance 
the formation of chromosomal translocations. In the SD-EJ pathway, also known as SD-
MMEJ, (v) POLQ can catalyze extension of minimally paired 3′ single-stranded DNA ends 
(shown in blue) to facilitate end joining and suppress the formation of chromosomal 
translocations. POLQ-independent alternative end joining pathways (vi) may exist but are 
still unclear. B cell isolation and culture and DNA isolation was performed by MJY. Sean 
Hensley performed PCR amplification of translocation derivative and Dr. Yunxiang Mu 
performed Southern Blotting. 
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2.4 Conclusion 
POLQ suppresses hypersensitivity to direct DNA double-strand breaks 
Taken together, the data presented in this chapter show that in mammalian cells, 
POLQ has a specific role in defense against DNA damaging agents that directly cause DNA 
double-strand breaks, including ionizing radiation, bleomycin, and certain topoisomerase 
inhibitors. Our findings indicate that POLQ participates in a novel pathway of alternative-end 
joining of DSBs, a process that can occur throughout the cell cycle in mammalian cells 
(Thompson, 2012). The minimal additional sensitization to camptothecin by olaparib in Polq-
defective cells suggests that one function of PARP is to participate in a Polq-dependent 
altEJ pathway, which could serve as a backup pathway in homologous recombination-
deficient cells. Our experiments indicate that POLQ is an important factor in DNA DSB repair 
in all cells, not just cells of the hematopoietic lineage. Indeed, Polq is broadly expressed in 
murine tissues (Figure 16). 
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Figure 16. Absolute quantification of transcript number shows that Polq is broadly 
expressed in tissues. Total RNA was isolated from necropsied C57BL/6 mice using Trizol 
(Life Technologies). Transcript abundance for Polq and DNA polymerase delta catalytic 
subunit Pold1 was determined by the absolute quantification method as described in the 
Material and Methods. Gapdh was used as an internal control to normalize samples. Tissue 
collection and RNA isolation were performed by MJY with assistance from Dr. Kei-ichi 
Takata. qPCR probe and primer sets were designed by MJY and Dr. Kei-ichi Takata. qRT-
PCR was performed by the Science Park Molecular Biology Core and the data were 
analyzed by  MJY and Dr. Kei-ichi Takata with the generous assistance of Dr. John Repass. 
 
 
Mutants of POLQ homologs in Arabidopsis (TEBICHI), C. elegans (polq-1), 
and Drosophila (Mus308) are hypersensitive to ICL-inducing agents (Yousefzadeh and 
Wood, 2013), whereas Polq-defective mammalian cells are not appreciably hypersensitive 
to such agents (Figure 5). This difference may arise because of differences between 
organisms in the priority of DNA repair pathway engagement. In proliferating mammalian 
cells, ICLs are usually dealt with through the Fanconi anemia pathway, which produces 
enzymatically induced double-strand breaks that are channeled into homologous 
recombination repair (Kottemann and Smogorzewska, 2013). In Drosophila and some other 
organisms, an altEJ-dependent pathway may be more important for resolving ICL-
associated double-strand breaks. Although Drosophila Mus308 mutants are not 
hypersensitive to IR, pronounced IR sensitivity occurs in a double mutant when HR is also 
inactivated (Chan et al., 2010). The phenotypic consequences of POLQ-dependent altEJ 
repair of double-strand breaks may thus depend on the relative dominance of HR, which 
varies between organisms. 
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In this chapter I show that the DNA polymerase activity of POLQ is necessary to 
prevent cell death and chromosome breaks (micronuclei) caused by a double-strand break-
inducing agent (Figure 5 and 6). Disruption of the ATPase activity in the helicase-like 
domain of POLQ did not, however, alter the correcting function of POLQ addition to 
knockout cells (Figure 7). A previous study with mouse cell lines suggested that disruption 
of the polymerase domain of the murine Polq gene has less severe consequences than 
complete disruption of Polq (Li et al., 2011), but the result is difficult to evaluate in the 
absence of quantitative measurements of expression of the disrupted form. No activity has 
yet been shown for the helicase-like domain, other than a DNA-dependent ATPase function 
(Seki et al., 2003). It is likely that an additional role remains to be discovered that is 
dependent on the ATPase function of POLQ. 
 
POLQ aids DNA double-strand break repair through alternative end joining and nucleotide 
insertions 
When double-strand breaks form in mammalian cells, a majority will be repaired 
through cNHEJ. However, a subset of these breaks will be handled by alternative end-
joining pathways, for example, in situations where the DNA end is not compatible with 
processing by Ku-dependent cNHEJ, or if core components of the cNHEJ machinery are 
absent or unavailable (Figure 15D). In general, altEJ is defined as a DNA repair mechanism 
distinct from Ku-dependent, classically defined NHEJ (Deriano and Roth, 2013), and 
dependent on other factors (CtIP, MRN) that resect double-strand breaks to generate 
extended 3′ ssDNA tails (Bennardo et al., 2008; Lee and Lee, 2007) (Figure 12A and 15D). 
Accordingly, we showed that joining of a “pre-resected” extrachromosomal substrate 
(substrate with 45 nucleotide 3′-ssDNA tails) was stimulated in Ku-deficient cells, similar to 
results using chromosomal substrates (Bennardo et al., 2008). Joining of this substrate was 
also dependent on Polq (Figure 12C). Thus, our experiments define an altEJ subpathway in 
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mammalian cells that involves POLQ (termed synthesis-dependent end joining, SD-EJ or 
SD-MMEJ) (Figure 15D). Additional POLQ-independent altEJ subpathways may also be 
operational (Figure 15D). To some extent, different end-joining pathways can be been 
distinguished from one another by the ligase employed in the pathway, with DNA ligase IV 
(LIG4) suggested as essential for cNHEJ, and DNA ligase III (LIG3) for altEJ in mammalian 
cells (Frit et al., 2014; Simsek et al., 2011a; Simsek and Jasin, 2010). There are caveats, 
however. For example, some functional redundancy is apparent between LIG1 and LIG3 in 
altEJ (Arakawa et al., 2012; Boboila et al., 2012b; Han et al., 2014; Simsek et al., 2011b). 
Ligase deficiencies may thus not be the best means for distinguishing different end-joining 
pathways. For the altEJ subpathway under consideration here, dependence on POLQ is the 
best available definition. 
 The biochemical properties of POLQ provide a mechanistic explanation for its 
contribution to altEJ. POLQ has a unique ability to add nucleotides to the 3′ ends of single-
stranded DNA (Hogg et al., 2012), primed by minimal pairing with other available DNA 
molecules (Figure 13 and Figure 17). The distinct ability for POLQ to catalyze DNA 
synthesis from the minimally paired ends is supported by recent structural evidence that 
POLQ uniquely grasps the primer terminus via additional protein-DNA contacts that are not 
present in bacterial A-family DNA polymerases (Zahn et al., 2015). Synthesis by POLQ in 
this context is consistent with the unusually efficient ability of the polymerase to extend from 
mismatched DNA termini (Seki et al., 2004; Seki and Wood, 2008), and its tendency towards 
primer-template slippage (Arana et al., 2008). In future studies it will be of interest to 
examine the action of POLQ and DNA ligases at double strand breaks with 3′-single-
stranded overhangs that closely mimic the resected ends of a DNA double-strand break. In 
vivo studies with such substrates, including those that can form hairpins in the single-
stranded region, would give insight as to the preferred structures for POLQ-catalyzed 
extension. 
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Figure 17. Mechanism of insertion formation by POLQ during double-strand break 
repair. After a double-strand break is formed (i), the broken ends are frequently resected 
enzymatically to form 3’ single-stranded tails (ii). POLQ can extend a 3’ end by templated 
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synthesis from another available DNA strand (iii). This may be the 3’-tailed end near the 
break, or a DNA strand available at a more distant location, or through possible “snapback 
synthesis” whereby the tail serves as its own intramolecular template. POLQ has the unique 
ability to prime DNA synthesis (blue) with minimal base pairing, sometimes slipping in the 
process (Figure 14). The newly synthesized DNA end then anneals via microhomology to 
the other 3’ tail at the break (iv), and repair is completed (v) after further DNA synthesis 
(gray). This process results in an insertion of DNA sequences (blue). 
 
 
A unique marker of the POLQ-dependent altEJ process is repair junctions that 
display templated DNA insertions. Some form of altEJ has been implicated in resolution of a 
subset of double-strand break intermediates in CSR, producing templated 
insertions (Boboila et al., 2012a). Our data support a role for POLQ in generating the CSR 
products with these templated insertions. These events are consistent with the templated 
insertions that occur during Mus308-dependent repair of directed double-strand breaks 
in Drosophila (Chan et al., 2010; White and Lambowitz, 2012) and in C. elegans (Koole et 
al., 2014). In the absence of POLQ, the lack of insertion-containing joins is observed, but the 
global CSR frequency is relatively unchanged (Figure 11). These insertions are best 
explained by repeated initiation of synthesis by POLQ (Figure 14) on template sites, 
ultimately leading to a joined product. An open question is whether these newly created 
POLQ-dependent insertions create novel microhomologies (2-5 bp) that allow for annealing 
of ends or the insertions produce a 3’ DNA end that anneals through minimal pairing of a 
single base. Further analysis into the end joining properties of POLQ is warranted. 
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POLQ prevents the formation of Myc/IgH chromosomal translocations 
In the absence of POLQ, we found a ~4-fold increase in the formation of the 
oncogenic translocation Myc/IgH in mice (Figure 15C). This increase is comparable to that 
seen in B cells that have lost Tdrd3, a regulator of R-loop formation during transcription 
(Yang et al., 2014) and miRNA-155 which regulates AID and suppresses oncogenic 
translocations (Dorsett et al., 2008). In the absence of Polq there is also an apparent 
enhancement of rearrangement events in the IgH locus, consistent with the elevated level of 
chromosomal instability observed in cells lacking POLQ (Roerink et al., 2014). 
altEJ is typically associated with frequent annealing of the DNA ends at existing 
microhomologies (2–5 bp) and large deletions at repair junctions (Decottignies, 2013). Since 
translocations commonly feature such microhomologies at their breakpoint junctions 
(Bunting and Nussenzweig, 2013; Weinstock et al., 2006) and occur more frequently in 
cNHEJ defective cells, altEJ is considered the primary mechanism by which translocations 
occur. Thus, a striking finding of the present work is that the formation of 
Myc/IgH translocations is suppressed when the POLQ-dependent altEJ subpathway is 
operational. It is possible that DNA DSBs persist for a longer time in the absence of POLQ, 
giving more opportunity for the formation of translocations. Alternatively, the POLQ-
dependent pathway may be the most efficient at repairing a structurally distinct class of 
translocation-prone DNA breaks. 
These studies clearly define a role for POLQ in DNA repair and provide a 
mechanism for template-dependent extension of DNA ends necessary to repair breaks in a 
subpathway of altEJ. This distinct altEJ pathway is required to prevent the formation of 
Myc/IgH  translocations as shown by our in vivo experiments.  
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Chapter 3. Does a POLQ “signature” exist in translocations and immunoglobulin V 
regions. 
3.1 Introduction 
As just described, there is an “insertional” signature for POLQ in the immunoglobulin 
(Ig) switch regions of murine B cells. Sequencing of the switch regions showed that POLQ 
was required for longer insertions observed at the Sµ-Sγ1 junctions of B cells that result in 
IgG1+ antibodies displayed on the B cell surface (Figure 11, Table 4) (Yousefzadeh et al., 
2014).  These longer insertions feature homologies found up to 2-5 kb away from the 
breakpoint junction and this synthesis-dependent end joining (SD-EJ) function of POLQ is 
conserved in homologs found in Drosophila and C. elegans (Chan et al., 2010; Roerink et 
al., 2014; Yousefzadeh et al., 2014). This alternative end joining (altEJ) pathway is 
independent of the canonical non-homologous end joining (cNHEJ) factors Ku70 and Ku80 
(Figure 11 and 12) (Yousefzadeh et al., 2014). POLQ-mediated SD-EJ is supported by 
biochemical evidence of POLQ’s ability to prime synthesis from minimally-paired ends, +1/-1 
slippages, and to extend from a mismatched terminus (Arana et al., 2008; Seki and Wood, 
2008; Yousefzadeh et al., 2014).  
This POLQ-dependent subpathway of altEJ repair of DNA double-strand breaks 
(DSBs) is hypothesized to promote chromosomal translocation; however the mechanism 
through which this occurs is still unclear (Simsek and Jasin, 2010; Zhang and Jasin, 2011).  
We analyzed translocations between the Ig heavy chain locus and the Myc oncogene and 
found a 4-fold increase in the translocation frequency in Polq-null B cells when compared to 
wild-type controls.  Our findings were surprising in that we found that POLQ-dependent SD-
EJ, an altEJ pathway, is actually suppressive to chromosomal translocations, which breaks 
with the current paradigm (Figure 15) (Yousefzadeh et al., 2014). 
 During the development of B cells, programmed induction of DNA damage is 
required for the diversification of immunoglobulin genes. RAG1/2 are required for initial 
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assembly of antibody gene segments. Further immunological diversification through class 
switch recombination (CSR) and somatic hypermutation (SHM) occur later on in an 
activation-induced cytosine deaminase (AID)-dependent fashion (Chahwan et al., 2011; Di 
Noia and Neuberger, 2007; Stavnezer et al., 2008). U:G mismatches, created when AID 
deaminates cytosines, are processed by uracil-DNA glycosylases and error prone 
polymerases to generate point mutations in SHM (Rajewsky, 1996). DSBs are also 
generated in an AID-dependent fashion that initiates CSR, causing a change in antibody 
isotype class without modifying antigen affinity (Chahwan et al., 2011; Di Noia and 
Neuberger, 2007; Stavnezer et al., 2008).  The bulk of AID activity is targeted at the Ig 
locus, but AID also targets a number of transcribed genes, including tumor suppressor 
genes (p53) and oncogenes (MYC), which are associated with lymphomas (Gazumyan et 
al., 2012; Yamane et al., 2011). The DNA DSBs generated by AID are common substrates 
for chromosomal translocations like translocations between IgH and MYC, which are 
commonly observed in Burkitt lymphoma patients (Gazumyan et al., 2012; Ramiro et al., 
2006).   
 During the repair of AID-generated DSBs, both cNHEJ and altEJ are involved but 
have divergent roles in the formation of chromosomal translocations.  Previously altEJ, and 
specifically the microhomology-mediated end joining (MMEJ) pathway, was shown to 
promote translocations, suggesting that altEJ may be the primary pathway underlying these 
chromosomal aberrations in mice, while translocations appear to be dependent upon cNHEJ 
in humans (Boboila et al., 2012a; Ghezraoui et al., 2014; Simsek and Jasin, 2010). Our data 
suggests that the SD-EJ pathway that is dependent upon POLQ-catalyzed extension of 3’ 
DNA ends serves as a genome stability mechanism that limits chromosomal translocations 
(Yousefzadeh et al., 2014). We hypothesize that POLQ suppresses translocations at the 
cost of nucleotide insertions and deletions (indels). However the impact of POLQ on 
translocation at the genomic sequence level is not known and would be of great value.  We 
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hypothesize that the sequence composition of breakpoint junctions from translocations that 
occur when POLQ is impaired or absent are different from those that occur in the presence 
of POLQ. 
Indels can disrupt the open reading frames of genes, but in the current context, these 
indels are another important antibody diversification mechanism. Nucleotide additions and 
deletions are found in V(D)J junctions during RAG-mediated recombination and in the 
variable (V) region of Ig genes during SHM (Helmink and Sleckman, 2012; Sale and 
Neuberger, 1998). The latter group of indels are termed somatic hypermutation associated 
(SHA) indels and can be found in the antigen-binding complementarity determining region 
(CDR) of Ig V regions and result from SHM (Reason and Zhou, 2006).  Approximately 2-6% 
of peripherally-circulating human B cells feature SHA indels in their V regions (Briney et al., 
2012; Wilson et al., 1998). While the frequency of these indels is low, they are crucial for 
antibody response to pathogens like influenza, HIV-1, and S. pneumonia (Krause et al., 
2011; Reason and Zhou, 2006; Yu et al., 2008).  Certain individuals infected with HIV-1 
(termed “elite controller individuals) harbor neutralizing antibodies to HIV-1. Sequencing 
revealed that some of these neutralizing antibodies have nucleotide insertions in the 
framework regions either the heavy or light chain V regions, and functional analysis affirms 
that these indels are required for the neutralizing capacity of these antibodies (Klein et al., 
2013). Therefore, these insertions create significant structural alterations resulting in novel 
antigen-antibody interactions.  SHA-indels present a unique and understudied antibody 
diversification mechanism that is associated with SHM, but is distinct from point muations 
that arise during SHM. Our prior study supports a role for POLQ-dependent insertions in 
CSR junctions and we hypothesize that SHA-indels are POLQ-dependent as well. 
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3.2 Material and methods 
Experimental Mice 
Polq-heterozygous (Polq+/−) (Shima et al., 2004) and wild-type mice were obtained from 
Jackson Laboratories and maintained in a C57BL/6J background. Polq-heterozygous mice 
were crossed to generate Polq-null mice.  Mice were maintained in specific pathogen free 
conditions before experimental mice (2-6 mo) were transferred to a holding room that was 
positive for mouse parvovirus, minute virus of the mouse, and H. pylori. Mice were sacrificed 
by CO2 euthanasia followed by cervical dislocation. Three mice per genotype were used for 
four independent experiments. Peyer’s patches were isolated from the mice and filtered 
through 70 µm filters into 1X PBS.  Cells were stained with the following:  Propidium Iodide 
(PI), anti-CD19-APC, anti-CD19-PE, anti-CD95-PE-Cy7, and anti-GL7-FITC.  Cells were 
then sorted for germinal center B cells based on the following scheme:  PI-, CD19++, CD95+, 
and GL7+. Cells were plated into 96 well plates at 50-100 cells per well and frozen at -80°C. 
RNA isolation and cDNA amplification of IgK and IgH V(D)J regions were performed by the 
McBride laboratory.  2 µL of PCR product was TOPO TA (Life Technologies, Carlsbad, CA) 
cloned according to manufacturer’s specifications and sequenced using M13 reverse 
primers at Molecular Biology Core Facility. Sequences were analyzed via the IgBLAST 
database (NCBI).  
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3.3 Results and Future Work 
Immunoglobulin V region sample preparation and sequencing 
 In order to examine V region indels in Polq mice, Peyer’s patches were isolated with 
Dr. Kevin McBride from mice and germinal center B cells were sorted by FACS. 
Immunoglobulin transcripts were amplified with the assistance of Sean Hensley and Monika 
Zelazowska and prepared for next generation sequencing analysis to determine if Polq 
status had an effect on V region indels. Before initiating next generation sequencing of 
immunoglobulin V regions in Polq mice, I wanted to ascertain population diversity of 
amplified transcripts.  Initial sequencing of immunoglobulin genes showed numerous clonal 
populations, along with clonal derivations and some unique immunoglobulin genes by 
(Table 6).  Following this, samples were prepared and submitted to the Next Generation 
Sequencing Core for analysis on the MiSeq sequencing platform (Illumina, San Diego, CA) 
using 300 bp paired end reading. NGS data will be analyzed by the Bioinformatics Core at 
the Science Park Molecular Biology Core. Our hypothesis is that based upon our findings 
that insertions in CSR junctions are POLQ-dependent that in the absence of Polq we will 
see a significant reduction in SHA-indels (Yousefzadeh et al., 2014). Future experiments 
could include the investigation of POLQ influencing antibody repertoire and responses to 
model antigens.  
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Table 6.  Sequencing of IgH and IgK sequences from Polq mice.  cDNA amplicons were 
TOPO TA cloned and sequenced.  Sequences were analyzed by IgBLAST.  Individual V, D, 
J recombinants are denoted and amino acid mutations are enumerated.  Clonal sequences 
with identical VDJ gene segments and mutations, their clonal derivatives featuring novel 
mutations (bracketed into groups), and unique sequences are stratified. Germinal Center B 
Identical Clones
genotype sequence clone ID V gene D gene J gene Mutations
Polq+/+ IgK K6, K17 V19-93*02 ND J5*01 3
Polq+/+ IgH M3, M6 V1-67*01 D2-5*01 J3*01 5
Polq+/+ IgH M7, M16 V6-3*01 D1-3*01 J4*01 12
Polq -/- IgK K6, K8 V3-4*01 ND J5 9
Polq -/- IgH M5, M11 V14-2*01 D3-3*01 ND 11
Polq -/- IgH M8, M9 V7-3*01 D1-1*02 J4*01 8
Polq -/- IgH M10, M13 V2-9*01 D2-3*01 J1*03 8
Clonal Derivation
genotype sequence clone ID V gene D gene J gene Mutations
Polq+/+ IgK K2 V3-12*01 ND J2*01 10
Polq+/+ IgK K20 V3-12*01 ND J2*01 9
Polq+/+ IgK K4 V14-111*01 ND J4*01 10
Polq+/+ IgK K10 V14-111*01 ND J4*01 7
Polq+/+ IgK K13 V14-111*01 ND ND 7
Polq+/+ IgK K21 V14-111*01 ND J5*01 8
Polq+/+ IgH M12 V7-3*01 D3-2*01 J4*01 10
Polq+/+ IgH M20 V7-3*01 D3-2*01 J4*01 11
Polq+/+ IgH M13 V1-9*01 D4-1*02 J2*01 11
Polq+/+ IgH M18 V1-9*01 D4-1*02 J2*01 12
Polq -/- IgK K2 V3-4*01 ND J5 12
Polq -/- IgK K7 V3-4*01 ND J5 12
Polq -/- IgH M4 V7-3*01 D1-1*02 J4*01 9
Polq -/- IgH M6 V2-9*01 D2-3*01 J1*03 12
Unique Clones
genotype sequence clone ID V gene D gene J gene Mutations
Polq+/+ IgK K1 V6-23*01 ND J2*01 0
Polq+/+ IgK K5 V3-10*01 ND J4*01 5
Polq+/+ IgK K7 V3-7*01 ND J2*03 18
Polq+/+ IgH M10 V1-85*01 D1-1*02 J2*01 16
Polq+/+ IgH M21 V1-34*01 D2-5*01 J1*03 17
Polq -/- IgK K3 V14-111*01 ND J4*01 9
Polq -/- IgH M1 V6-3*01 D4-1*02 J2*01 18
Polq -/- IgH M5 V14-2*01 D3-3*01 ND 11
Polq -/- IgH M17 V14-3*01 D2-12*01 J3*01 6
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cells were isolated by Dr. Kevin McBride and MJY. Immunoglobulin transcript amplification 
was performed by Sean Hensley, Monika Zelazowska, and MJY. MJY cloned the cDNA 
amplicons and analyzed the sequencing results generated by the Science Park Molecular 
Biology Core.  
 
Translocation analysis is Polq/Tp53 mice 
 In the absence of Polq, Myc/IgH translocation frequency increases nearly four-fold 
relative to the wild-type control (Figure 15) (Yousefzadeh et al., 2014). However, in 
stimulated B cells from wild-type mice, the translocation frequency is quite low (~1 
translocation per 500,000 cells), making translocation analysis reagent-intensive (Figure 15)  
(Yousefzadeh et al., 2014). Therefore I am crossing of Polq mice to Tp53 mice to enhance 
the translocation frequency. Tp53-null mice exhibit a 5 to 10-fold increase in the frequency 
of Myc/IgH translocations compared to wild-type mice (Ramiro et al., 2006). Our hypothesis 
is that POLQ prevents the formation of chromosomal translocations but it comes at the cost 
of creating indels. Thus it is important to learn the locations and compositions (insertions, 
microhomologies, etc.) of translocation junctions that are dependent upon POLQ. C57BL/6J-
Polq- and FVB-Tp53-null mice are being crossed to generate Polq-/- Tp53-/- mice and will be 
available for use soon.  These mice will be used for analysis of translocation breakpoints by 
NGS. Future studies could spring from this initial analysis such as the investigation of 
POLQ’s impact on other common translocations.  
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Chapter 4:  The effect of POLQ suppression on radiosensitivity of breast cancer cells. 
 
4.1 Introduction 
 For many breast cancer patients, surgical tumor resection is followed by treatment 
with ionizing radiation (IR). A salient need in breast cancer therapeutics is to enhance the 
effectiveness of IR. “Triple-negative” breast cancer (TNBC), a particular subset of breast 
cancers, are refractory to most conventional therapies (André and Zielinski, 2012), including 
IR, and pose a major clinical challenge (Lehmann et al., 2011). As previously reported, cells 
lacking POLQ are notably hypersensitive to IR and the radiomimetic bleomycin (Goff et al., 
2009; Higgins et al., 2010b; Yousefzadeh et al., 2014). Our lab and others demonstrated 
that abnormally high levels of POLQ in breast cancer patients correlates with poorer 
outcomes (Begg, 2010; Higgins et al., 2010a; Lemée et al., 2010). Notably POLQ is a 
component in the Genomic Grade Index (GGI) signature and “76-gene signature” set which 
are used to assess tumor grade and prognosis (Sotiriou et al., 2006; Wang et al., 2005).  
 While multiple studies have delved into the correlation between POLQ expression 
and breast cancer outcomes, very little was known about POLQ single nucleotide 
polymorphisms (SNPs) and breast cancer until recently. A SNP of POLQ (c.-1060A>G) was 
shown to be significantly more frequent in hereditary breast cancer patients than in sporadic 
breast cancer patients or control individuals (Brandalize et al., 2014). This SNP is located in 
the promoter region of POLQ but it is not known how this SNP affects POLQ expression or 
how it modifies the disease in these hereditary breast cancers. 
 The mounting evidence supporting a role for POLQ in breast cancer, makes it an 
ideal new therapeutic target. Targeting DNA replication as a therapeutic intervention is a 
time tested and clinically used principle.  For example chemotherapeutics like 5-fluorouracil 
and hydroxyurea, and nucleoside analogs such as gemcitabine and cytarabine are 
commonly used in the treatment of cancer patients (Kelley, 2011). Since POLQ is the only 
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DNA polymerase to be significantly overexpressed in breast cancer, is involved in replication 
timing, and is not essential for cell viability (Fernandez-Vidal et al., 2014; Lemée et al., 2010; 
Yousefzadeh and Wood, 2013). POLQ a logical choice and appealing target for therapeutic 
development. 
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4.2 Material and methods 
Cell lines 
The following cell lines were purchased from American Type Culture Collection:  MCF7, 
MCF10, HCC1569, HCC1599, HCC1806, BT-474, MDA-MB-361, and MDA-MB-436.  Cells 
were STR fingerprinted, checked for mycoplasma contamination, and cultured in their 
appropriate media (Neve et al., 2006). 
 
RNA isolation and qPCR analysis 
Total RNA was isolated from the each of the breast cancer cell lines. RNA quality and purity 
was analyzed using a RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of 
total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life 
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT 
thermocycler and the following Taqman Probe set or primer set with iTAQ SYBR Green 
Supermix with ROX (Bio-Rad, Hercules, CA): (POLQ) Qexon FWD 5′-
TGCCTTTCAAAAGTGCCCGGAAGGC3′, Qexon REV 5′-
TGCCAGTCACCCANATAGTTCNCAT-3′ (where N represents a dSpacer); (POLD1) 
HsPOLD1_FWD 5′-CGACCTTCCGTACCTCATCTCT-3′, HsPOLD1_R 5′-
ACACGGCCCAGGAAAGG-3′, probe 5′-CCCTCAAGGTACAAACAT-3′; (POLN) 
HsPOLN_FWD 5’-ACTGATGGTTCCACCCAGCTA-3’, HsPOLN_REV 5’-
GCGTTTTACTAACACCACAATTCCT-3’, probe 5’-ACCAGACCCCCGTTTCT-3’; HELQ 
(Hs00431095_m1); REV3L (Hs01076848_m1); REV7 (Hs01057448_m1); EXO1 
(Hs01116195_m1); MCM2 (Hs01091564_m1); RAD51C (Hs00427442_m1). Data were 
analyzed using the ∆∆Ct method. GAPDH was used as an internal control in all experiments 
and relative quantification analysis was performed with MCF10 cells serving as the non-
tumorigenic control. 
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Transfections and Transductions 
293T cells (kindly provided by Dr. Christopher Bakkenist, University of Pittsburgh Medical 
School) were plated at 1.5 x105 cells per well in six-well plates and transfected the following 
day with 5 µg of either SIGMA Mission shRNA non-targeting control (shCTRL); or five 
different shRNAs against POLQ (shQ46, shQ47, shQ48, shQ49, shQ50) using jetPRIME 
(Polyplus, New York, NY) according to manufacturer's specifications. 48 h after transfection, 
cells were harvested for RNA isolation (RNeasy, Valencia, CA) or for immunoblotting. To 
generate lentivirus used for transduction, 2.5 ×106 293T cells were plated and cotransfected 
the following day with psPAX2 (6 µg), pMD2G (6 µg), and (12 µg) SIGMA Mission shRNA 
vector (shCTRL, shQ46, shQ50) using jetPRIME. One day prior to transduction, HCC1806 
cells were seeded into a 10 cm dish at 1.5 ×105 cells with 15 mL complete media. 48 h post-
transfection virus-containing media was harvested, filtered through a 0.45 µm syringe filter 
and used to replace the media on the plated HCC1806 cells with 15 µL of 4 µg/mL 
polybrene (1 µL of polybrene stock per mL of complete media). Cells were incubated in the 
virus-containing media for 24 h before being split into T-75 flasks and grown to 80% 
confluence before undergoing three weeks of puromycin selection (2.5 µg/mL). Following 
selection, pure clones were isolated and cultured with complete media containing puromycin 
(1 µg/mL). 
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shRNA sequences 
shCTRL (SHC002)  5’-CCGGCAACAAGATGAAGAGCACCAACTC-3’ 
 
shQ46 (TRCN0000290546) 5’- 
CCGGCCTTCAATCTTGCTTGCGAAACTCGAGTTTCGCAAGCAAGATTGAAGGTTTTTG-
3’ (anneals to POLQ cDNA sequence 5840:5861) 
 
shQ47 (TRCN0000290547) 5’- 
CCGGCGGGCCTCTTTAGATATAAATCTCGAGATTTATATCTAAAGAGGCCCGTTTTTG-3’ 
(anneals to POLQ cDNA sequence 2967:2991) 
 
shQ48 (TRCN0000290548) 5’- 
CCGGCGTCGTCTCATTCAAGTGTTACTCGAGTAACACTTGAATGAGACGACGTTTTTG-
3’ (anneals to POLQ cDNA sequence 7036:7056) 
 
shQ49 (TRCN0000290549) 5’- 
CCGGCCCTGTTACATTCTAGTACATCTCGAGATGTACTAGAATGTAACAGGGTTTTTG-3’ 
(anneals to POLQ cDNA sequence 2705:2725) 
 
shQ50 (TRCN0000290550) 5’- 
CCGGGCTGACCAAGATTTGCTATATCTCGAGATATAGCAAATCTTGGTCAGCTTTTTG-3’ 
(anneals to POLQ cDNA sequence 699:719) 
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4.3 Results and future work 
 
To evaluate our hypothesis that suppression of POLQ in breast cancer cells confers 
radiosensitivity, we chose a number of breast cancer cell lines of different statuses (p53, ER, 
PR). We are particularly interested in triple-negative breast cancers (TNBC), which, through 
bioinformatics analyses, have been shown to overexpress POLQ and are quite refractory to 
treatment.  Relevant cells lines from the Basal A (MCF10, MDA-MB-436), B (HCC1569, 
HCC1806, HCC1599), and luminal (MCF7, BT-474, MDA-MB361) subtypes were obtained 
from ATCC and tested to ensure no mycoplasma contamination.  The cell lines were then 
analyzed for expression of POLQ and other DNA replication and repair genes (Figure 18A) 
with similar expression patterns to POLQ as previously determined through microarray 
analysis of breast tumor subtypes.   
In the various breast cancer cell lines POLQ was expressed at 8 to 114-fold higher 
levels than in the non-tumorigenic MCF10 control cell line (Figure 18B), whereas related 
gene family members POLN and HELQ show very little variability in expression amongst all 
the cell lines (Figure 18C).  Other DNA polymerases are expressed at comparable levels 
between the cell lines (Figure 18D and E).  Thus, the high degree of POLQ expression in 
multiple breast cancer cell lines, including TNBC cell lines, is unique to this DNA 
polymerase.  These results are consistent with a previous study that also found that POLQ 
was the only DNA polymerase significantly overexpressed in multiple breast cancer tumors 
(Lemée et al., 2010). However, there was a broad range of expression patterns amongst 
different DNA repair genes (EXO1, MCM2, and RAD51C) (Figure 18F). 
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Figure 18.  Survey of DNA polymerase and repair gene expression in breast cancer 
cells.  Expression of the indicated genes was quantified by qPCR in multiple breast cancer 
cells.  Relative quantification of gene expression was determined using Taqman probes, 
data was analyzed using the ∆∆Ct method and GAPDH expression was used as an internal 
control. Abbreviations: MT (mutated), ER (presence of estrogen receptor), PR (presence of 
progesterone receptor), HER2 (amplification of HER2/neu).  
Baseline POLQ expression levels have now been established for different breast 
cancer cell lines and breast cancer subtypes. These studies provide insight for selecting cell 
lines that will be candidates for POLQ-silencing. Initial analysis of shRNAs directed at POLQ 
was performed in 293T cells and RNAi-mediated suppression was measured by qPCR 
analysis (Figure 19A). Two individual POLQ shRNAs (shQ46 and shQ50) knockdown 
POLQ by ~50-60% alone, but did not act synergistically or additively when combined 
(Figure 19B).  
Efficient shRNA suppression of POLQ is needed in order to test radiosensitivity by 
clonogenic assays.  Using this method, we wish to test our hypothesis that cell lines with 
elevated levels of POLQ will exhibit greater radiosensitivity than cells with reduced POLQ 
levels due to shRNA treatment. As a proof of principle experiment to test this hypothesis we 
chose to test the HCC1806 cell line, as it had the highest relative level of POLQ expression 
when compared to the MCF10 non-tumorigenic control cell line. Stable knockdown and 
relevant control cell lines were generated after lentiviral transduction of shRNA constructs 
and puromycin selection before testing for POLQ suppression. POLQ transcript levels were 
reduced by ~50% in HCC1806 POLQ knockdown cells transduced with either shQ46 or 
shQ50 (Figure 19C). Clonogenic survival assays of irradiated cells are currently in progress 
to measure radiosensitivity upon suppression of POLQ by shRNA. We may fail to observe 
enhanced radiosensitivity in breast cancer cell lines if the shRNA-mediated suppression of 
POLQ fails to adequately suppress POLQ. 
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Figure 19. shRNA knockdown of POLQ in cancer cell lines. 293T cells were transfected 
with either shCTRL non-targeting control shRNA or an shRNA targeted against POLQ 
(shQ46-50).  RNA was harvested from the cells 48 h post transfection and analyzed for 
POLQ expression by qPCR. qPCR analysis was performed in duplicate (A) or triplicate (B) 
for the indicated experiments. (C) HCC1806 cells stably knocked down for POLQ by shRNA 
were surveyed for POLQ expression in a similar manner. GAPDH was used as an internal 
control and ∆∆Ct analysis was performed. 
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POLQ inhibitors being performed in conjunction with the Texas Screening Alliance for 
Cancer Therapeutics and Texas Institute for Drug and Diagnostic Discovery, will be 
screened against the breast cancer cell lines and Polq knockout mouse embryonic fibroblast 
(MEF) lines.  If POLQ is the rate limiting factor for altEJ, then we hypothesize that small 
molecule inhibitors of POLQ will further radiosensitize breast cancer cells with aberrantly 
high levels of POLQ (responders) while having a smaller effect on radiosensitivity in those 
cells with lower levels of POLQ (non-responders). Specificity of the small molecule inhibitors 
will also be verified by looking at the enhancement of radiosensitization of Polq MEFs, 
where Polq-proficient MEFs should only show a synergistic increase in sensitivity to ionizing 
radiation while Polq-deficient MEFs should have no further increase in radiosensitivity above 
their already elevated baseline. A validated compound could then be further analyzed to 
understand its interaction with, and mechanism of, POLQ inhibition (catalytic, allosteric, 
etc.). This compound could then be used for in vitro studies in Polq-deficient cell lines to 
determine if its effects are POLQ-specific. Much work remains to be done but a small 
molecule inhibitor of POLQ could be of great clinical value in breast cancer therapeutics by 
enhancing radiosensitivity, particularly in TNBC patients, whose tumors already express 
aberrantly high levels of POLQ (unpublished data, C. Marcelo Aldaz and Richard Wood), 
and are quite refractory to most treatments (André and Zielinski, 2012). 
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Chapter 5. A-family DNA polymerases and the repair of x-ray induced DNA damage. 
5.1 Introduction 
The human genome is under constant attack from both endogenous and exogenous 
sources of damage.  About 2% of our genome is committed to maintaining genomic stability. 
There are more than 175 proteins involved in DNA repair (Friedberg et al., 2006) 
(http://sciencepark.mdanderson.org/labs/wood/dna_repair_genes.html).  These proteins are 
critical in the repair or tolerance of lesions that result from many sources such as 
endogenously generated reactive oxygen species or exogenous damage caused by 
ultraviolet radiation. The “DNA damage response” is an a collective term for the various 
molecular pathways including DNA repair and replication, and cellular checkpoints that 
occur after DNA damage.  The synergistic activities of these different processes allow cells 
to detect DNA damage, arrest cells at given points in the cell cycle and potentially initiate 
destruction of the cell if the damage is too great.   
Various repair pathways can repair the damage but despite the prominence of these 
repair mechanisms, lesions can escape the repair process.  These lesions create 
roadblocks for the replicative polymerases (α,δ,ε), which catalyze DNA synthesis during S 
phase of the cell cycle (Lange et al., 2011).  However, the replicative polymerases cannot 
bypass the damaged DNA, thereby creating stalled replication forks that can lead to the 
formation of double strand breaks.  Replication through the damaged DNA is achieved by a 
group of enzymes known as translesion synthesis (TLS) polymerases.   
The mammalian genome encodes seven polymerases capable of performing TLS in 
vitro: PrimPol, pol ζ, pol η, pol ι, pol κ, pol ν, and pol θ.  Two models currently exist for TLS:  
the one-step model in which a TLS polymerase inserts a nucleotide across from the 
damaged template and catalyzes further extension along the template, or the two-step 
model, in which one polymerase inserts across the damaged template and falls off, followed 
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by another TLS polymerase extending past the damage (Lange et al., 2011).  The presence 
of these specialized polymerases suggests that bypass of the DNA lesions is an important 
component of DNA damage tolerance. 
Human DNA polymerase ν (POLN) is an A-family DNA polymerase related to 
Escherichia coli polymerase I.  POLN was identified by searching for sequence similarity to 
the mus308 Drosophila DNA polymerase (Figure 1) (Marini et al., 2003), which was 
identified in a genetic screen for genes that granted resistance to DNA damaging agents 
(Harris et al., 1996).  The human POLN gene is 160 kb long and encompasses 24 exons 
with conservation of C-terminal exons 14-24, producing a 4kb transcript and 900 amino acid 
protein.  Many inactive alternative splicing variants were found, as a result of exon skipping 
or alternative exon inclusion, in cell lines (Marini et al., 2003). POLN is broadly conserved 
amongst the vertebrate lineage. POLN possesses DNA polymerase activity in vitro, 
including low fidelity DNA synthesis, as well as the ability to accurately and efficiently bypass 
thymine glycol DNA adducts and specific protein-DNA crosslinks (Takata et al., 2006; 
Yamanaka et al., 2010).  By way of northern blot analysis, full-length POLN has been shown 
to be present in both human and mouse testes (Marini et al., 2003).  Due to its high 
expression in testis, POLN may serve as a recombinase for spermatogenesis, which occurs 
during meiosis.  POLN may not be limited to the testis. Transcripts have also been found in 
both human testis (833K) and hematopoietic cell lines from human (K562) and mouse 
(L1210) cell lines (Marini et al., 2003). Previously, POLN was reported to play a role in DNA 
interstrand crosslink (ICL) repair in human cells (Moldovan et al., 2010; Zietlow et al., 2009), 
and a role for POLN in homology-directed repair was proposed in chicken DT40 cells 
(Kohzaki et al., 2010). Further analysis is required to determine the in vivo role of POLN in 
mammals. 
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5.2 Material and methods 
Mouse tissue RNA isolation 
 Wild-type C57BL/6 mice were sacrificed via carbon dioxide euthanasia and 
immediately necropsied in order to isolate their organs.  The organs were placed into RNA 
Later buffer (Ambion) on ice and taken to the laboratory for RNA isolation.  The tissues were 
flash frozen with liquid nitrogen and ground by mortar and pestle into a fine powder.  The 
powder was placed into Trizol (Invitrogen) and homogenized using a 16-gauge needle to 
lyse the cells. Chloroform extraction (Sigma-Aldrich) was performed to purify the RNA and 
concentration was measured by absorbance at 260 nm using a Nanodrop spectrometer.  
RNA quality was ensured by first measuring the 260/280 nm ratio and then running 5 µg of 
total RNA on a 1% denaturing agarose gel.  After ethidium bromide (Sigma-Aldrich) staining 
and subsequent destaining, RNA quality was measure by the absence or presence of the 
18S and 28S ribosomal RNA bands visualized by UV transillumination using an Alpha 
Imager system. 
 
Absolute quantification of Poln expression 
1 µg of total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life 
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT 
thermocycler and the following Taqman Probe set or primer set with iTAQ SYBR Green 
Supermix with ROX (Bio-Rad, Hercules, CA):  (Poln) FWD 5’-
GATGTACAAGGATGGTTCCACACA-3’, REV 5’-
GCCTACATGGCTTTTTAGTAACACTACAAT-3’, probe 5’-AAAGCCTCCTTGGCGCTCA-3’;   
(Pold1) FWD 5’-TTTGACCTCCCATACCTCATCTCT-3’, 5’-ACGCGGCCCAGGAAAG-3’, 
probe 5’-AAGCGGTCCACCTTTAG-3’ For absolute quantification, titration of 
DEST17/MmPolN and pET/MmPold1 plasmids were used to generate standard curves. 
Transcript abundance was determined by extrapolation from linear regression analysis of 
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best-fit lines from titration experiments. Gapdh was used as an internal control in all 
experiments. 
 
B cell culture and CSR analysis 
B cells were isolated from mouse spleens (n = 6 per genotype) and stimulated for class-
switching, in culture, for 72 h as described in Chapter 2 by Dr. Kevin McBride, Dr. Kei-ichi 
Takata, and Shelley Reh. Dr. Takata prepared genomic DNA from stimulated B cells using 
the DNeasy kit rather than as described in Chapter 2, but was not able to PCR amplify Sµ-
Sγ1 CSR junctions. I repurified the DNA by phenol chloroform extraction and PCR amplified 
Sµ-Sγ1 CSR junctions were amplified as specified in Chapter 2. The resulting product was 
TOPO TA cloned and transformed into Top10 E. coli cells (Life Technologies, Carlsbad, 
CA). Plasmids were purified and sent for sequencing using M13 FWD and REV primers in 
addition to the primers used for PCR amplification. 50 clones for each group were analyzed 
for mutations, deletions, insertions, and sequence overlaps at the junction, and both 30 nt 
upstream and downstream of the junction. p-values were determined by using the two-tailed 
Fisher's exact test. 
 
Generation and complementation of Poln-/- Polq-/- MEFs 
Polq-heterozygous (Polq+/−) mice (Shima et al., 2004) were obtained from Jackson 
Laboratories and were crossed to generate Polq-null mice. Mice were maintained in a 
C57BL/6J background before being crossed with C57BL/6J Poln-/- mice (developed by Kei-
ichi Takata). Double heterozygous mice (Poln+/- Polq+/-) were crossed to yield double 
knockout mice (Poln-/- Polq-/-), which were used for timed pregnancies in order to generate 
MEFs. Isogenic primary MEFs were harvested from 13.5 d pregnant females and cultured in 
a 2% O2 atmosphere. MEFs were then transfected with 1 µg of pSV-Tag (Lange et al., 2012; 
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Sobol et al., 1996; Yousefzadeh et al., 2014) and grown in atmospheric (~20%) oxygen for 
six population doublings to allow for immortalization. 
 
DNA damage sensitivity assays 
Complemented MEF lines were plated in triplicate into white 96 well plates at 1250 cells per 
well and grown overnight using complete media containing puromycin (1 µg/mL). The 
following day, cells were cultured with complete media containing the indicated amounts of 
bleomycin (dissolved in 150 mM NaCl) or mitomycin c (dissolved in ethanol). After 24 h of 
bleomycin treatment, the medium was changed and cells were allowed to recover for 72 h 
before cellular viability was measured using the ATPlite 1Step kit (Perkin Elmer, Waltham, 
MA) using a Biotek plate reader. Cells treated with mitomycin c were incubated in drug for 
48 h before cellular viability was measured. Experiments were repeated three times. Both 
bleomycin and mitomycin c were purchased from Sigma-Aldrich (St. Louis, MO). 
 
POLQ gain of function 
293T cells were plated at 1.5 x105 cells per well in six-well plates and transfected the 
following day with 2 µg of either pCDH/POLQ (Q), pCDH/POLQ-D2330A,Y2331A (P), or 
empty vector control (E).  The next day, cells were plated in triplicate into white 96 well 
plates at 1250 cells per well and grown overnight using complete media.  At 48 h post-
transfection, cells were cultured with complete media containing the indicated amounts of 
bleomycin (dissolved in 150 mM NaCl) for 72 h and cellular viability was measured using the 
ATPlite 1Step kit (Perkin Elmer, Waltham, MA) using a Biotek plate reader.  Experiments 
were repeated three times. 
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Immunoblotting   
For immunoblots, cells were resuspended in 200 µL of 2X SDS loading buffer (4% SDS, 
0.2% bromophenol blue, 20% glycerol, 100 mM Tris HCl pH 6.8, 12% 2-mercaptoethanol) 
and heated at 95°C for 5 min. 20 µL of extract was separated on a 4-20% polyacrylamide 
gel, transferred to PVDF membrane, blocked, and blotted with anti-αTubulin (Abcam, 
Cambridge, UK) ab4074, 1:10,000), anti-FLAG (Sigma F7425, 1:5,000), or anti-POLQ 
(MDACC POLQ20, 1:250) antibodies and corresponding secondary antibodies (Sigma 
A0168, A0545; 1:10,000), and visualized with ECL reagent (Pierce, Rockford, IL). 
 
2X SDS Loading Buffer 
20% Glycerol 
4% SDS 
0.2% Bromophenol Blue 
12% 2-Mercaptoethanol 
100 mM Tris-HCl pH 6.8 
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5.3 Results 
Poln is highly-expressed in testis 
 To obtain a more definitive and precise picture of Poln expression, Poln transcript 
levels were measured using qPCR and absolute quantification (AQ) of Poln in various 
mouse tissues.  Plasmids were obtained for Pold1 and Poln. These plasmids were used in 
respective ABI Taqman assays to create a standard curve of CT values to be able to 
determine absolute quantification of transcript level and copy number for Poln and Pold1.  
qPCR analysis showed that the highest levels of Poln transcripts were found in the testis 
(Figure 20), correlating with prior Northern blot data that suggested Poln expression is only 
easily detectable in the testis (Marini et al., 2003). Thus it appears amongst all the mouse 
tissues surveyed, POLN is most highly expressed in the testis. 
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Figure 20. Absolute quantification of transcript number shows that Poln is highly 
expressed in testis. Total RNA was isolated from necropsied C57BL/6 mice by Trizol (Life 
Technologies). Transcript abundance for Poln and DNA polymerase delta catalytic subunit 
Pold1 was determined by absolute quantification method as described in the Material and 
Methods. Gapdh was used as an internal control to normalize samples. Dr. Kei-ichi Takata 
and MJY isolated tissues, purified RNA and analyzed qPCR data generated by the Science 
Park Molecular Biology Core. 
 
 
POLN does not operate in the POLQ-dependent altEJ pathway  
 Within the past few years Dr. Kei-ichi Takata of the Wood Laboratory has generated 
constitutive Poln knockout mice (data unpublished). Phenotyping of the mice is still ongoing 
and includes everything from aging studies to analysis of cells derived from the mice. Due to 
POLN being related to the POLQ gene family, we hypothesized that POLN could play a role 
in synthesis-dependent end joining pathway in the repair of DNA DSBs as POLQ does 
(Yousefzadeh et al., 2014). To test this hypothesis we performed class switch recombination 
analysis on naïve B cells isolated from Poln-deficient and -proficient mice. The frequency of 
IgG1+ B cells in mice lacking Poln were comparable to levels found in the wild-type mice, an 
observation similar to that observed in the Polq mice (unpublished data, Kei-ichi Takata and 
Richard Wood) (Yousefzadeh et al., 2014).  
In an effort to bias this end joining-dependent pathway to further utilize alternative 
end joining (altEJ), B cells were treated with NU7026, a DNA-PKcs inhibitor that inhibits 
classical non-homologous end joining (cNHEJ). While inhibition of DNA-PKcs does increase 
the frequency of switch as previously noted (Callen et al., 2009), there was no discernable 
difference in switching between genotypes (unpublished data, Kei-ichi Takata and Richard 
Wood). In my analysis of CSR junctions, Poln status, unlike Polq status, has no bearing on 
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the long insertions into CSR junctions that are thought to be altEJ-dependent (Figure 21) 
(Yousefzadeh et al., 2014). Longer insertions that are homologous to nearby sequences are 
still found in the absence of POLN (Figure 21, Table 7). Although POLQ may still play a role 
in DNA repair, it does not appear to function in the SD-EJ pathway of DNA DSB repair. 
 
 
 
Figure 21. Analysis of CSR junctions in Poln mice. Isolated wild-type (WT) 
and Poln−/− (KO) naïve splenic B cells were stimulated for CSR and either mock-treated or 
treated with NU7026. Genomic DNA isolated from B cells of wild-type (A) and Poln KO (B) 
mice was amplified by PCR and 100 Sµ-Sγ1 junctions from each group were sequenced 
and analyzed for overlaps and insertions at breakpoints.  
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Table 7. Sequence composition of >1 nucleotide CSR insertions in Poln mice. New 
mutations (different from the reference sequence) are shown in red. For some longer 
insertions (blue), homologies were identified in the switch region, at the positions indicated 
in the right column. Microhomologies at the junction site are underlined. Sequences 
(graphed in Figure 21) are from wild-type (Poln+/+) and Poln-null (Poln-/-) splenic B cells that 
were treated with NU7026 (Pki) or mock-treated. 
 
 
Neither POLN nor POLQ alter DSB repair capacity or kinetics in the testis 
 Based upon knowledge that both Poln and Polq appear to be highly expressed in the 
testis (Figure 20) (Yousefzadeh et al., 2014), we hypothesized that both enzymes are 
involved in DNA repair in this tissue. The formation of H2AX foci and the resultant p53 
signaling that occurs in mouse testis is known to occur independently of DNA-PK, 
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suggesting that these γH2AX foci are involved in repair pathways outside cNHEJ (Hamer et 
al., 2003). We hypothesize that these foci are formed during altEJ and that POLN, POLQ, or 
both enzymes are required for in vivo DSB repair in the testis of mice. Wild-type, Poln, and 
Polq-deficient mice were irradiated to study dose response, repair over time and check for 
the presence of γH2AX foci in the spermatids of mice. Spermatids are post-meiotic cells and 
thus are no longer undergoing programmed Spo11-dependent DSBs, therefore any observe 
γH2AX foci should reflect DNA damage inflicted by radiation or spontaneous DNA damage 
(Mahadevaiah et al., 2001).   
γH2AX foci found in spermatids could either be the result of DSBs or replication 
stress (Hamer et al., 2003; Mahadevaiah et al., 2001). As expected γH2AX foci increased in  
a dose-dependent manner. Spermatids from the testis of Poln or Polq mice did not display 
an elevated level of γH2AX foci above the wild-type mouse upon x-irradiation (Figure 22A). 
γH2AX foci reached maximum levels at 30 min post-irradiation before returning to pre-
irradiated levels 48 h later (Figure 22B). Both Poln and Polq mice behaved similar to wild-
type mice. This data suggests that POLN and POLQ do not play a prominent role in the 
repair of x-ray-induced DSBs in mouse testis. Note that unirradiated Polq mice do have 
elevated spontaneous levels of γH2AX foci when compared to control mice (Figure 22). 
However it does not appear that POLQ-dependent altEJ plays a significant role in the repair 
of DSBs in the testis. 
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Figure 22.  Loss of Poln or Polq does not dramatically alter DNA repair capacity in 
mouse testis.  (A) Dose response study of wild-type (WT), Poln, and Polq mice. Mice were 
irradiated at the indicated Gy and were sacrificed 0.5 h later.  (B) Time course of DNA 
repair. Mice were irradiated with 2 Gy and sacrificed at the indicated time points.  Testis 
were removed post-mortem and sent for immunohistochemical processing.  γH2AX foci 
were enumerated for 300 spermatids per mouse. 3 mice of each genotype were collected 
per data point, yielding a total of 900 spermatids analyzed for each experimental group. 
Mouse colonies were maintained by Dr. Kei-ichi Takata, Shelley Reh, and MJY. Mice were 
irradiated by Dr. Kei-ichi Takata and MJY and testis were harvested by Dr. Kei-ichi Takata, 
Shelley Reh, and MJY. Histologic preparations were made by the Science Park Histology 
Core and stained for γH2AX and DAPI by the Science Park Histology Core and Shelley 
Reh. Shelley Reh captured 63X immunofluorescence images on DMI6000B Leica 
fluorescence microscope. Dr. Kei-ichi Takata, Shelley Reh, Allegra Abbey, and MJY 
quantified foci. Data were analyzed by MJY. 
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Loss of Poln does not enhance DNA damage sensitivity in Polq-/- cells 
 We hypothesized that deletion of Poln in a Polq-deficient background could 
exacerbate the hypersensitivity to DNA damaging agents seen in Polq-null mouse cells 
(Yousefzadeh and Wood, 2013; Yousefzadeh et al., 2014). Poln-/- mice were bred to Polq-/- 
mice to eventually generate Poln-/- Polq-/- mice. The Poln-/- Polq-/- mice are fertile and no 
gross alterations to testis morphology based on histologic samples, were found (data not 
shown, MJY, Kei-ichi Takata, and Richard Wood). I isolated mouse embryonic fibroblast 
(MEF) lines from these mice and along with the appropriate control cell lines, were exposed 
to bleomycin and mitomycin c and analyzed for cell survival. Unlike loss of Polq, loss of Poln 
did not induce hypersensitivity to bleomycin (Figure 23A). Furthermore, deletion of both 
Poln and Polq did not cause a greater increase in bleomycin sensitivity when compared to 
the Polq-/- MEFs (Figure 23A). These data suggest that POLN and POLQ are not epistatic to 
one another and that POLN does not participate in the same repair pathway as POLQ. Poln 
and Polq single or double knockout MEFs did not exhibit hypersensitivity to the ICL-forming 
agent mitomycin c (MMC) (Figure 23B).  Lack of MMC sensitivity suggests that neither 
POLN nor POLQ function in the HR pathway to repair ICLs. 
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Figure 23. Loss of Poln does not enhance DNA damage hypersensitivity found in Polq 
MEFs.  Poln and Polq-proficient and -deficient MEFs, as well as the newly created Poln 
Polq double KO MEFs (NQ) were plated in 96 well plates and exposed to either (A) 
bleomycin or (B) mitomycin c and cellular ATP levels were measured as a surrogate for cell 
survival. Dr. Kei-ichi Takata and Shelley Reh derived and established the Poln MEFs. The 
Polq MEFs and Poln Polq MEFs were derived and established by MJY. MJY performed 
damage sensitivity assays. 
 
 
 As discussed in Chapter 4, multiple studies have shown that cells lacking POLQ are 
hypersensitive to ionizing radiation and DSB-inducing compounds. POLQ confers resistance 
to DNA damage through its polymerase activities and participates in an altEJ pathway 
(Figure 7, Figure 11-12) (Yousefzadeh et al., 2014). Overexpression of POLQ in the tumors 
of breast cancer patients also confers poorer patient outcomes (Begg, 2010; Higgins et al., 
2010a; Lemée et al., 2010). Coupling these facts together, I hypothesized that the aberrant 
levels of POLQ observed in these breast cancer patients contributes to their poor outcomes 
by making them resistant to DNA damage, possibly through elevated altEJ activity. To test 
the hypothesis that aberrant levels of POLQ induces DNA damage resistance, 293T cells 
were transfected with POLQ expression constructs to express either wild-type POLQ, 
polymerase-dead POLQ, or an empty vector control and assayed for bleomycin sensitivity 
(Figure 24). While empty vector control or polymerase-dead POLQ failed to confer 
additional bleomycin resistance, ectopic expression of wild-type POLQ conferred increased 
resistance to bleomycin. This finding suggests that ectopic levels of POLQ are mediating 
DNA damage resistance in cancer cells through use of its polymerase activity and that 
POLQ may be the rate limiting factor in POLQ-dependent altEJ. 
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Figure 24.  Ectopic expression of POLQ in cancer cells induces DNA damage 
resistance. (A) 293T cells were transiently transfected with pCDH containing no insert (E), 
wild-type POLQ (Q), or polymerase-dead POLQ (P) using jetPRIME (Polyplus) according to 
manufacturer’s specifications.  Cells were then plated in triplicate in 96 well plates and 
exposed to the indicated concentrations of bleomycin for 72 h.  Cellular ATP levels were 
measured for three independent experiments as a surrogate for survival.  (B) 
Representative immunoblot of ectopic POLQ levels at the time of damage.  αTubulin serves 
as a loading control. Cell culture, transfections, immunoblotting, and damage sensitivity 
assays were performed by MJY. 
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5.4 Conclusion and future directions 
 The data presented here show that consistent with previous reports, Poln is highly 
expressed in the testis (Figure 20) (Marini et al., 2003). This suggests that any in vivo 
function for POLN may be detectable only be in the testis. Loss of Poln did not impair class 
switch recombination or alter how the breaks are repaired in B cells (Figure 21). While 
previous observations demonstrate that longer insertions in the CSR junctions of B cells are 
POLQ-dependent (Figure 11) (Yousefzadeh et al., 2014), POLN appears to be dispensable 
for the formation of these long insertions in this cell type (Figure 21, Table 7). Although the 
polymerase domain of POLN shows homology to those of POLQ and Drosophila Mus308, it 
does not appear to operate in the altEJ pathway they do (Figure 21, Table 7) (Chan et al., 
2010; Yousefzadeh et al., 2014; Yu and McVey, 2010). Furthermore, mice lacking Poln do 
not show an increase in DNA damage signaling or a persistence of markers of DSBs after 
irradiation (Figure 22). Mice lacking Polq do show an increase in DNA damage markers, but 
only spontaneously and not upon exposure to ionizing radiation (Figure 22). This finding is 
consistent with previous work showing inherent genome instability as measured by 
micronuclei formation that spontaneously occur both in the cultured cells and the peripheral 
blood of mice lacking Polq (Shima et al., 2004; Yousefzadeh et al., 2014). The lack of 
enhanced or persistent DNA damage signaling in spermatids in the absence of POLQ, could 
be explained by the fact that the POLQ-dependent SD-EJ pathways does not participate in 
the repair of DSBs that occur in murine testis. 
 Prior reports provided evidence of ICL hypersensitivity upon suppression of POLN by 
siRNA in human cancer cell lines (Moldovan et al., 2010; Zietlow et al., 2009). In contrast 
with these published reports, we show that MEFs lacking Poln do not display 
hypersensitivity to MMC (Figure 23B).  This could be a cell-specific effect whereby MEFs 
may not show hypersensitivity if they do not form full-length POLN (the majority of 
transcripts could be non-functional splicing variants) but POLN may still play a role in the 
  115
repair of ICL-mediated DNA damage. Loss of Poln did not enhance the DNA damage 
sensitivity phenotype seen in Polq-null cells and loss of Poln, Polq, nor did both genes did 
not affect MMC sensitivity (Figure 23). These results provide evidence that POLN and 
POLQ are not epistatic with each other and that POLN does not function in the same altEJ 
pathway as POLQ does. Based upon tissue expression data (Figure 20) and a suggested 
function for POLN in homology-directed repair (Kohzaki et al., 2010), a role for POLN in 
meiotic recombination may exist, but any evidence is lacking. 
 We have yet to find an unequivocal phenotype for mice lacking Poln, this may be 
because Poln mice have an extremely subtle phenotype, or the redundancy of other 
specialized DNA polymerases (or other DNA repair pathways) in mammals masks the 
effects of Poln deficiency. The original intent of crossing the Poln mice to the Polq mice was 
that loss of Poln would further stress the Polq mice and allow insight into the in vivo function 
of POLN. Unfortunately, this exacerbation of the Polq phenotype did not occur and leaves 
us with no phenotype for the Poln mice. Though they are related DNA polymerases, POLN 
and POLQ do not appear to have similar functions in the cell. Crossing the Poln mice to 
other mutants like Rev1 mice may give insight as to POLN’s function in the cell. 
 POLN was previously reported to interact with components of the Fanconi anemia 
(FA) pathway (Moldovan et al., 2010) and Drs. Kei-ichi Takata and Junya Tomida found 
interaction between POLN and FANCJ (unpublished data, Drs. Kei-ichi Takata, Junya 
Tomida, and Richard Wood). While we have been unable to detect hypersensitivity of POLN 
to ICL agents, the interaction with FANCJ may still be explained in a plausible fashion 
(Figure 23B). It is known that FANCJ is quite adept at unwinding G-quadraplexes (G4) and 
this activity occurs independently of the rest of the FA pathway (Brosh and Cantor, 
2014). FANCJ could be opening up these G4s for specialized DNA polymerases (like POLN) 
to synthesize through these structures. The lack of a significant detectable phenotype 
in Poln knockouts could be explained through functional redundancy of the polymerases. 
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For example, REV1 is the primary DNA polymerase involved in replicating past difficult G4-
mediated replication blocks in chicken DT40 cells (Sarkies et al., 2012); therefore, deletion 
of Rev1 would lead to the cell using other specialized DNA polymerases like POLN in order 
to replicate G4 sites in DNA. If so, then a severe replicative stress phenotype might be seen 
in mice that lack both Rev1 and Poln. 
 While a role for POLN in the repair of ionizing radiation-induced DNA damage has 
yet to be substantiated, one clearly exists for POLQ. As discussed in Chapters 2 and 4, 
POLQ mediates the repair of DSBs through participation in an altEJ pathway and 
overexpression of POLQ in breast cancer confers poorer outcomes (Lemée et al., 2010; 
Yousefzadeh and Wood, 2013; Yousefzadeh et al., 2014). Preliminary evidence presented 
in this chapter demonstrates that aberrantly high levels of POLQ confer DNA damage 
resistance to cancer cells (Figure 24). This could mimic what is occurring in these breast 
cancer patients with elevated POLQ levels, suggesting that chemoresistance may be the 
mechanism that is conferring their poorer outcomes, but many other genes are also co-
upregulated in cancer. Further analysis is needed to understand the detailed mechanism of 
how POLQ-dependent end joining promotes DSB repair and why elevated POLQ 
expression has a negative impact on patient outcomes in breast cancer. 
  
  117
Chapter 6.  Generation and validation of human POLQ antibodies. 
Note: This chapter discusses the generation of human POLQ antibodies that was discussed 
in Chapter 2 and used in subsequent chapters, in addition to other antibodies that were 
used in the laboratory. 
6.1 Introduction 
 A valuable tool for studying the function of POLQ in cells is an antibody that 
recognizes endogenous POLQ with great specificity.  Until recently, an antibody that 
recognizes endogenous POLQ in immunoblots or for immunoprecipitation studies, was 
unavailable (Fernandez-Vidal et al., 2014).  The Wood laboratory previously produced a pair 
of rabbit polyclonal antibodies (NT and CEN) that were raised against fragments of 
recombinant human POLQ (Seki et al., 2003), but the supply of these two antibodies was 
exhausted.  Our lab endeavored to generate a new series of antibodies against POLQ and 
set upon making monoclonal antibodies in order to create a POLQ antibody that had great 
specificity. 
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6. 2 Material and Methods 
Please note that this section is written as a protocol for persons that may be trying to repeat 
these experimental procedures. 
 
Note on centrifugation: 
Cells were centrifuged in Thermo Sorvall Legend RT+ in Sorvall Heraeus swinging bucket 
rotor at 1000 or 3000 rpm. At the bench top, lysates were centrifuged in an Eppendorf 5424 
R centrifuge at 15000 rpm / 21,000xg. 
Note on lysates: 
All lysates were mixed 1:1 with 2X SDS loading buffer and heat denatured at 95°C for 5 min. 
 
Western Blot Protocol 
Use 4-20% TGX gels from Bio-Rad 
-Run gel at 150 V for 1-1.5 h. 
-Transfer to PVDF Immobilon at 20 V overnight or 30 V for 3 h in transfer buffer (1X Tris-
Glycine + 10% methanol) at 4° C. 
-Block 1 h in 10% milk TBST. 
-Incubate in primary antibody overnight (in TBST, no milk) at the indicated concentration at 
4° C. Antibodies are also stored in 1X TBST with 1:400 dilution of 5% sodium azide. 
-Wash three times in 1X TBST for 5 min. 
-Incubate in secondary anti-mouse (A0168) or anti-rabbit (A0545) antibody (Sigma-Aldrich) 
(1:10,000 dilution in 5% milk TBST) for 1.5-2 h at room temperature. 
-Wash three times in 1X TBST for 5 min. 
-Visualize with ECL. 
 
  
  119
Nuclear Extract Preparation  
Cells are trypsinized and neutralized with media. 
-Pellet cells in Sorvall, 1000 rpm, 5 min, 4°C. 
-Wash pellet with PBS.  Count cell number, need at least 2 x108 cells for extracts, but can 
make larger extract preps. 
-Pellet cells in Sorvall, 1000 rpm, 5 min, 4°C. 
-Wash pellet with Hypotonic Buffer. 
-Pack cells in Sorvall, 3000 rpm, 5 min, 4°C. 
-Add 2 packed cell volumes of Hypotonic Buffer and resuspend cells. 
-Homogenize 10X slowly in 7 mL Wheaton Dounce Homogenizer (Tight).  Check lysis by 
trypan blue staining. 
-Centrifuge in Sorvall 13000 rpm, 15 min, 4°C. 
-Collect supernatant as cytosolic fraction.      ___________ mg/mL 
-Wash pellet in 5-10 volumes of Hypotonic Buffer. 
-Pellet cells in Sorvall 13000rpm, 5 min, 4°C. 
-Resuspend in 2 volumes of Nuclear Extract Buffer. 
-Homogenize 10X slowly in 7 mL Wheaton Dounce Homogenizer. 
-Incubate on rotation for 30”. 
-Spin 13000 rpm, 15 min, 4°C. 
-Collect supernatant as NE1.                            ___________ mg/mL 
 
-Store extract in minus 80 freezer. 
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Hypotonic Buffer     Nuclear Extract Buffer 
10 mM HEPES, pH 7.9    10 mM HEPES, pH 7.9 
10 mM KCl      0.42 M NaCl 
1.5 mM MgCl2      1.5 mM MgCl2 
0.5 mM PMSF      0.5 mM PMSF 
1 mM DTT      1 mM DTT 
       10% Glycerol 
Roche Protease Inhibitor Cocktail Tablet  Roche Protease Inhibitor Cocktail Tablet
        
Notes: 
Roche Protease Inhibitor Cocktail Tablet (Catalog # 11 836 170 001) 
Adapted from (Dignam et al., 1983; Lee et al., 1988). 
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Whole Cell Extract Preparation 
-Resuspend 5 x106 cells in 40 µL of Lysis buffers and incubate on ice in the cold room for 30 
minutes. 
-Centrifuge 13,000 rpm, 15 min, 4°C  
-Collect supernatant as whole cell extract. 
 
Whole Cell Extract Buffer 
50 mM Tris-HCl pH 7.5 
0.25 M NaCl 
1 mM EDTA 
0.5 mM PMSF 
0.1% Triton X-100 
Roche Protease Inhibitor Cocktail Tablet 
Protocol adapted from (Welsh et al., 2004). 
 
Transfection of 293T cells and Crude SDS Lysate Preparation 
-1.5 x105 293T cells were plated into each well of a 6-well dish. 
-The following day, cells were transfected with 2 µg of either pCDH/empty vector control or 
pCDH/POLQ. 
-48 h post-transfection cells from one well of a 6 well plate were resuspended in 200 µL of 
2X SDS Loading Buffer. 
-Heat denature at 95°C for 5 min. 
  
  122
Immunoprecipitation Protocol   
-Plate 1.5 x106 293T cells into four 10 cm dishes with 10 mL of complete media (DMEM). 
-The following day, cells were transfected with 10 µg of either pCDH/empty vector control or 
pCDH/POLQ. 
-48 h post-transfection, scrape cells in 1X PBS. Centrifuge 3,000 rpm, 5 min, 4°C. 
-Resuspend cells in 200 µL per dish in IP Lysis Buffer.  Vortex for 30 seconds and agitate in 
the cold room for 15 minutes. Centrifuge 13,000 rpm, 15 min, 4°C. 
-Collect supernatant.  Determine concentration.   ___________ mg/mL 
-Collect 25 µL and add 1:1 volume of 2X SDS Lysis Buffer. Heat denature at 95°C for 5 m. 
-Wash 50 µL (per sample) FLAG-Dynabeads three times in IP Buffer. 
-Use 5 mg of protein in 2 mL total volume for IP. Incubate overnight on rotation in cold room. 
-Wash 3X in IP Wash Buffer. 
-Add 50 µL of 2X SDS Lysis Buffer to beads and heat denature at 95°C for 5 m. 
-Transfer liquid to new tube and freeze. 
-For immunoblot:  Load 10 µL of input (30 g total protein) and 25 µL IP product. 
 
IP Lysis Buffer    IP Buffer   IP Wash Buffer 
 
50 mM Tris-HCl pH 7.5  50 mM Tris-HCl pH 7.5 50 mM Tris-HCl pH 7.5 
0.15 M NaCl    0.15 M NaCl   0.15 M NaCl 
1 mM EDTA    1 mM EDTA   1 mM EDTA 
0.5 mM PMSF    0.5 mM PMSF   0.5 mM PMSF 
1% Triton X-100   0.2% NP-40   0.2% NP-40 
Please add a Roche Protease Inhibitor Cocktail Tablet to each buffer before use. 
 
Adapted from protocol of Arijit Dutta of Sankar Mitra’s Lab (Houston Methodist Research 
Institute). 
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Immunofluorescence 
-1.5 x104 293T cells were plated into 4-well chamber slides (LabTek). 
-The following day, cells were fixed in 2% p-formaldehyde for 10 min at room temperature. 
-Rinse slides with 1X PBS. 
-Permeabilize cells in 1X PBS + 0.2% Triton X-100 for 2 min at room temperature. 
-Block for 30 m in 1X PBS + 0.2% Triton X-100 + 5% BSA at room temperature. 
-Dilute primary antibody to 1:100 in 1X PBS + 0.2% Triton X-100 + 5% BSA and incubate 
overnight at 4°C. 
- Wash slides in 1X PBS + 0.2% Triton X-100 for 5 min at room temperature. 
- Dilute secondary antibody (Molecular Probes Anti-mouse AlexaFluor-488) to 1:1,000 in 1X 
PBS + 0.2% Triton X-100 + 5% BSA and incubate 1 h at room temperature. 
- Wash slides in 1X PBS + 0.2% Triton X-100 for 5 min at room temperature. 
-Mount with Vectashield + DAPI (Vector Labs) [Note dilute Vectashield + DAPI 1:5 in 
Vectashield without DAPI.  Or better yet, just DAPI stain and wash to clear up heavy DAPI 
background.]. 
-Paint edges of slides with nail polish. 
Adapted from (Bhagwat et al., 2009). 
 
2X SDS Loading Buffer 
20% Glycerol 
4% SDS 
0.2% Bromophenol Blue 
12% 2-Mercaptoethanol 
100 mM Tris-HCl pH 6.8 
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6.3 Results 
Matthew Hogg of Sylvie Doublié’s laboratory (Univ. of Vermont) graciously provided 
us with a fragment of recombinant POLQ (Figure 25A) that possessed polymerase activity 
(Hogg et al., 2011). This recombinant fragment was expressed in E. coli and was used to 
generate antibodies against POLQ.  The MDACC antibody core and Epitomics respectively 
generated the mouse and rabbit monoclonal antibodies, respectively.  A SUMO3 fusion tag 
protein made from the same vector (Life Sensors) as the recombinant fragment was sent to 
both sites as a control protein for ELISA screening.  Over 80 mouse hybridoma clones that 
were positive by ELISA were provided to me for further screening (Figure 25B).  I 
immunoblotted the recombinant protein fragment used to immunize the mice with the 
supernatants from the hybridoma clones (Figure 25B) and narrowed the selection down to 
13 different mouse monoclonal antibodies that underwent further purification and analysis 
(Table 8).  The rabbit monoclonal antibodies were screened in a similar fashion (Figure 
25C).  The purified mouse monoclonal antibodies were then screened against whole cell 
and nuclear extracts from various cell lines (Figure 25D-F) as well as recombinant full-
length POLQ (Figure 25G).   
Each monoclonal antibody recognizes a band larger than 250 kDa that might 
represent full-length POLQ.  Attempts to determine whether any of these bands are 
endogenous POLQ by siRNA suppression have yielded variable results (Figure 25H). Each 
of the monoclonal antibodies was epitope mapped by Shelley Reh using peptide arrays from 
JPT (Figure 26, Table 8).  The POLQ20 antibody was predominantly used for 
immunoblotting in the laboratory because it maps near motif 1 and insert 1 of the 
polymerase domain of POLQ (Figure 26, Table 8), and provides high sensitivity and low 
background on immunoblots. It may be useful for immunoprecipitation experiments (Figure 
25F-I).  The POLQ20 antibody is able to recognize recombinant human POLQ, high 
molecular weight bands (>250 kDa) in whole cell extracts that could be consistent with 
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endogenous POLQ. POLQ20 recognizes no bands that correspond to full-length POLQ 
when immunoblotted against extracts made from MEFs (Figure 27). All mouse monoclonal 
hybridoma cell lines are stored at the MDACC monoclonal antibody core facility in Houston 
and purified POLQ monoclonal antibodies are stored in my -80° C storage.  A monoclonal 
antibody against POLQ (pol θ 1B1) provided by Jean-Sebastién Hoffman was screened with 
various extracts and recognizes a band very similar to the POLQ20 (Figure 28) (Fernandez-
Vidal et al., 2014). This antibody is able to recognize recombinant POLQ but recognizes 
higher molecular weight bands sporadically upon very high levels of exposure, making it a 
less than ideal antibody for use. 
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Figure 25.  Screening of human POLQ antibodies.  (A) Schematic of the QLH fragment of 
POLQ that was used to immunize rabbits and mice to generate monoclonal antibodies. (B) 
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Primary screening of raw mouse monoclonal supernatants by immunoblotting against 150 
ng of purified QLH fragment. + symbols below immunoblots represents the initial ELISA 
analysis of monoclonal antibodies (++++ being the highest score and + being the lowest 
score.  (C) Rabbit monoclonal supernatants from Epitomics were similarly screened. (D) 
Purified monoclonals, including one from Jean-Sebastién Hoffman are immunoblotted 
against 75 µg of RKO whole cell extracts (WCE).  POLQ83 and POLQ20 mouse monoclonal 
antibodies were screened against (E) 100 µg WCE from HeLa and 293T cells, (F) 35 µg 
nuclear extract 1 and 100 µg WCE from 293T cells, and (G) 10 µL of recombinant POLQ 
preps purified from baculovirus-infected insect cells.  (H) RKO cells were transfected with 
non-targeting siRNA (siCTRL), a pool of 4 siRNAs (siPOLQ), or a single siRNA (siQ6) 
against POLQ. WCE were made 48 h post transfection and 100 µg were immunoblotted with 
the POLQ20 mouse monoclonal antibody.  The band below just above the 250 kDa marker 
is putatively thought to be POLQ.  (I) Immunoblot of FLAG-IP experiment with 293T cells 
transiently transfected with either pCDH/POLQ or empty vector control.  Arrow denotes full-
length POLQ. All gels are 4-20% polyacrylamide gels (E is a 5% polyacrylamide gel). 
 
 
 
Antibodies    Epitope      Amino Acid # 
MOUSE MONOCLONAL ANTIBODIES1 (MDACC ANTIBODY CORE) 
 
POLQ20*   (REMKN)    2147:2151 
POLQ5    (QPGESYLFGS)   1767:1776 
POLQ12    (QPGESYLFGS)   1767:1776 
POLQ16**    (PRDFEIKMP)   2246:2254  
    (LNTGADVFRS)   2345:2354 
POLQ35    (VNPWK)    1757:1761 
POLQ46 (TSASK)    1742:1746  
(QPGESYLFGS)   1767:1776 
POLQ58   (VNPWK)    1757:1761 
POLQ78   (VNPWK)    1757:1761 
POLQ81   (VNPWK)    1757:1761 
POLQ83**   (PRDFEIKMP)   2246:2254  
    (LNTGADVFRS)   2345:2354 
POLQ88   (VNPWK)    1757:1761 
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Hoffman antibody from 2014 Nature Communications 
    Antigen 
pol θ 1B1   (CSIFRARKRASLDINKEKPG)  983:1002 
 
 
RABBIT MONOCLONAL ANTIBODIES2 (EPITOMICS) 
 
MDA7-8-4   (N/A) 
MDA7-8-8   (N/A) 
MDA7-8-12   (N/A) 
MDA7-14-6   (N/A) 
MDA7-14-7   (N/A) 
MDA7-14-8   (N/A) 
MDA7-15-2   (N/A) 
MDA7-15-7   (N/A)  
MDA7-15-8   (IGFSTAECESQKHIM)  2092:2106 
MDA7-16-2   (N/A)  
MDA7-16-6   (N/A) 
MDA7-16-8   (N/A) 
MDA7-36-2   (N/A) 
MDA7-36-7   (N/A) 
MDA7-36-8   (N/A) 
MDA7-37-7   (N/A) 
MDA7-37-8   (N/A) 
MDA7-37-10   (N/A) 
 
 
RABBIT POLYCLONAL ANTIBODIES3 (CELL SIGNALING TECHNOLOGIES) 
 
CST PP3*** 
CST PP16**** 
CST PP27*** 
CST PP28*** 
CST PP36***** 
 
RABBIT POLYCLONAL ANTIBODIES4 (BETHYL LABORATORIES) 
 
BL18474 
BL18475 
BL18476 
BL18477****** 
 
1I typically use the mouse monoclonal antibodies at a dilution between 1:250-1:500 for 
western blotting and the pol θ 1B1 mouse monoclonal antibody and the rabbit polyclonal 
antibodies are recommended for use at 1:10,000 and 1:1000 dilutions.  Epitopes to human 
POLQ are listed above, amino acid in red denote deviations from homology between human 
and mouse POLQ. 
*Best antibody for western blotting, it is the most sensitive of the panel and has the least 
background. 
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**Both POLQ 16 and POLQ83 epitope map to where the secondary antibody control binds 
on the QLH fragment but with much greater affinity. 
 
2Rabbit monoclonal hybridoma lines that were raised against the QL fragment by Epitomics 
are currently stored in liquid nitrogen storage on site and with Cryogene.  All of the 
hybridomas recognize a high molecular weight band in 293T cells that could be consistent 
with full length POLQ.  Of these antibodies MDA7-15-8 was selected and sent to the 
MDACC antibody core for ascites production and purification and epitope mapping.  The 
rest of the rabbit monoclonal antibodies still need to be epitope mapped for future use. 
 
Epitomics clones are described by Project #-Original hybridoma clone #-Subclone #. 
Therefore for MDA7-15-8, it is the 8th subclone of original clone 15 for the MDA7 project. 
These hybridomas were generated from a single rabbit. 
 
3Rabbit polyclonal antibodies were generated by Cell Signaling Technologies using multiple 
unknown peptide sequences of POLQ.  Purportedly PP36’s epitope is conserved between 
human and mouse.  PP36 recognizes recombinant POLQ but with a lower affinity when 
compared to the POLQ20 mouse monoclonal antibody.  All of the antibodies recognize 
recombinant POLQ seen in lysates from 293T cells transfected with either empty pCDH 
vector or pCDH/POLQ by MJY. As of July 2014 the rabbits producing the PP16 and PP36 
were moved into the monoclonal antibody production pipeline. 
***PP3, PP27, and PP28 appear to be unsuitable as they fail to recognize bands above 
~250 kDa in 293T and HeLa extracts. 
**** PP16 antibody has a high background.  
*****PP36 recognized a high molecular weight band that may be endogenous POLQ in 293T 
cells but not in HeLa cells. 
 
4Rabbit polyclonal antibodies were generated by Bethyl Laboratories using multiple 
unknown peptide sequences of POLQ.  Purified antibody was sent to us and used at a 
1:5,000 dilution for immunoblotting.  
******BL18477 did not recognize recombinant POLQ in lysates from 293T cells transfected 
with pCDH/POLQ.  I would not recommend using this antibody. 
 
Table 8:  Human POLQ antibodies. Epitope sequences and amino acid numbers are 
shown for each antibody.  Amino acid residues in red are those that differ between human 
and mouse. 
  
  130
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
hao
s1
M
otif
 1
Inse
rt
 1
M
otif
 2
Inse
rt
 2
M
otif
 3
M
otif
 4
M
otif
 6
In
se
rt
 3 M
otif
 5
P
olym
e
rase
 D
o
m
ain
~C
e
ntral
 D
o
m
ain
1740
2590
PO
LQ
20
(2147
:2151)
PO
LQ
16/83
(2246
:2254)
PO
LQ
16/83
(2345
:2354)
M
D
A7
-15
-8
(2092
:2106)
PO
LQ
46/77
(1742
:1746)
PO
LQ
35/58/78/81/88
(1757
:1761)
PO
LQ
5/12/46
(1767
:1776)
H
offm
a
n
 polθ
-1
(983
:1002)
im
m
u
n
oblotting
H
offm
a
n
 polθ
-2
(1714
:1733)
im
m
u
n
op
re
cipitatio
n
A
B
C
  131
Figure 26.  Epitope mapping of human POLQ antibodies.  JPT epitope mapping 
microarray containing peptides that correspond to the antigen sequence is diagramed (A) 
where 11 amino acid peptides are covalently attached to slide. (B) These peptides overlap 
by 7 amino acids (shown in red) with the preceding peptide in order to specifically determine 
the epitope site for each of the antibodies that were mapped. (C) Schematic of the QLH 
fragment of POLQ showing the location of where each monoclonal antibody maps.  Amino 
acid numbers of epitope sites are shown in parentheses with the corresponding antibody. 
Epitope mapping was performed and analyzed by Shelley Reh and MJY. 
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Figure 27. Screening of human POLQ rabbit polyclonal antibodies from Cell Signaling 
Technologies. POLQ20 mouse monoclonal antibody and three rabbit polyclonal antibodies 
raised against POLQ peptides (CST3, CST16, CST36) were immunoblotted with:  10 µL of 
crude SDS lysates from 293T cells transfected with either pCDH/empty vector control or 
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pCDH/POLQ; 100 µg WCE from 293T, RKO, Polq-proficient (+/+) and deficient (-/-) mouse 
embryonic fibroblasts. 
 
 
 Recently we have collaborated with Cell Signaling Technologies (CST) on human 
POLQ antibodies (Table 8).  We received multiple rabbit polyclonal antibodies raised 
against different POLQ peptides for validation (CST PP 3, 16, 36).  Each of the three 
antibodies recognized recombinant POLQ, as did the control mouse monoclonal POLQ20 
antibody (Figure 27).  The antibodies also recognized bands above 250 kDa in whole cell 
extracts but were unable to recognize a band specific to endogenous mouse POLQ.  As of 
September 2014, CST was utilizing our data to move the antibodies into their monoclonal 
antibody production pipeline. 
Human POLQ rabbit polyclonal antibodies from Bethyl Laboratories were also 
screened in the laboratory (Table 8).  Three of the four antibodies provided by Bethyl 
Laboratories recognized recombinant POLQ (Figure 28), as did the mouse monoclonal 
antibody controls (POLQ20, pol θ 1B1).  The Bethyl antibodies yield a high amount of 
background using the specified conditions and would need further purification (affinity 
purification with recombinant POLQ) or dilution before further use. 
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Figure 28. Screening of human POLQ rabbit polyclonal antibodies from Bethyl 
Laboratories. POLQ20 and pol θ 1B1 mouse monoclonal antibodies and four rabbit 
polyclonal antibodies (BL18474-7) raised against POLQ peptides by Bethyl Laboratories 
were immunoblotted with 3 µL of crude SDS lysates from 293T cells transfected with either 
pCDH/empty vector control or pCDH/POLQ. 
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Figure 29. Cell staining and immunofluorescence with human POLQ antibodies.  293T 
cells were fixed and stained with the indicated mouse monoclonal antibodies and AlexaFluor 
488 conjugated secondary before stained with DAPI and imaged. 
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6.4 Conclusion and future directions 
Moving forward, there are many applications for which these antibodies against 
POLQ could be of great use.  These antibodies would be useful for immunofluorescence 
(Figure 29), immunoprecipitation (Figure 25I), and potentially immunohistochemical staining 
of human tissues.  However, further validation of these antibodies is needed and proper 
POLQ human knockout cell line would be vital to confirm specificity of these antibodies.  Dr. 
Kei-ichi Takata and Mrs. Shelley Reh (Wood laboratory) are currently generating POLQ 
human knockout cell lines.  These cell lines could be the key reagent to screening the POLQ 
antibodies to find an antibody clone that recognizes POLQ with great sensitivity and 
specificity.  Then a validated antibody could be used to further determine subcellular 
localization of POLQ, its interaction partners, and potentially any relevant post-translational 
modifications that modulate its activity.   
As it stands, the POLQ20 mouse monoclonal antibody appears to be the most 
suitable for detecting human POLQ. This is based upon the high degree of sensitivity and 
modest background levels observed when immunoblotting with this antibody as well as its 
ability to recognize recombinant human POLQ and high molecular weight bands in an 
extract (Figure 25, Figure 27). Only POLQ20 and POLQ83 mouse monoclonal antibodies 
have been used in the immunoblotting of extracts made from MEFs. While both antibodies 
recognize high molecular weight bands, they do not appear to be specific to POLQ. The 
possibility that one of other mouse monoclonal antibodies against POLQ that were 
generated by the MD Anderson Monoclonal Antibody Core recognizes endogenous mouse 
POLQ is possible as they have not been immunoblotted with extracts from the MEFs. My 
frank suggestion is avoid using the pol θ 1B1 mouse monoclonal antibody. It does not 
reliably recognize high molecular weight bands in whole cell extracts of Polq MEFs or 
HCT116 cells. Until a POLQ antibody has been properly vetted we must maintain a healthy 
dose of skepticism with regard to immunoblotting results with antibodies against POLQ 
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Chapter 7. Future directions. 
7.1 POLQ maintains genomic integrity through its altEJ activity 
 Genetic screens have shown that POLQ and its homologs in C. elegans and 
Drosophila are key components of an alternative end joining pathway that facilitates the 
repair of DNA double strand breaks (DSBs) (Figure 5, Figure 12) (Koole et al., 2014; 
Yousefzadeh et al., 2014; Yu and McVey, 2010). This repair pathway, termed synthesis-
dependent end joining (SD-EJ) or synthesis-dependent microhomology-mediated end 
joining (SD-MMEJ), relies upon POLQ-dependent DNA polymerization to extend 
enzymatically-processed 3’ DNA ends to create a novel microhomology. This homologous 
region can then anneal to the other 3’ end from the DSB (Yousefzadeh et al., 2014). This 
complex nucleotide insertion relies upon the presence of a free 3’ end (whether it be from 
the other end of the break or from another free DNA end) to provide a suitable template for 
creating the “insertion” (Chan et al., 2010; Yousefzadeh et al., 2014; Yu and McVey, 2010). 
This alternative end joining pathway appears to be suppress to the formation of large 
deletions and chromosomal translocations (Roerink et al., 2014; Yousefzadeh et al., 2014). 
Consistent with this idea, we observed a four-fold increase in the frequency of Myc/IgH 
translocations murine B cells deficient for Polq (Yousefzadeh et al., 2014).  
This finding call into question the current paradigm that alternative end joining in toto 
is responsible for the formation of potentially oncogenic translocations. Many oncogenic 
translocations found in patients contain microhomologies in their breakpoint junctions 
(Bunting and Nussenzweig, 2013; Weinstock et al., 2006). The subset of broken DNA ends 
that ultimately give rise to chromosomal translocations are hypothesized to be formed 
primarily through the microhomology-mediated end joining pathway (MMEJ) subpathway 
(Bunting and Nussenzweig, 2013). MMEJ relies upon the broken DNA ends annealing at 
existing microhomologies with only minimal end processing (flap trimming, gap filling, 
ligation) (Decottignies, 2013). The POLQ-dependent altEJ pathway, which prevents 
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translocations, is distinct from the MMEJ repair pathway that promotes chromosomal 
translocations. While no definitive data have been presented to suggest that POLQ has a 
role in MMEJ, we cannot exclude this possibility. We observed a ten-fold decrease in the 
repair of substrates with 3’ DNA ends containing 4-nucleotide terminal microhomologies in 
when Polq was absent (Figure 12) (Yousefzadeh et al., 2014). This finding still allows for a 
role for POLQ in MMEJ in addition to SD-EJ which is supported by recent biochemical 
evidence showing that POLQ can perform MMEJ with substrates that contain 3’ single-
stranded overhangs with at least two nucleotides of homology (Kent et al., 2015). 
Why chromosomal translocations form in the absence of POLQ is still unclear. 
Translocations could form because in the absence of POLQ:  (1) DNA breaks persist and 
eventually free 3’ DNA ends find each other and anneal at a microhomology to create a 
translocation or (2) there is a class of DNA ends that is preferentially handled by POLQ-
dependent SD-EJ and are those that form translocations in the absence of POLQ. Further 
analysis of translocations as proposed in Chapter 3 of this thesis will help clarify how these 
translocations are formed. A recent study, reported a decrease in insertions at an artificial 
translocation generated by CRISPR/Cas9 in Polq-null MEFs, however the overall frequency 
of translocations was decreased in the absence of Polq (Mateos-Gomez et al., 2015). It 
would be interesting to know how POLQ status affects translocations at naturally occurring 
breaks versus those that are generated through site-specific nucleases. 
NGS studies of translocations that occur in mice lacking Tp53 and Polq may 
demonstrate preferential genomic sites, secondary structures, and sequence specificity that 
facilitates Myc/IgH translocations. Human knockout cell lines, currently being developed by 
Kei-ichi Takata, could provide insight into the apparent dichotomy that altEJ drives for in vivo 
translocations in mice, whereas, cNHEJ drives translocations in human cell lines (Ghezraoui 
et al., 2014). 
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 By understanding which proteins POLQ interacts with, we may gain a better 
understanding as to how POLQ operates in SD-EJ and the repair of DSBs. So far POLQ 
has only been shown to interact with the replication origin proteins ORC2 and ORC4 
(Ramiro et al., 2007). Preliminary data from our collaborator, Dr. Sankar Mitra (Houston 
Methodist Research Institute), suggests that POLQ interacts with the DNA repair protein 
XRCC1. XRCC1 is known to interact with DNA Ligase III and DNA polymerase β (Rice, 
1999), and the XRCC1-pol β interaction is regulated by HSP90 (Fang et al., 2014). 
Therefore further investigation of the putative POLQ-XRCC1 interaction may also lead to 
discovery that HSP90 also interact interacts with POLQ. A proteomics approach to 
understand the role of POLQ in altEJ is well warranted. Many of the other key proteins 
involved in altEJ (MRN complex, PARP, XRCC1, DNA Ligases I and III) are also involved in 
other DNA repair pathways and thus make genetic analysis more difficult to tease out the 
effects on altEJ (Decottignies, 2013). Phenotypes of certain genetic crosses with Polq (ex. 
XRCC6) could be problematic as loss of both Atm and Polq causes synthetic lethality in 
mice. Understanding the detailed mechanism of alternative end joining pathways will give 
better clarification to how these pathways act and the regulation of alternative end joining 
with respect to classical non-homologous end joining and HR repair of DNA double-strand 
breaks. 
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7.2 POLQ diversifies the immunological portfolio 
 DNA polymerases play a vital role in adaptive immunity in order to help mammals 
cope with a multitude of pathogenic insults. Following VDJ recombination, the variable 
regions of immunoglobulin genes are further diversified through the somatic hypermutation 
pathway (SHM). SHM relies upon AID-catalyzed deamination of cytosine to generate uracils 
in the variable region that are processed by UNG to yield abasic sites that are further 
enzymatically processed. These nucleotide gaps are then filled in by specialized DNA 
polymerases (Weill and Reynaud, 2008). POLQ was thought to generate most of the A/T 
mutations found in the variable region of murine B cells, but upon later examination, this 
class of mutations was largely pol η-dependent (Martomo et al., 2008; Seki et al., 2005). A 
role for POLQ in SHM may exist whereby POLQ is required to generate SHM-associated 
indels, as discussed below. 
 Class switch recombination (CSR) is a programmed break rejoining in the constant 
region of the immunoglobulin locus. This mechanism allows isotype switching enabling 
antibodies to interact with different effector molecules without modifying antibody specificity 
(Bunting and Nussenzweig, 2013; Weill and Reynaud, 2008). Investigation of POLQ function 
in CSR showed that although cells lacking POLQ continue to switch at a normal frequency 
compared to their wild-type counterparts, the junctions are different (Martomo et al., 2008; 
Yousefzadeh et al., 2014). Sequencing of the Sµ-Sγ1 junctions showed that up to 10% of 
CSR junctions in wild-type mice contained insertions longer than a single nucleotide, and 
these insertions were dependent upon POLQ (Figure 11) (Yousefzadeh et al., 2014). Such 
insertions form in an altEJ dependent manner (Callen et al., 2009). Our findings support that 
these insertions arise from POLQ-dependent SD-EJ (Yousefzadeh et al., 2014). Consistent 
with prior findings, we identified also homologies to nearby sequences around the break in 
these longer insertions (Table 4) (Callen et al., 2009; Yousefzadeh et al., 2014). At least for 
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CSR junctions, POLQ is responsible for creating the inserted sequences but it may be 
creating insertions elsewhere in immunoglobulin genes. 
 Insertions and deletions (indels) that form as a result of SHM, termed SHM-
associated (SHA-) indels, represent an understudied but important mechanism of 
immunological diversity. While most of the purposeful mutations that arise in SHM are point 
mutations, indels are observed in variable regions at a low frequency (2-6%) (Briney et al., 
2012; Wilson et al., 1998). These indels, which are created through AID-mediated breaks, 
are thought to be a radical new way in which to further evolve our antibody repertoire 
(Bowers et al., 2014). Currently, it is unknown which polymerase(s) induce these indels in 
the V regions. However, given that long insertions found in CSR junctions are POLQ-
dependent (Yousefzadeh et al., 2014) given evidence that POLQ can cause frameshifts in 
vitro (Arana et al., 2008), we hypothesize that POLQ is the DNA polymerase responsible for 
the creation these SHA-indels. 
 SHA-indels are commonly found in the complementarity determining region of 
antibodies. This is the region where the antibody interacts with the antigen. On rare 
occasions these SHA-indels are found in the antibody framework regions, which act as the 
structural scaffold for the antibody (Klein et al., 2013). Indels in the framework regions are 
generally poorly tolerated, but in rare instances they give rise to unique antibody abilities.  
One such unique ability is the creation of broadly neutralizing antibodies. Broadly 
neutralizing antibodies that feature nucleotide insertions in their framework regions are 
responsible for highly effective responses to pathogens like influenza, HIV-1, and S. 
pneumonia (Krause et al., 2011; Reason and Zhou, 2006; Yu et al., 2008).  These 
framework indels are thought to create new and unconventional ways for antibodies to 
interact with antigens and notably, deletion of these indels ablates their broadly neutralizing 
capacity (Klein et al., 2013). Whether POLQ is involved in this rare but distinct mechanism of 
increasing immunological diversity remains to be seen.  The NGS experiments proposed in 
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Chapter 3 will investigate the whether POLQ regulates the formation of SHA-indels, 
including those that occur in the framework region in B cells proficient. If POLQ does 
contribute to the creation of these indels in either the CDR or framework regions, then the 
regulation of POLQ’s activity will be of great interest in developing new immunotherapeutics. 
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7.3 The impact of POLQ on breast cancer and chemotherapeutics 
 Reports that depletion or loss of POLQ in murine and human cancer cell lines 
caused radiosensitivity, stimulated the idea of POLQ as a potential drug target (Begg, 2010; 
Goff et al., 2009; Higgins et al., 2010b). Upon investigation of replicative stress in breast 
cancer, our lab and collaborators reported that POLQ is the only DNA polymerase that is 
significantly overexpressed in breast cancer. Further, POLQ overexpression is correlated 
with poorer patient outcomes (Lemée et al., 2010). Subsequent reports also show that 
overexpression of POLQ is associated poorer survival rates in early breast cancers. In 
addition they identified specific POLQ SNPs that were associated with hereditary breast 
cancer (Brandalize et al., 2014; Higgins et al., 2010a). Two questions float in the ether 
unanswered right now: (1) If elevated POLQ expression leads to poorer outcomes in breast 
cancer patients, what is the underlying mechanism and (2) if POLQ is of therapeutic value, 
are there particular breast cancer subtypes that would display a greater therapeutic 
response when POLQ is inhibited? 
 I sought to answer the first question of how POLQ causes poorer outcomes by in 
vitro analysis. Preliminary evidence that I present in Chapter 4 demonstrates that ectopic 
expression of POLQ in 293T cells increases resistance to the DNA damaging agent 
bleomycin (Figure 24). This thesis presents evidence to demonstrate a role for mammalian 
POLQ in an altEJ repair pathway that is involved in DSB restitution (Yousefzadeh et al., 
2014). I hypothesize that this bleomycin resistance seen in 293T cells expressing 
recombinant POLQ is through its SD-EJ activity. This is supported by the fact that no DNA 
damage resistance was seen in cells transfected with a polymerase-dead version of POLQ 
and I have shown that the polymerase activity of POLQ is necessary for its DNA damage 
resistance activities (Yousefzadeh et al., 2014). Further analysis is needed to see if this 
DNA damage resistance effect upon ectopic expression of POLQ extends to breast cancer 
cell lines and if increased SD-EJ is occurring in these cells. If ectopic POLQ expression 
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leads to an increase in DNA damage resistance in cell culture models of breast cancer, then 
further analysis using in vivo transgenic mouse models of POLQ would be warranted. I 
would recommend the use of a conditional transgenic (such as STOP-floxed POLQ and 
MMTV-Cre) to combat potential issues that may arise from constitutive gain of function of 
POLQ. 
 With regard to the second question of whether particular breast cancer subtypes are 
more responsive to POLQ inhibition, the Wood Laboratory (with the help of C. Marcelo 
Aldaz) performed a meta-analysis of breast cancer microarray expression data. We found 
POLQ to be highly expressed in triple negative breast cancers (TNBC), which are refractive 
to common therapies (unpublished data, C. Marcelo Aldaz and Richard Wood). We 
hypothesize that by suppressing POLQ by shRNA in TNBC lines we would be able to 
achieve a significant increase in radiosensitivity in these cells. We are also surveying breast 
cancer cell lines with a variety of different cancer genotypes (ER, PR, Her2/neu, p53 status) 
to see if suppression of POLQ would induce hypersensitivity to ionizing radiation (IR). In the 
mean time, we are investigating small molecule inhibitors of POLQ in the hope that if POLQ-
suppression mediates hypersensitivity to IR, that a POLQ-specific inhibitor will cause a 
similar outcome. 
 If inhibition of POLQ induces further radiosensitization of breast cancer cells this 
creates a fantastic therapeutic opportunity. Suppression of POLQ had no effect on a normal 
human cell line (Higgins et al., 2010b), suggesting only limited off target effects in healthy 
tissue. Thus delivery (oral or intravenous) of a POLQ-specific inhibitor to patients would 
make radiotherapy more effective and allow for use of lower doses of radiation. POLQ was 
shown to have as much predictive value for survival outcome for breast patients as CyclinE 
(Lemée et al., 2010), which is currently being used for clinical prognoses (Keyomarsi et al., 
2002). Use of a POLQ antibody (like those presented in Chapter 6) could be useful to 
determine which patient prognosis and which tumor types would be more responsive to 
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POLQ inhibition. To date no POLQ antibody exists to serve that role but we have many 
candidate antibodies that require further validation. While much work remains to investigate 
the role of POLQ in breast cancer outcomes, POLQ presents a novel biomarker that is of 
diagnostic and therapeutic interest. 
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7.4 An “origin”al role for POLQ in DNA replication 
 A recent report demonstrated a role for POLQ in general DNA replication and that 
loss of POLQ altered the firing of replication origin in cells (Fernandez-Vidal et al., 2014). 
This finding, coupled with the data that POLQ interacts with the replication origin proteins 
ORC2 and ORC4, serve as the first suggestions that POLQ operates at the replication fork 
(Fernandez-Vidal et al., 2014). Expression of POLQ correlates with the expression of other 
genes involved in DNA replication and in regulation of the cell cycle (Pillaire et al., 2009). 
Ectopic expression of POLQ induces DNA damage signaling, increased chromosomal 
aberrations, and defective progression of the replication fork (Lemée et al., 2010). In 
Arabidopsis, mutants of the POLQ homolog, TEBICHI, exhibit impairments in meristem cell 
division and differentiation (Inagaki et al., 2009; Inagaki et al., 2006). Furthermore, a recent 
study suggested that in human cells POLQ promotes translesion DNA synthesis through 
thymine glycol adduct (Yoon et al., 2014). These finding add further complexity to the 
function of POLQ in the cell and now when working with POLQ, we must consider its 
activities in replication, repair, and damage tolerance. While these in vitro findings give 
pause for thought, these effects do not appear to have a large-scale effect at the organismal 
level in mice lacking Polq. These mice only display a subtle phenotype of increased 
spontaneous micronuclei (Shima et al., 2004). Therefore, more work is needed to fully 
understand the biological relevance of POLQ’s activities during general DNA replication. 
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7.5 Conclusion 
 DNA polymerase θ (POLQ) is a specialized DNA polymerase for which we are only 
beginning to understand. Studies so far give insight into how this unique enzyme functions 
in cells, but a considerable amount of information about this enzyme is still unknown. 
Further exploration of how and with what other proteins POLQ functions with in alternative 
end joining is required. How the synthesis-dependent end joining pathway, which is 
predicated upon the polymerase activities of POLQ, functions in relation to other DNA 
double-strand break pathways is still unclear. How DNA breaks are channeled into this 
specific pathway in lieu of others is still a mystery. Is the nucleotide insertion activity of 
POLQ salvaging genomic integrity and preventing Myc/IgH translocation formation at the 
cost of creating indels? This is our current hypothesis but additional evidence is needed to 
substantiate this notion.  
 The function of POLQ in other activities besides DNA double-strand break repair is 
intriguing but requires more validation. If POLQ regulates origin firing and replication 
dynamics, it would be valuable to know to what extent and the biological consequences of 
misregulation. Also does POLQ share responsibility for these actions with any of the other 
specialized DNA polymerases remains to be seen. Based on the published literature and 
preliminary data generated in the lab, there are many unanswered questions about POLQ. 
POLQ aids in maintaining a healthy genomic relationship through rejoining broken DNA 
ends by inserting some common ground. We have only a limited knowledge of how it does 
this, temporospatial nature of this activity, and how to exploit POLQ for better therapies. But 
there is much to learn about POLQ and the sky is the limit.
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Appendix 1. Analysis of REV7 in breast cancer and DNA damage sensitivity.  
 DNA polymerase ζ, another specialized DNA polymerase that is studied by the lab, is 
includes REV3L and REV7 that form the catalytic and accessory subunits of pol ζ, 
respectively. Pol ζ is required for viability and defends cells against chromosomal instability, 
as well as suppresses spontaneous tumor formation in vivo (Lange et al., 2011). However, 
how human REV7 interacts with REV3L and the biological consequences of this interaction 
on the human pol ζ complex remains to be clarified. Dr. Junya Tomida of our lab discovered 
that in addition to a previously identified binging site, REV3L also contains a second REV7 
binding motif (Tomida et al., 2015). Further work demonstrated that both REV7 binding sites 
must be present for pol ζ to confer resistance to DNA damage (unpublished data, Junya 
Tomida and Richard Wood). Dr. Tomida also found that reduced REV7 protein levels 
increased the abundance of REV3L and that ectopic expression of REV7 in HeLa cells 
induced mitomycin c (MMC) hypersensitivity compared to the empty vector control 
(unpublished data, Junya Tomida) (Tomida et al., 2015). 
 Previously, I had surveyed expression of a number of DNA repair genes in breast 
cancer cell lines (Figure 19) and found an elevated level of REV7 expression in HCC1806 
cells (Figure 19E, Figure 30A), which is a triple negative breast cancer line that lacks 
functional p53 (Neve et al., 2006). Following this, I surveyed the HCC1806 (REV7 high) and 
MCF7 cell (REV7 low) lines for MMC sensitivity at different time points (Figure 30B). 
Compared to MCF7 cells, HCC1806 cells display greater sensitivity to MMC, however this 
may not be dependent upon REV7 levels alone (Figure 30B). To test the hypothesis that 
elevated levels of REV7 confer DNA damage sensitivity, MCF7 (REV7 low) cells were 
transiently transfected with a recombinant human REV7 expression vector or an empty 
vector control (Figure 30C and D). MCF7 cells that expressed recombinant human REV7 
were much more hypersensitive to MMC than cells containing the empty vector control 
plasmid (Figure 30C). 
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Figure 30. Ectopic expression of REV7 can induce DNA damage hypersensitivity in 
breast cancer cells. (A) Expression of the indicated genes was quantified by qPCR in 
multiple breast cancer cells.  Relative quantification of gene expression was examined using 
Taqman probes. Data was analyzed using the ∆∆Ct method and GAPDH expression was 
used as an internal control. (B) MCF7 and HCC1806 breast cancer cells were treated with 
mitomycin c and surveyed for ATP levels as a surrogate marker of survival at 48 and 72 h 
after damage. (C) Similarly MC7 cells were transiently transfected with either pOZN/empty 
or pOZN/REV7. Transfected cells were replated and treated with the indicated 
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concentrations of mitomycin c and ATP levels were similarly measured 48 h after damage. 
Data reflects three independent experiments. (D) Representative immunoblot of pooled 
crude SDS lysates from the three independent experiments. The asterisk denotes 
endogenous REV7, while the arrow indicates the recombinant N-terminal FLAG-HA-tagged 
REV7. Cell lines were cultured and maintained by MJY. MJY isolated RNA and analyzed 
qPCR expression data that was gathered by the Molecular Biology Core. 
 
 
 Further analysis of these preliminary findings is warranted. Analysis of breast cancer 
outcomes and disease-free survival correlated to REV3L and REV7 levels or analysis of 
tumor samples by REV7 immunohistochemistry is needed. The finding that ectopic 
expression of REV7 increases DNA damage sensitivity in cultured cells should be further 
evaluated by examining increased and decreased levels of REV7 protein in REV7 high 
expressing cell lines, like HCC1806 (Figure 30). If elevated REV7 abundance is found in 
these cells then ectopic expression of recombinant REV7 should have minimal effect protein 
levels are already at a level that is saturating. However, once protein levels reach a certain 
point, it is plausible that protein could become cytotoxic.  Also REV7 levels are tightly 
regulated and shRNA suppression of REV7 could rescue the MMC sensitivity phenotype, 
but only up until a point as REV7-deficient chicken DT40 cells are hypersensitive to MMC 
and cisplatin (Okada et al., 2005). Thus there is a fine balance required in regard to the 
regulation of REV7 levels as too much or too little could pose grave consequences to the 
cell. 
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Material and methods 
Please note that this section is written as a protocol for persons that may be trying to repeat 
these experimental procedures. 
 
Cell lines 
The following cell lines were purchased from American Type Culture Collection:  MCF7, 
MCF10, HCC1569, HCC1599, HCC1806, BT-474, MDA-MB-361, and MDA-MB-436.  Cells 
were STR fingerprinted, checked for mycoplasma contamination, and cultured in their 
appropriate media (Neve et al., 2006). 
 
RNA isolation and qPCR analysis 
Total RNA was isolated from the each of the breast cancer cell lines were analyzed for 
quality and purity using RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of 
total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life 
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT 
thermocycler and the following Taqman Probe set (Bio-Rad, Hercules, CA): REV3L 
(Hs01076848_m1); REV7 (Hs01057448_m1). Data were analyzed using the ∆∆Ct method. 
GAPDH was used as an internal control in all experiments and relative quantification 
analysis was performed with MCF10 cells serving as the non-tumorigenic control. 
 
Transfection of 293T cells and Crude SDS Lysate Preparation 
1.5 x105 293T cells were plated into each well of a 6-well dish. The following day, cells were 
transfected with 2 µg of either pOZN/empty vector control or pOZN/REV7 that was provided 
by Dr. Junya Tomida. 48 h post-transfection cells from one well of a 6 well plate were 
resuspended in 200 µL of 2X SDS Loading Buffer. Lysates were heat denatured at 95°C for 
5 min.  
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2X SDS Loading Buffer 
20% Glycerol 
4% SDS 
0.2% Bromophenol Blue 
12% 2-Mercaptoethanol 
100 mM Tris-HCl pH 6.8 
 
  
  153
Appendix 2.  Analysis of Fam35a expression in murine tissues. 
FAM35A was identified by co-immunoprecipitation/mass spectrometry analysis as an 
interaction partner of human REV7, the catalytic subunit of DNA polymerase ζ (unpublished 
data, Junya Tomida and Richard Wood). Little is known about the protein, but suppression 
of FAM35A in human cancer cell lines induces hypersensitivity to the interstrand-
crosslinking agent mitomycin c and causes elevated levels of DNA damage based on 
enumeration of RAD51 and γH2AX foci (unpublished data, Junya Tomida and Richard 
Wood). To get a better understanding of FAM35A and its role in cells, I surveyed Fam35a 
transcript levels in murine tissues from C57BL/6J mice by qPCR using absolute 
quantification method (Figure 31).   
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Absolute quantification of transcript number shows that Fam35a is broadly 
expressed in tissues. Total RNA was isolated from necropsied C57BL/6J mice by Trizol 
(Life Technologies). Transcript abundance for Fam35a was determined by absolute 
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quantification method as described in the material and methods section. Gapdh was used 
as an internal control to normalize samples. Animal tissue was harvested and isolated for 
RNA by MJY. MJY analyzed qPCR expression data generated by the Science Park 
Molecular Biology Core. 
 
 
 Fam35a is broadly expressed in a number of tissues from mice, with the highest 
expression in the liver. Further analysis (genetic, proteomic, etc.) of this gene in mammals 
will reveal its cellular function and which DNA repair pathways that FAM35A could 
participate in.  
 
Material and methods 
Quantitative real-time PCR analysis of mouse tissues.  RNA was isolated from tissues of 
C57BL/6J mice by Trizol and was analyzed for quality and purity using a RNA 6000 Nano kit 
(Agilent Technologies, Santa Clara, CA).  1 µg of total RNA was used to generate cDNA 
using the High Capacity cDNA RT kit (Life Technologies). qPCR analysis was performed in 
triplicate using the ABI Prism 7900 HT thermocycler and the Fam35a (Mm01209709_m1) 
Taqman Probe and primer set with iTAQ SYBR Green Supermix with ROX (Bio-Rad, 
Hercules, CA). Data were analyzed using the absolute quantification method, where titration 
of pT7T3D-PacI-Fam35a-AA242674 plasmid was used to generate standard curves for 
expression. Transcript abundance was determined by extrapolation from linear regression 
analysis of best-fit lines from titration experiments.  Gapdh was used as an internal control 
for normalization. 
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